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Introduction and Overview 
The work presented in the following chapters covers a period from 1985 to 1992. Progress in 
our understanding the clinical problem of restenosis following coronary angioplasty has been 
slow and has been due not only to our failure to accurately determine the pathophysiology of 
restenosis but also to our inability to understand the limitations of our measurement systems 
in documenting and assessing the process. 
The original restenosis study, conducted at the Thoraxcenter. ·In which au patients were to 
have follow-up angiography at a predetermined time was begun in an era when assessment 
was entirely on a categorical basis, the value of angiographic follow-up questionable and the 
use of quantitative angiography largely unknown amongst clinical cardiologists. The initiative 
to start the study by the Gardiac Gatherisation laboratory and the impetus by Patrick Serruys 
to carry it through reflects an insight into the problem that was well ahead of its time. 
Chapters 2 and 3 detail our understanding of the early results and represent the first attempts 
to move away from the established criteria for assessing restenosis and to make the 
distinction between restenosis as it applies to the individual patient and the assessment of 
restenosis as it applies to populations undergoing coronary angioplasty. Chapter 2 is the first 
publication to delineate the timing of restenosis which prior to this was described as occurring 
within six months, and Chapter 3 is the first to describe the Gaussian distribution of the 
restenosis population, a concept whose importance has only this year been widely 
recognised. 
Chapter 4 represents another major landmark in our understanding of clinical restenosis. 
This was published simultaneously with complementary animal studies and had the effect of 
reversing the considerable resistance to the concept built up over the previous 2 years. The 
distribution of the restenosis parameters, first addressed in Chapter 2, are further developed 
This controversial paper makes the distinction between a sub-optimal angioplasty results and 
late restenosis. It describes new risk factors for restenosis and questions the relevance of 
virtually all previous publications dealing with risk factors related to restenosis. 
The final chapter in this section summarises the developments at the end of the first decade 
of angioplasty and makes recommendations for more appropriate methodology in future 
studies, which are particularly relevant to the assessment of new devices. 
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Part II deals with the application of quantitative angiography as applied to the assessment of 
new devices in general and to stent implantation in particular. The assessment of the clinical 
utility of these devices have been controversial, with disagreement between published 
reports. The failure of investigators to report the benefrts and lim~ations in a clear and 
scientifically precise manners has lead investigators to undertake many unnecessary studies 
subjecting patients inappropriate and inconvenient investigations. Chapter 9 in particular 
conveys a different and more appropriate evaluation of the benefits and complications of 
intracoronary stent implantation. The adoption of concepts developed in Part I, particularly 
the distinction between the dilating effect and the restenosis process. have allowed more 
appropriate evaluation. There is now a much greater acceptance among interventional 
cardiologists of the methods covered in Part 1, and it seems likely that this will lead to a more 
uniform and cohesive understanding of the benefits and limitations. However. the exact way 
in which the results should be documented remains controversial. The proposal put forward 
by the author is dea~ with in Chapter 14. and is the only one that adequately takes into 
account the ~paradoxA of restenosis. 
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Part I 
Populations and Characteristics of coronary angiographic 
variables in patients following angioplasty 
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Chapter 1 
Incidence of restenosis after successful coronary angioplasty: a 
time-related phenomenon. A quantitative angiographic study in 342 
consecutive patients at 1, 2, 3, and 4 months. Circulation 1988; 
77:361-371. 
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THERAPY AND PREVENTION 
CORONARY ANGIOPLASTY 
Incidence of restenosis after successful coronary 
angioplasty: a time-related phenomenon 
A quantitative angiograpbic study in 342 consecutive patients 
at 1, 2, 3, and 4 months 
P. W. SER.RUYS. H. E. LUUTEN. K. 1. BEATI. R. GEUSKENS. P. J. DE fEYI'ER. M. VAN DEN BRAND, 
J. H. C. REIBER. H. J. lEN KATEN. G. A. VANEs. AND P. G. HuGENHOLJZ 
ABSTRACf Data from experimental. clinical. and pathologic studies have suggested that the process 
ofrestenosis begins very early after coronary angioplasty. The present study was performed to determine 
prospectively the incidence of restenosis with use of tbe four National Heart. Lung. and Blood Institute 
and the 50% or greater diameter stenosis criteria. as well as a criterion based on a decrease of0.72 
mm or more in minimal luminal diameter. Patients were recatheterized at 30. 60. 90. or 120 days after 
successful percutaneous rransluminal coronary angioplasty (PTCA). After PTCA all patients received 
10 mg nifedipine three to six times a day and aspirin once a day until repeat angiography. Of 400 
consecutive patients in whom PTCA was successful (<50% diameter stenosis). 342 underwent 
quantitative angiographic follow~up (86%) by use of an automated edge-detection technique. A wide 
variation in the incidence of restenosis was found dependent on the criterion applied. The incidence 
of restenosis proved to be progressive to at least the third month for all except NHLBI criterion II. At 
4 months a further increase in the incidence of restenosis was observed when defined as a decrease 
of 0. 72 mm or more in minimal luminal diameter. whereas the criteria based on percentage diameter 
stenosis showed a variable response. The lack of overlap between the different restenosis criteria applied 
affirms the arbitrary nature of angiographic definitions currently in use. Restenosis should be assessed 
by repeat angiography. and preferably ascertained according to the change in absolute quantitative 
measurements of the luminal diameter. 
Circulation 77. No. 2. 361-371. 1988. 
PREVIOUS STUDIES with exercise thallium~201 
scintigraphy and exercise~gated radionuclide ventric-
ulography performed in asymptomatic patients after 
successful percutaneous transluminal coronary angio-
plasty (PTCA) have suggested that the process of 
restenosis begins early after the procedure. 1- 3 Data 
from experimental, clinical. and pathologic studies 
have indicated that restenosis may occur within 60 days 
via two mechanisms: first. platelet deposition at the site 
of endothelial denudation early after angioplasty (min-
utes to days) can induce spasm and the formation of a 
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mural thrombus, which may subsequently undergo 
organization and cause restenosis4-7 ; second. release 
of platelet-derived gro\1/th factor may induce an exces~ 
sive intimal fibroproliferative response consisting 
mostly of proliferating smooth muscle cells which may 
contribute to late (7 to 150 days) restenosis.5 • S-IS 
It is generally considered that evidence of restenosis 
usually presents itself within 6 months after angio-
plasty. and is extremely infrequent after 12 months. 
However. several angiographic studies have demon~ 
strated that most patients with symptomatic restenosis 
manifest anginal symptoms by the third month after 
angioplasty. l6-::l The timing and incidence of .. silent ... 
restenosis (e.g .. recurrent stenosis without symptoms) 
in the first 3 months after PTCA remains unknown. 
The present study was performed to determine the 
incidence and time to restenosis with the use of six 
different angiographic criteria in a consecutive series of 
patients. For this purpose the study population was 
subdivided into four groups of patients allocated to be 
recatheterized at 30. 60. 90, and 120 days after sue~ 
cessful PTCA, respectively. This approach permits a 
critical assessment of !:he values and limitations of the 
currently used restenosis criteria and raises several 
methodologic issues. including !:hose related to how we 
define and quantify restenosis: should we express our 
quantitative measurements in absolute values or in 
relative percentages? 
Materials and methods 
Study population. The initial cohon of patients consisted of 
400 patients who had undergone successful coronary angio-
plasty. defined as: (1) less than 50% diameter stenosis on visual 
inspection of the postangioplasty coronary angiogr.un obtained 
in multiple views. (2) no in~hospita1 complications. namely 
recurrence of angina. coronary bypass grafting. repeat PTCA. 
acute myocardial infarction. or death. 
Patients with stable and unstable angina pectoris. as defined 
previously_n. :::~were included. Patients with acute myocardial 
infarction were excluded. 
The recruitment period for the study was subdivided into four 
equal time interVals of5 months each. Patients with a successful 
PTCA enrolled during the first time interVal were allocated to 
undergo follow~up angiography at 30 days. the second at 60 
days. the third at 90 days. and the fourth at 120 days. 
Of the 400 patients who met the inclusion criteria. 342 
patients had repeat angiograms suitable for quantitative anal-
ysis. The reasons for failure to complete the study are detailed 
in figure 1. 
Rccathetcrization was considered to be contraindicated for the 
following reasons: disabling concomitant disease (e.g .• renal 
PATIENTS WITH SUCCESSFUL PTCA 
(<50% OSTEN POST-PTCA) 
25 recath. refused 
'----- 1 8 angiogram not suitable 
for analysis 
PATIENTS WITH LATE F/U 
(86% follow-up) 
lesions 
FIGURE l. Total number of patients who menhe inclusion criteria. and 
the IC!Sans forfailUI"I: to complete the study. Dsten "' diameter stenosis: 
FlU "' follow-up; Rec:ath. "' JtCalbctcrization. 
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failure. lung cancer). severe peripheral vascular disease. or more 
than four prior angiographic investigations. 
Of the tota1 srudy population of 342 patients (398Iesions). 93 
patients v.oere scheduled for recatheterization at 30 days (11 0 
lesions). 79 patients at 60 days (89 lesions). 82 patients at 90 
days (93lesions). and 88 patients at 120 days (1061esions) after 
PTCA. 
The baseline clinical characteristics of patients in the four 
groups were comparable for the variables listed in tables 1 and 
2. The mean time from PTCA to follow·up angiography in the 
four srudy groups were 40 days. 61 days. 102 days. and 120 
days. respectively. Patients who were reinvcstigated before their 
preset time because of evidence of recurrent ischemia were 
retained in their initially assigned follow-up group for the pur-
pose of analysis. 
Prior myocardial infarction was defined according to the 
Minnesota code.14 and in the case of conduction abnormality the 
presence of regional akinesia or dyskinesia on the left ventric-
ulogram was used as the criterion. In table 2 the vessels dilated. 
the number of patients with tandem lesions. and the number of 
patients with more than one lesion dilated is listed for each 
follow-up group. 
Metbods 
Coronary angioplasty was performed with a steer.l.blc, mov-
able guidcwire system via the femoral route. Details rebarding 
the procedure used in our laboratory have previously been 
reponed. :a.. :;:~ At the beginning of the angioplasty procedure all 
patients received 10.000 IU of inttavenous heparin. 500 mg of 
inttavcnous aspirin. and a continuous infusion ofRbcomacrodcx 
(low molecular weight dextran) was started. After dilatation 10 
mg nifedipine was given orally every 2 br for the first 12 hr after 
PTCA. and thereafter three to six times a day together with 500 
mg aspirin orally once a day for at least 6 months . .8-blockcrs 
were withdrawn unless hypertension was present. 
Quantitative cor-onary angiography. The quantitative anal-
ysis of the stenotic coronary segments was carried out with the 
computer-assisted Cardiovascular Angiography Analysis ~Sys­
tem (CAAS). which has been described in detail elsewhere. 2!5. u. 
To analyze a coronary arterial segment in a selected frame of35 
mm cinefilm. an optically magnified portion of the image 
encompassing that segment was converted into video format by 
means of a cine-video convener. The contours of the vessel were 
detected :wtomatically on the basis of the weighted sum of first 
and second derivative functions applied to the digitized bright-
ness information. Calibration of the diameter data of the vessels 
in absolute values (mm) was achieved by use of the contrast 
catheter as a scaling device. To tills end. the contours of a 
user-defined portion of the optimally magnified catheter 
(optimal magnification factor 2 j 2) were detected automatically 
and corrected for piDcushion distortion caused by the image 
intensifiers. From the contours. the vessel diameter functions, 
in absolute millimeters. were determined by computing the 
shortest distances between the two contour positions. 
A representative analysis. with the detected contours and the 
diameter functions superimposed on the original video image. 
is shown in figure 2. Multiple matched views. orthogonal if 
possible. were analyzed for each dilated lesion and the results 
were averaged. 
To standardize the method of acquisition and analysis of the 
PTCA and follow-up ang:iograms. the following four measures 
were undcnaken.:;:6 First. the x-ray system was repositioned to 
correspond as much as possible to the projections and settings 
used during the previous angiographies. For this purpose. the 
angular settings of the x-ray gantry and the various height levels 
were readjusted according to the values previously documented 
with the on-line registration system. 
TABLE I 
Clinical characteristics or the 342 patients with suec:essf'ul PTCA entered into the study 
Follow-up period 
30 days 60 days 90 days 120 days Overall 
No. of patienh 93 79 
" 
88 342 
No. of lesions 110 89 93 106 398 
Mean No. of lesions 
dilated/patient l.l8 1.13 Ll3 1.20 1.16 
Age (yr: mean::SDJ 57-z9 57-z9 56=9 57::9 57::9 
(range. 35-75) (range. 31-75) (range. 32-74) (range. 31-74) (range, 31-75) 
Sex ratio (MIF) 5.6 (79114) 5.1 (66/13) 3.3 (63119) 3.9 (70118) ·U 0.78164) 
Ttme from PTCA 40::'::7 61::':: 12 102= 18 120::32 80::38 
to FlU (days) (range. 18-62) (range, ll-80) (range. 33-164) (range. 4-226) (range. 4-226) 
Extent of CAD 
1 vessel 62 (679.:) 56 (71%) 52 (63%) 62 (70%) 232 (68%) 
2 vessels 24 (26%) 13 (16%) 21 (26%) 16 (18%) 74 (22%) 
3 vessel5 7 (8%) 10 (13%) 9 (11%) 10 (11%) 36 (llo/c) 
Previous como.:uy 
bypas~ grafting (n) 9 (10%) 7 (9%) 6 (7<;C) 8(9%) 30 (9%) 
Previous myocardi3..1 
inf.m:tion (n) 40 (43%) 39 (49%) 32 (39%) 30 (34%) 138 (40%) 
Pn::vious coronary 
angiopla:sty (n) 10 (11%) 2 (3%) 11 (13%) 12 (14%) 35 (I Co/c) 
CAD "' coronary artery disease; F/U "" follow-up angiography. 
Second, for all studies cinefrarnes to be analyzed were 
selected at end·diastole to minimize any possible foreshortening 
:md blurring effect. 
Third. the user-determined beginning and end points of the 
major coron:uy segments were identified according to the def-
initions of the American Heart Association.~., 
Finally. Polaroid photographs were taken of the video image 
with the detected contours superimposed to ensure that the 
analyses were performed on the same coronary segment in the 
consecutive angiograms. "Interpolated" percent diameter sten-
osis measurements wen: used. Thls is a method that expresses 
the severity of a coronary obstruction without dependency on 
a user-defined reference region. The principle of this technique 
is the computer estimation of the original vessel diameter at: the 
site of the obstruction. assuming there is no coronary ancry 
disease present. 2:' The interpolated percent diameter stenosis 
TABLE 2 
measurement was obtained by comparison of the minimal lumi-
nal diameter value at the obstruction site with the corresponding 
value of the reference diameter in this position. 
The accuracy of this quantification method has previously 
been validated with Plexiglas phantoms filled with contrast 
medium (Perspex; modds). 28-
De6nitions orrestenosis. To allow comparison of our results 
with those of other published studies and to evaluate the dif-
ferences between various criteria, the following six pm·iously 
proposed definitions of restenosis were applied: (I) an increase 
in diameter stenosis of 3t !east 30% by the time of follow-up 
angiography (National Heart, Lung. and Blood Institute 
{NHLBI) I). (2) an immediate post-PTCA diameter stenosis of 
less than 50% increasing to greater than or equal to 70% at 
follow-up (NHLBI II). (3) an increase in stenosis severity to 
within I 0% or less of the predilat:ation diameter stenosis at the 
Ves:sd dilated. number of pat~ts witb tandem lesions. and number or patients with more tboo one lesion dilated in each 
or the four study groups 
Rtllow-up period 
30 days 60 days 90 days 120 days 0-<=11 
!%) 
" 
(%) 
" 
{%) (%) (%) 
Vesseldtlau:d 
LAD 61 (56) 61 (69) 
" 
(59) 62 (58) :!39 !60) 
LCX 18 (16) 16 (J8) 19 (20) 16 (15) 69 (17) 
RCA 26 (24) II (12) 16 (17) 23 (22) 76 (19) 
Bypass 4 (4) 0 !OJ (2) 4 (4) 10 (3) 
LMCA I (!) (!) (!) I Ill 4 Ill 
No. of patien~ with tandem lesion 6 
"' 
2 (3) 2 (2) 5 (61 15 (4) 
No. of patien~ with more than one le1;ion dilated 15 (16) 10 (13) 10 (12) 18 (20) 53 (15) 
Bypass "' aonocoron.ary bypass graft; LAD : left ant~rior descending coronary artery: LCX = l~ft circumflex coronary 
artery; LMCA = left main coronary artery; RCA = right coronary artery. 
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FIGVRE 2. A single-fr.:une angiogram of a left coronary artery with 
superunposition of the automated contour5 at the coronary artery seg-
ment of interest. Beneath this is sh0"'1l the chameter function of the 
detected contours of the left anterior dcsce:ndi."lg coronary artery. The 
mini.J:n;llluminal diameter (verticallir:le) is 1.29 mm. co=spondin~ to 
a diameter stenosis of 69% and an are::t Stenosis of 90SC. 
time of follow-up angiography (NHLBI ill). (4) a loss of at least 
507C of the gain in luminal diameter achieved at PTCA (NHLBI 
IV). (5) an increase of the diameter stenosis from less than 50% 
after angioplasty to greater than or equal to 50% at follow-up. 
and (6) a decrease in minimal luminal diameter of greater th.:m 
or equal to O.i:2 rrun v.ith respect to the post-PTCA siruation. 
This last definition is based on the variabilirv of minimal luminal 
diameter measurements in millimeters (0:36 mm). This vari-
abilitv is 1 SD of the di:fferenceofthe means of two observations 
on the same lesion. which ii used would result in a 17.5% 
false-positive resrenosis rate. while the use of2 SDs as a cnterion 
(2 X 0.36 = 0. 72 rrun) results in a false-positive rate of2.5%. ~~ 
Statistical anaJ"sis. To test for differences in mean values and 
proponions betw~n the four follow-up groups with respect to 
the baseline characteristics (tables I and 2). univ::uiate analysis 
L\BLE 3A 
of variance was performed for the continuous variables. and 
multi way chi-sguare analysis was used fonhe discrete variables. 
For the quanriurive variables listed in tables 3A and 3B. uni-
variate analysis of variance was performed (B:MDP statistical 
sofuvare. Universin.· of California Press. Berkelev 1985) .• 4.nal-
ysis of variance foi- a line;JI trend was done on-the change in 
minimal luminal diameter from after PTCA to follow-up (Glim 
statistical package). All statistical rests were two tailed. A 
probability value below .05 was regarded as indicating statis-
tical significance. 
Results 
The results of quantitative angiography in the 342 
patients who completed angiographic follow-up are 
detailed in tables 3A and 3B. together with the p value 
computed by analysis of variance for the indi>idual 
variables used to compare the follow-up groups. Before 
and after PTCA all the quantitative angiographic vari-
ables for the four groups were comparable. except for 
a smaller reference diameter in the 4 month group 
before angioplasty. and a slightly lower percentage 
diameter stenosis immediately after PTCA in the 4 
month group. After PTCA there was. as expec:ed. a 
significant improvement in minimal luminal diameter 
and diameter stenosis for each of the four follow-up 
groups (p<.OOOI). However. analysis of variance per-
formed on the obstruction-related variables at follow-
up showed a significant difference in the four groups: 
there was no significant Change at 1 and 2 months. but 
a significant increase in the severity of the stenosis in 
the 3.month group (p<.OOI for each obstruction-re-
lated variable). and a further but smaller increase that 
did not reach statistical significance in the 4 month 
group. 
Table 4 and figure 3 illustrate the incidence of reste-
nosis according to the NHLBI criteria and the two cri-
Results or quantitative coronary angiography. expressed as mean!: 1 SD. for the 93 JY.Itients (110 lesions) recatheterized 
~t30 days. the79 patients (891esions) recatbeterUed at 60 days. the 82 patients (931esions) Tee~.theteri;r:ed ~t 90 days. and 
the 88 patients (106 lesions) recathetcrized at 120 da~-s after PTCA 
Variable 30 day group 60 day group 90 day group 
MinlmaJ. luminal cli.am. t=l 
"'' 
1.16=0.41 !.16=0.3/ 1.20::::0.40 
Post 2.06-=.0.46 2.00=0.4:?. 2.14.::::0.42 
FG 2.11::::0.:56 1.93::::0.64. !.17=0.58 
Di=eter stenosis (%) 
Pre 58.2= 12.5 59.5= 11.8 59.3=11.8 
Post 28.5::::12.0 31.0= 12.0 28.1 = 11.0 
FU 26.9:::: 1J..7 33.5=19.8 37.1::::18.4 
Reference diameter (mm) 
Pre 2.81::::0.66 2.86::::0.62 2.%=0.58 
Poc< 2.92!::0.63 2.91!::0.50 3.02::::0.56 
Fe 2.90=0.60 2.92=0.54. :!.86::::0.55 
Pre "" before PTCA; Post "" immediately after PTCA; FC = follow-up. 
"By a:aalysis of variance. 
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120 day group p value" 
1.13::::0.41 .70 
2.10!::0.40 .25 
1.69=0.55 <.00001 
57.7::::15.2 .73 
26.3::::9.9 .04 
35.4::::16.7 <.0001 
2.69=0.68 .03 
2.86=0.49 .31 
2.62.=0.51 .003 
TABLE 3B 
Absolute cbnnge in listed variables from pre- to post-P'TCA, and 
from post-PTCA to the respective time or the follow-up angiOI):· 
raphy 
Variable 
30 day 60 day 
group group 
Minimal luminal d1am. (mm) 
Pre to post + 0.89 -0.86 
Post toFU ... O.Q.l. -0.06 
Diameter stenoSIS(%) 
Pre to post -:?:9.8 -28.5 
Post toFU - 1.6 +:?:.5 
Reference diameter (mm) 
Pre to post +0.12 +0.06 
Post toFU -0.0:?: -O.Ql 
Abbreviations are as in table 3A. 
"By analysis of vanancc. 
90 day 
group 
+0.94 
-0.37 
-31.:?: 
+9.0 
+0.07 
-0.17 
1:.!0 day 
poop 
+0.97 
-0.4:?: 
-31.5 
+9.1 
+0.19 
-0.26 
value~ 
.33 
<.00001 
.53 
<.00001 
03 
<.00001 
teria used at our institution. Table 4 also lists the 
percentage of patients experiencing recurrent angina at 
the time of repeat angiography. From these data two 
conclusions"t":an be drawn: first. there is a wide variation 
in the incidence of restenosis according to the criterion 
applied. and second. the incidence of restenosis is 
progressive to at least the third month for all the criteria 
except NHLBI II. At 4 months a further increase is 
observed in the percent restenosis defined as a decrease 
of 0.72 mm or more in minimal luminal diameter. 
whereas use of the criteria based on diameter stenosis 
shows a variable response. 
The relationship between the different criteria for 
restenosis was also analyzed and the results are illus-
trated in figure 4. which shows the total number of 
lesions meeting each criteria and also the overlap 
among individual criteria. Comparison of the four 
NHLBI criteria showed that all lesions that fulfilled 
criteria I and II met criteria Ill and IV. Few patients met 
all four criteria (n.:::: 9). but when NHLBI criteria III and 
IV were compared with the two criteria used at our 
institution. additional lesions were defined as having 
undergone restenosis. Finally. a large number of lesions 
TABLE 4 
so 
40 
~ 30 
. 
0 
0 
·~ 20 
~ 
NHLSI IV 
---o:l!>-=-~ >0.72 mm 
NHLBI Ill 
FIGURE 3. Percentages of kslons that fulfilled. the various restenosis 
critena at 30. 60. 90. and 120 days. 
( 119 of 398) fulfilled at least one of the six criteria 
with 291esions fulfilling all six of them. Although the 
percentages of lesions fulfilling the four criteria for 
restenosis were similar. it must be emphasized that each 
of the four criteria identified unique lesions that were 
not identified by the other three. 
Figure 5 shows the individual minimal luminal 
diameters (mm) of all lesions immediately after PTCA 
compared with the follow-up value at I. 2. 3. and 4 
months. Lesions that had at least a0.36mm change are 
represented by closed circles. Lesions in which there 
was regression. defined as an increase. and progres-
sion. defined as a decrease in minimal luminal diameter 
of at least 0. 72 mm (2 x 0.36 mm). are represented 
by the closed circles that fall outside of the dashed lines 
in figure 5. There was a wide scatter in the change in 
minimal luminal diameter of the individual lesions 
within each group, and also a clear trend with time. 
Lesion regression was observed mainly in the first 2 
months (6.4% and 5.6%. respectively). while an 
increasing trend in the number of lesions undergoing 
progression was demonstrated up to 120 davs. These 
trends could be fitted with the following lin~ model 
based on linear trend analysis (p<.OOOl): 
.:lMLD post-fu {mm) = 0.21-0.17 X time (months) 
Le:sior.-rdated incidence of restenosis for each of the four follow-up groups .accordinl': to six previously pro~ 
nngiotrnphic delin.ition:s or restenosis 
Rcc=t 
Criterion 
llllgm.a NHLBI I NHLBI II NHLBJ III NHLBJ IV >SO<;C OS >0.72 mm 
I month(%) 15 0.9 0.9 10.0 9.1 3.6 0.9 
2 month(%) 19 4.5 3.4 19.1 :!0.2 9.0 12.4 
3 month (%) 
" 
9.7 :.::: 24.7 33.3 :?:3.7 22.6 
4 month(%) 
" 
10.4 2.8 2!.7 30.2 13.2 15.5 
Cumulative(%} 
" 
6.3 2.3 18.6 :?::?:.9 12.! 17.7 
D$ - dlamcter stcnos~. 
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JIIHLBI I 
"'' 
' 
' 
" 
JIIHLSI Ill 
"'' 
J'OHLBI II 
'" 
JIIHLBI Ill 
"'' 
J'OHLBI IV > 50'Ib 
(91) (48} 
J'OHLBI IV 
(91) 
>0.72 mm 
"" FIGURE4. The relationships between the differenr restenosiscrirena. 
On the kft relationships between all four NHLBI criteria. and on the right 
th:!t between NHLBI criteria ill and IV and the two alternative criteria 
are given. The rota! number of lesions fulfilling the various restenosis 
criteria are shown in brackets. and the breakdown of these numbers 
according to overlap are shown wirhin the circles.. The center {over-
lapped by all four circles.) represents the number of les1ons fulfilling a.Jl 
four criteria. "Three additional lesions were identified as having reste-
nosis according to NHLBI criteria I and IV (left-sided Venn diagram). 
Similarly, one additional lesion complied with the NHLBI IV ana the 
50% or greater cnteria in the right Venn diagram. 
where AMLD post-fu = change in minimal luminal 
diameter from after angioplasty to follow-up. 
Discussion 
With the high success and low complication rate. 
restenosis remains the·· Achilles' beer' ofPTCA. 29 The 
rate of restenosis reported in a profusion of studies 
.:o ..... 
-"~ --10.11'1 
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varies from 12% to 48% (table 5): however. critical 
evaluation and valid comparison of the available data 
in the literature is extremely difficult for a number of 
reasons. 
First of all. the diagnosis of recurrent stenosis should 
be based on reproducible quantitative angiographic 
measurements. Visual estimation of stenosis severity 
alone yields unacceptable variation in the assessment 
of changes of coronary artery lesions. 3943 To obtain 
objective and reproducible values a computer~assisted 
technique using either automated edge detection or 
videodensitometry should be applied."-4-56 
Second. the rate of restenosis varies considerably 
according to the definition used. 17 Essentially. angie-
graphic definitions of restenosis are either based on the 
increase in narrowing with respect to the immediate 
post-PTCA ang:iographic appearance. or are defined as 
a loss of the gain achieved by successful PTCA. Since 
many angiographic definitions of restenosis are now 
used (table 5). comparative evaluation of these defi-
nitions is crucial for imerpretation of the data iu the 
literature. and for the assessment of the values and 
limitations of the currently used criteria for restenosis. 
Third. to prevent over- or underestimation. the 
detection of restenosis requires strict adherence to a 
protocol that involves routine follow-up angiography at 
a predetermined time in all patients. 
FIGURE S. Individual minimal luminal diameter 
(mml after PTCA compared with that at control 
angiogr:aphy for the four group:.. The tv.-o solid lines 
on either side of the identity line correspond tO the 
long-term variability (0.36 mm) of repeated mea-
surements for this variable.~~ Thi:s V3llability is I SO 
of the difference in the means of duplicate angio-
gmphie me;c,-urements. Here :; SDs we~ used (:; x 
0.36 "' 0.71 mm: dashed hnes) as a cnterion for 
bion progression or regression. 8<1$C(! on this cri· 
terion the percentages of lesions showlng pr~ssion 
or regn::ssion (O outside da:;hed Jines) are shown 
within the rel=r br.lek.ets. 
TABLE 5 
Reported restcoosis rates. together with the angiographic:: defin.ition(s) applied, the number ofpatierots studied, and the 
time interval between PTCA and follow-up angiography 
l111erval 
fU angiog· PTCA-RJ % re-
Study Y<~ Patients r;,.phy (%) (months) Restenosi:> criterion stenosis 
M. 1\obuyoshiXI 1987 137 100 Next day ~SOli Joss of gain 5.1 
I <=50% loss of gain 12.0 
3 <:50% loss of gam 36.4 
M. Kaltenbaehl' 1985 356 94 5.6 Ds <20% below pre-
" PTCA 05 
T. Con:os)1 1985 
" 
100 8.2 ~70% Ds at FU l8.S 
J. Meyer"~ 1983 70 90 6 >8S% area stenosisA 
" R. Uebis" 1986 100 89 5.9 ~50% loss of gain 24.8 
P. de Feyter=-' 1985 56' 
" 
2.3 <SO% to >50% 05 :u fU 28 
P.P. L:imgruber--o 1986 1758 57 7 >SO% 05 at RJ 30.3 
M.A. Thornton_.. 1984 
'"' 
72 6-9 <=50% Joss of gam 31 
M.E. Bertrand)) 1986 3198 Not reported 7 ~SO% loss of gain 32 
D.R. Holmes" 1984 665 84 6.2 <=30% Ds increase or <=SOS'C 33.6 
loss of gain 
S. levine"' 1985 100 92 6 ~50% loss of gain 
" E. Aeck" 1984 5I 100 6 >I mm~ Slenosis area 
" A.R. Zaidil' 1985 184 100 Not reported Not reported 
"' 
The percent restenosis varies considerably. Likewise. the definition(s) used. rate and timmg of repeat catheterization, and 
method of assessment of the aneriogr::uns are far from unifom~. makmg a critical comparison extremely difficult. The author:; 
cited were selected primarily for the purpose of pointmg out the vanability in rates and deftnitions. rather than in an attempt to 
cover all liter.uure on restenosis to date. 
Ds "" diameter stenosis; FU "" follow-up. 
"Pen:ent stenos.is of cross-sectional :an:a. 
8Patients with un~uble angi11!1. 
The current literature suggests that evidence of 
restenosis usually becomes apparent within 5 months 
of the angioplasty procedure. 17 • 20• 21 and the vast 
majority of restenosis in the series of Kaltenbach et 
a!.. 18 occurred within 3 months. However. some of 
these studies exhibit a methodologic bias in that the 
time to and indication for repeat angiography was 
dictated predominantly by the recurrence of symptoms. 
In two of the larger studies. 17• zo the prevalence of 
ischemic symptoms in patients angiograj,hically re-
evaluated within 5 months exceeded 80%. Whereas the 
observed restenosis rates were .. as low as" 32.8% and 
31.6%. respectively (::=:::50% loss of gain criterion). The 
selection of symptomatic patients might be expected to 
either artificially increase the angiographic restenosis 
rate, or to decrease the rate by not identifying asymp-
tomatic patients with angiographic recurrence. 
In the present study only 23% of the total srudy 
population of 342 was symptomatic at the time of 
reinvestigation. while the overall incidence of reste-
nosis within the first 4 months was 22.9% (NHLBI 
criterion IV: table 4). It therefore appears that the 
difference in the restenosis rate of 9% to 10% (22. 9% 
vs 32.8% or 31.6%) 17• 20 might be related to the sub-
stantial dissimilarity in the percentage of patients with 
recurrent angina at the time of repeat angiography. This 
point emphasizes the importance of routine angiogra-
phic reevaluation. irrespective of ischemic symptoms. 
in establishing the .. true" incidence of restenosis and 
consequently in identifying the determinants of this 
process. 
As previously alluded to. direct comparison of our 
observed rates of resrenosis with those of Holmes and 
Leimgruber and their colleagues17• 20 is hampered by 
major differences in study design and fo1low-up strat-
egy. For instance. Leimgruber et al. 20 reported the 
follow-up of 998 patients originating from an initial 
cohort of 1758 patients with single-vessel disease in 
whom PTCA was successful (57% angiographic 
follow-up). The observed restenosis rate of 31.6% 
(::=:::50% loss of gain criterion) at a mean follow-up time 
of 7 ± 5 months pertains to a time window ranging 
from less than 2 to 42 months. This is in contrast to the 
22.9% overall restenosis rate at a mean follow-up time 
of80::!:: 38days(range4to226days)inthisstudy(86% 
angiographic follow-up). 
The PTCA Registry of the NHLBI reported on 557 
patients who underwent angiographic reinvestigation 
19 
from a group of 665 with successful PTCA (84% angie-
graphic follow-up). Their definition of success. a 
greater than 20% reduction in luminal diameter nar-
rowing. is in contrast to our definition of less than 50% 
diameter stenosis immediately after PTCA. In this par-
ticular report time to follow-up ranged from less than 
I month to approximately 12 months. with only 42% 
of the patients being reinvestigated within the first 6 
months. 17 Moreover. although the number of patients 
in our study may appear to be relatively small (n = 342) 
in comparison with the total study population in the 
reports of Holmes et aL 17 (n = 557) and Leimgruber 
et al.20 (n = 998). it should be pointed out that the 
number of patients reinvestigated within the first 4 
months in these two studies did not exceed 125and 200. 
respectively. 
In view of the above. the question of whether the 
incidence of restenosis peaks within the first 3 to 5 
months can be answered more precisely by an approach 
that minimizes multiple biases as much as possible. 
Based on the criteria of the NHLBI. our data show that 
the incidence of restenosis appears to reach a plateau 
at4 months. while restenosis according to the absolute 
criterion (=::0.72 mm) is still increasing at 4 months. 
An interesting observation of this study was that the 
percent restenosis fell rather unexpectedly from 23.7% 
to 13.2% benveen 90 and 120 days. when defined as 
a 50% or greater diameter narrowing at follow-up. 
However. this apparent reduction was paralleled by a 
disproportionate decrease in the reference diameter 
compared with the change in minimal luminal diameter 
(figure 6 and table 3B). Consequently. use of the indi-
vidual diameter stenosis values. derived from the ratio 
of the reference diameter over the minimal luminal 
diameter. results in an erroneous lowering of the reste-
nosis rate by the 50% or greater criterion. Additionally. 
this reduction is discordant with the observation that 
the mean minimal luminal diameter is still diminishing 
between 90 and 120 days after angioplasty. Although 
no definite explanation can be given for the fact that the 
mean reference diameter progressively decreases with 
time. it could be hypothesized that this is in some way 
related to lhe local remodeling process within the arte-
rial vessel wall after the uncontrolled barotrauma at the 
site of the obsouction. 
The absence of standardization with respect to def-
inition of restenosis. method of angiogram assessment. 
and timing and indication for angiographic control may 
lead investigators to prematurely draw important -
and possibly erroneous - conclusions about factors 
responsible for a low or high rate of restenosis. such 
as technique of angioplasty. drug regimen after angio-
plasty. or modification of risk factors. 56 
In addition to this. it is becoming clear that the 
,.. 
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FIGURE 6. The me;m (:bange5 in minima.! luminal 
and reference diameters from after PTCA tO fol-
low-up at 30. 60. 90. or 120 day~ are graphiea!Jy 
displayed by the solid lmes in the borrom panel. Th.: 
deer= in reference diameter is most apparent at 120 
days after PTCA, and i:s disproponionate to the 
decrease in minimal luminal diameter. The effeCt of 
this phenomenon on the individual percentage diam-
eter stenosis values. derived from me r:atio of the 
reference over to the minimal luminal diameter. is 
shown in the rop p:mel. The number of lesions with 
a SOo/c or greater diame!er stenO'.iis diminished from 
90 tO I20days. As ;:a result, !he incidence of restenosls 
according to this criterion falls from 23.7% ;:at 90 days 
to 13.2% at 120 d;:ays . 
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definitions of restenosis in current use. which are based 
on relative percentages with more or less arbirriry 
cutoff points. do not adequately describe the progres-
sion to a physiologically significant obstruction. For 
instance. as can be seen from the individual lesion data 
plotted in figure 7. lesions that fulfill a criterion for 
restenosis based on changes in the relative percent 
diameter stenosis (NHLBI criterion IV) may represent 
relatively mild obstructions {percent diameter stenosis 
between 30 and 40 with absolute minimal luminal 
diameters ranging from 2 to 3 nun). amounting to what 
is a very satisfactory long-term result. Therefore. to 
avoid the arbitrariness of these floating-scale criteria 
the use of measurements in absolute terms (mm. mm:) 
is advocated. 
The most often reported visually assessed percent 
diameter stenosis overestimates lesion severity by 15% 
to 25%. as demonstrated by Bove et al.57 Our quan-
titative measurements. showing a mean diameter ste-
nosis before PTCA of 58% to 60o/o (table 3A) corre-
sponding to an area stenosis of 80 to 81 o/c. suppon this 
finding. Thus. since values obtained before PTCA or 
at follow-up are generally below 70% diameter ste-
nosis. we suggest that the more than 70% criterion 
(NHLBI criterion II) for restenosis not be used when 
quantitative measurements are employed. 
To circumvent the previously mentioned multiple 
biases and to define the true incidence of restenosis in 
the first 4 months. we tried to standardize as much as 
possible our methods and protocol of investigation. 
3.0 mm 
nGURE 7. Relationship between percem di:uneter 
~teno~is and the minimal luminal diameter at fol· 
low-up for !e~ion~ that fulfill NHLBI criterion IV A 
total of 48 of the 91 le:.10ns have a diameter stenosis 
of le~~ than 50<7c _ f.u "' follow-up. 
The problem of defining restenosis is not trivial. Apply-
ing the stringent criteria of the NHLBI PTCA Registry 
to visual estimates of severity of stenosis has major 
limitations. due to the large intra- and interobserver 
variabilities in interpretation. especially for stenoses of 
between 20% and 80%. 41 Therefore. in this study ste-
noses were analyzed by computerized edge detection. ::s 
Although this method may not be optimal for those 
lesions with an irregular angiographic vessel wall 
outline5'"· 56 immediately after angioplasry. it provides 
an objective and reproducible quantitative measure-
ment that avoids unintentional bias in reading the 
angiogram. The overall accuracy (average difference) 
and precision (pooled standard deviation of the differ-
ences) of this contour detection technique for the per-
centage diameter stenosis measurements are 2.00% and 
2.68%. respectively. and for the minimal luminal diam-
eter. -30 and + 90 ,urn. respectively. The mean dif-
ferences and standard deviations of the differences in 
the minimal luminal diameter and interpolated refer-
ence diameter. as well as in the interpolated percentage 
diameter stenosis. have previously been published for 
the short (5 min). medium (60 min) and long term (90 
days). The variability in minimal luminal diameter for 
these three types of studies ranged from 0.22 mm for 
the medium-term study to 0.36 mm for the least well 
controlled long-term study. In the long-term study 
group. the lack of significant variation in the mean 
difference in the minimal luminal diameters suggests 
that no detectable progression or regression of athero-
21 
sclerotic lesions occurred over the period of 90 days. 
Therefore. a change greater than the long~term mea~ 
surement variability of repeated coronary cineangi-
ography and quantitative analysis (0.72 mm for the 
minimal luminal diameter; i.e .. 2 SDs of difference of 
duplicate measurements) was considered significant 
and indicative of restenosis. This change in absolute 
valuescorrespondstoachangeof2 x 6.5% = 13.0% 
in percentage diameter stenosis.zs 
It is important to realize that the process of restenosis 
may be viewed either as a purely angiographic pro-
gression in focal narrowing without implication of any 
functional or clinical consequence. or as a functional 
deterioration assessed by means of a criterion able to 
identify a physiological!)' significant obstruction to 
blood flow. It is unclear what percent diameter nar-
rowing - which is the traditional method for grading 
a coronary stenosis - will consistently lead to myo-
cardial ischemia during exercise. However. a number 
of patients who meet the criteriaforrestenosis will have 
no symptoms and an adequate luminal diameter. It is 
therefore not surprising to see that the arbitrary nature 
of angiographic definitions of restenosis have funher 
obscured the relationship between angiographic and 
functional result. 
In conclusion. we believe that restenosis. when 
envisaged as a progressive encroachment on the lumen 
by the disease process in the vessel wall. should be 
assessed by repeat angiography and preferably ascer-
tained according to the change in absolute quantitative 
measurements of the luminal diameter. By doing so. the 
comparison of various studies and different treatment 
groups will be more scientifically valid. and more 
imponantly will provide a sound basis for the identi-
fication of the determinants of lesion recurrence. 
We gratefully acknowledge the assistance of Anja. van Huuks-
loot and Gusta Koster in the preparation of this manuscript. 
References 
1. Wijns W. SerruyspW, Reiber me. de Feyter PJ. van den Brand 
M. Simoons ML. Hugenholtz PG: Early detection of re$tenosis after 
sLICCeSsful pereutarleous ~uminal coronary angiopl.asty by o;er-
cise-rediscribution thallium ~intigraphy. Am J C!rdiol 55: 357. 
!985 
~. De Puey EG. Leatherman U.. Leachman RD. 0=- WE. Mo!:;sin 
EK. Mathur VS. Burdine JA: Restenosis after translumwal coro-
nary .angioplasty detected with exercise-gated mdionuclide ventric-
ulography. J Am Coli Cardiol 4: I 103. 1984 
3. Stuckey TD. Beiler GA, Gibson RS. WalSOn DD. Tcdesl» CL. 
Nygaard TW. Burwell LR: Multivariate an.alysis of clinical. angio-
graphic .and exercise TL-20 l variables for the prediction of recurrent 
angina after percutaneous a::ansluminal corona:y angioplasty 
(PTC.A). 1 Am Coil Cardiol 7: 106 A. 1986 {abst) 
4. Powelson S. Roubin G. \Vhi['WQnh H. Gruentzig A: lncidence of 
early restenosis aftersucce:ssful percu1a11eous tr.mslwninal coronary 
angioplasty (PTCA). 1 Am Co!l Cardiol 7: 63A. 1986 (abst) 
5. Steele PM. Chesebro m.scm:;on AW. Holmes DR Jr. Dewanjee 
MK. Badimon L. Fus.ter V: BallooP angioplasty: natural history of 
22 
the pathophysiological response to injury in a pig model. Circ Re 
57: 105. 1985 
6. Wilentz JR, Sanborn TA. Haudenschi!d CC. Valeri CR. Ryan TJ. 
faxon DP: Platelet accumulation in experimental angiop!asty: time 
CQurse and relation to vascular injury. Circul.atwo 75~ 636. 1987 
7. Lam JYT. Ch=bro JH, Steele PM. Badimon L. Fuster-Y: Is 
vasospasm rela.ted to platelet deposition? Relationship in a porcine 
prepar.nion of arterial injury in vivo. CitculaC!On 75: 243, 1987 
8. Austin GE. RatlitrNB. Hollman J. Tabei S, Phillips OF: Intimal 
proliferation of smooth muscle cells as an explanation for recurrent 
coronary artery stenQsis after percui:UleQUS transluminal co~Onai)· 
angwplasty. JAm Coli Cardiol 6: 369. 1985 
9. Castaneda-Zuniga WR. fQrm;mek A. Tad.avanhy M. VlodaverZ. 
Edwards JE. ZoHikofer C. Amplatz K: The mechan~m of balloon 
angil:lplasty. Radiology 1.35! 565. 1980 
10. DiiberC.JungbluthA.RumpcltHJ. ErbeiR.Meyer J. Thoene W: 
Morphology of the coronary aneri~ after combined thrombolysis 
and percutaneous cr.msluminal coronary angioplasty for acute myo-
cardial infarction. Am J Can:!iol 58: 698. 1986 
J I. Esse<! CE, van den Brand M. Becker AE: Transluminal coronarv 
angiopla.sty and early restenosis: fibrocellular occlusion after wail 
laceration. Br Heart 149: 393. 1983 
12. Giraldo AA. Esposo OM. MeisJM: Intimal hyperplasia as a cause 
of restenosis after percutaneous transluminal coronary .angioplasty. 
Arch Pathol Lab Med 109: 173. 1985 
13. Mizuno K. Kunu A. Imazeki N: Pathological findings after per-
cutaneous transluminal coronary angiQplasty. Br Heart J SC.. 588. 
1984 
14. Rutherford RB. Ross R: Platclet factors Stimulate fibroblasts and 
smooth muscle cells quiescent in plasma serum to prolifer:stc. 1 Cell 
Bioi 69: 196. 1976 
15. WallerBF .McM:musBM .Gorfinkel HJ. Kishel JC. SchmidtECH. 
Kent KM. Roberts WC: St:l.tlls of major epicard.i:ll coronary =nes 
80 to ISO days after percutaneous transluminal coronary angio-
plasty. Analysis of 3 necropsy patients. Am J Cardiol51: 81. 1983 
16. GrUntzig AR. Meier 8: Percutaneous cr.msluminal corona:y angio-
plasty. The fu-s:t five years and the future. lnt J Cardiol 2: 319. 1983 
17 Holmes DR. Viietstta RE. Sm1th HC. Yetrovec GW. Kent KM. 
Cowley MJ. Faxon DP, Gruentzig AR. Kelsey SF. Dctre KM. van 
Raden.MJ. Mock MB: Restenos~ after percut:l.lleous transluminal 
coronary ang1oplasty (PTCA): a report from the PTCA Regisuy of 
the National Heart. Lung. and Blood Institute. Am J Cardio15.3: 
nc. 1984 
!8. Kaltenbach M. Kober G. Scherer D. Vallbracht C: Recurrence r.ne 
after successful coronary angioplasty. Eur Heart J 6: 276. 1985 
19. Kober G. Scherer D. Koch M. Dowinsky S. Kaltenbach M: Tnns· 
lumm::tl coronary angioplasty. Early and long-term results in 250 
procedures. Hen: 6: 309. 1982 
20. Lcimgruber PP. Roubin GS. Hollm<:m J. Col<;Onis GA. Meier B. 
DouglasJS. King SB Ul. Gruentl:ig AR: Restenosi$ after successful 
coron:uy angiop!asty in patients v.ith single-vessel disease. Ci.r· 
culation 73: 710. 1986 
21. Meier B. King SB DI. Gruentzig AR. Douglas JS. Hollman J. 
lsdtinger T. Galan K. T~ey R: Repe;:~t coronary angioplasty. 
1 Am Col! Caroiol 4: 463. 1984 
22. de Feyter PJ. Serruys P\V. van den Brand M. Balakumaran K. 
Moehtar B. Soward AL. ArnoldAER. Hugenholtz PG: Emergency 
coronary angiop!asty in refractory unstable angina. N EPgl J Med 
313: 342. 1985 
23. Hugenholtz PG. van den Brand M. Scrruys PW. Laitd-Meeter K. 
Bos E: Surgery. angioplasty or drugs? Eur Heart J 6(suppl F); 47. 
1985 
24. Blackburn H: Elcetrocardiograpltic clas:sification for popula.tion 
comparisons: the Minnesota Cod~. J Eleetroeardiol 2: 5. 1969 
25. Reiber JHC. Serruys PW. Kooijman CJ. Wijns W. Slager CJ. 
Gerbrands JJ. Schuurbier:"> JCH. den Boer A. Hugenholtz PG: 
Assessment of $hort-. medium-. and long-term v:.nations in arterial 
dimensions from computer-assisted qu.antitation of coronary ci-
neangiograms. Cll"Culation 71: 280. 1985 
26. Reiber JHC. Serruys PW. KoolJman CJ. Slager CJ. Schuurbiers 
JCH, den Boer A: Approadl~s towards Sbndardi.zation 10 acqui-
sition and qwmtitation of artenal dimensions from cineangiograms. 
In Reiber me. Serruys PW. editors: State of the an in quantitative 
Cotc>n:uy arteriography. Dordrecht. !986. Martinu:; Nijho:tf Publi-
catioos. p 145 
'!7. Austc:n WG. Edwards JE, Frye: RL, Gensini GG, Gon VL. Griffith 
LSC, McGoon DC. Murphy ML. Roc: 88: A rc:porting systc:m in 
patic:nts evaluatc:d for grading of coronary anc:ry disease. Rc:pon of 
the: Ad Hoc Committe:~: for Groding Coronary Artery Disease:. 
Council on Cardiovascular Surgery. Amc:rican Hc:art Association. 
Circulation Sl: 7, 1975 
28. Rc:ibc:r JHC. Sc:rruys PW. Slago:r CI: Quantitative: coronary and left 
ventricular cineangiography. Mc:tbodology and clinical applica-
tions. Dortlrecbt, 1986, Maninus Nijhoff Publishers 
29. Block PC: Po:rcutano:ous trnnsluminal coronary angioplasty: role: in 
the: tre:Ument of coronary artc:ry disease. Circulation 72: 161, 1985 
30. Nobuyoshi M, Kimura T. Hosokawa H. Nosaka H: E;u1y anglo-
graphical ch;mges aftl:f prm:utanc:ous translumlnal coronary angio-
plasty. JAm Coli Cardiol9: 180 A. 1987 (abst) 
31. Corws T, David PR. Val PG, Renkin J. Dangoisse V.Rapold HG. 
Bo~ MG: Failure of diltiazem to prevent =c:nosis aftc:r pc:r-
cut:meous ttanslwninal coron<ll)' angioplasry. Am 1 Hc:art 109: 926. 
1985 
32. Meyc:r J. Schmitz HJ. Kic:sslich T. Erbel R. Krebs W, Schulz W, 
Ban!os P. Minale C. M=merBJ. Effen S: Po:rcuuncous tr:anslu-
minal coronary angioplas.ty in patients with stable and unstable 
angina pectoris: analysis of c:arty and late rc:sults. Am Hc:art J 106: 
973. 1983 . 
33. Uc:bis R. von Es~ R. vom Dah!J, SchmitzJH. Sc:iger K. Effert 
S: Recurrence rate after PTCA in n::lationship to the: initial lc:ngth 
of coronary artery narrowing. 1 Am Coli Cardiol 7: 62A, 1986 
{abst) 
34. ThorntOn MA, GruentZig AR. Hollman J. King SB m. Douglas JS: 
Coumadin and aspirin in the prevention of n::curn::ncc: aftc:r =-
luminal coronary angioplasty: A randornixcd 5tlldy. Circulation 69: 
72i. 1984 
35. Benrand ME. Marco J. Charier F. Sc1unitt R. Gaspafd P. Pucl I. 
Valeix B. Bory M. Croc:hetH. CeschwindH, BerlandR. Machecourt 
J. Foucault JP. Bassand JP, Bourdonnec C, Quin:t A. JaultF: French 
pc:rcutane(lus tr.msluminal coronary angioplasty {PTCA) Rc:gistry: 
four years experience, JAm Coli Cardiol7: 2IA, 1986 (abst) 
36. Levine S, Ewels CI. Rosing DR. Kent KM: Coronary angioplasty: 
Clinical and. angiographic follow-up. Am J Cardiol 55: 673. 1985 
37. Aeck E. Dacian S. Dirschingc:r J. Hall D. Rudolph W: Quantitative 
changes in stenotic coronary artc:T)" IC:S!Ons during follow-up after 
PTCA. Circulation 70(supplll): II·l76, 1984 labst) 
38. Zaidi AR. Hollman J. Galan K, Bc:lanli J, Franco I. Simpfendorfer 
CC. Klein ML: Predictive value of chest discomfon for n::stcnosis 
following successful coronary angioplasty. Circulation 72(suppl 
III): ID-456. 1985 (abst) 
39. DeRouen TA. Mun:ay JA. Owen W: Variability in the analysis of 
coronary aneriograms. Circulation SS: 324, 1977 
40 Dctre KM. Wright E. Murphy ML, Talwo T: Observer agfttment 
in evaluating coronary angio~. Circulation 52: 979. 1975 
41. Shub C. Vlietstra RE. Smith HC. Fulton RE, Elveback LR: The 
unpn::dietable progtesSJon of symptomatic coronary artery d.i5ease: a 
serial clinical-angiopaphic anal~is. Mayo Ciin Proc 56: 155, 1981 
42. Zir LM. Millc:r SW, Dinsmore: RE. Gilbert JP. Harthome JW: 
lnterObserver variability in coronary :mgiography. Circulation 53: 
627, 1976 
43. Meier B, Gruentti.g AR, Goebel N, Pyle R. von Gosslar W, 
Schlumpf M: Assessment of stenoses in coronary angioplasty: 
inter· and intraobservc:r variability. lnt J Cardiol3: 159, 1983 
44. Brown BG. Bolson E. Frimer M. Dodge: FIT: Quantitative coronary 
arteriography: Estimation of dimensions, bemoclynamic resistance, 
and atheroma mass of coronary anc:ry lesions using the: artc:riogram 
and digital eomputation. Circulation 55: 329. 1977 
45. Sandc:rs WJ, Alderman EL. Harrison DC: Coronary artery quan-
titation using digital image: processing technique. Comput Cardiol 
pIS. 1979 
46. Selzer RH. Shircorc: A. Lee PL. Hemphill L. Blankenlcom DH: A 
second look at quantitative coronary angiography: some: une:xpc:cted 
problems.Jn Rc:iber JHC. Serruys PW. editors: State of the an in 
quantitative coronary anc:riog:raphy. Dordrecht, 1986, Maninu:i 
Nijhoff Publishers. p 125 
47. Johnson MR. Braydc:n GP. Erieksen EE. Collins SM. Skonon DJ. 
Harrison DG. Marcus ML. White CW: Changes in cross-sectional 
area of the eoron:uy lumen in the six months after angioplasty: a 
quantitative analysis of the variable response to pc:rcutanc:ous trans-
luminal angioplasty. Circulation 73: 467. 1986 
48. Le Free M. Simon SB. LeW1S RJ. Bates ER. Vogel RA: Digital 
radiographie coronary artery quantification. Comput Cardiol p 99, 
1985 
49. Kirl:c:eidc: RL. Fung P. Smalling RW. Gould KL: Automated c:vaJ. 
uation of vessel diametc:rtiom aneriograms. Comput Cardiol p 215, 
1982 
SO. Smith DN, Colfc:r H, Brymer IF. Pin B. Kliman SH: A semiau-
tomatic cmnputc:r technique for processing coronary angiograms. 
Comput Drdiol p 325, 1982 
Sl. Doriot PA. Pochon Y. Rasoam:m:uubclo L, Ch:.uclain P. Wc:!z R, 
Rutishauer W: Dc:nsitom<:ay of coronary arteries- an improved 
physical model. Comput Cardiol p 91, 1985 
S::. Sandor T. Als AV, Paulin S: Cine-densitometric ~t of 
coronary arterial stenosis. Cathet Cardiovasc Diag:n 5: 2..'>9, 1979 
53. Spe:m; JR. SandorT, Als AV. Malagold M. Markis JE. Grossman 
W, Senu- JR. Paulin S: Computerized image analysis for quanti-
tali~ measutement of vessel diamc:ter from eineangiog:rams. Cir· 
culat~an 68: 453. 1983 
54. Tobi~ J, Nalcioglu 0, Iseri L. Johnston WD. Roeck W. Castleman 
E. Bauer B. Montelli S. Henry WL: Dc:tection and quantitation of 
coronary artery stenoses from digital subtraction angiogram& com· 
pare:<! with 35-millimetc:t film cineangiograms. Am ] Cardiol 54: 
489, 1984 
SS. Serruys RW. Reiber JHC, Wijns W, van den Brand M. Kooijman 
CJ. ten Katen HJ, Hugenholtz PG: Assessment of percutaneouS 
transluminal coronary angioplasty by quantitative coronary angiog-
raphy: diameter versus densitometric area measurements. Am J 
Cardiol 54: 48::. 1984 
56. Myler RK. Shaw RE. Stettter SH. QaO:: DA. FIShman 1, MlUphy 
MC: Recwttnce after coronary angioplasty. Cathc! Cardiovasc 
Diagn 13: 77. 1987 
57. Bove AA. Holmes DR. Owen RM, Bresruthan IF, Rc:eder GS, 
Smith HC, Vlietstra RE: Estimation of the effects of ang:ioplasty on 
coronary stenosis using quantitative video angiography. Cathet 
Cardiovasc Diag:n 11: S. 1985 
23 
24 
Chapter2 
Change in diameter of coronary artery segments adjacent to 
stenosis after percutaneous transluminal coronary angioplasty: 
failure of percent diameter stenosis measurement to reflect 
morphologic changes induced by balloon dilation. Journal of the 
American College of Cardiology 1988; 12:315-323. 
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Change in Diameter of Coronary Artery Segments Adjacent to 
Stenosis After Percutaneous Translnminal Coronary Angioplasty: · 
Failure of Percent Diameter Stenosis Measurement to Reflect 
Morphologic Changes Induced by Balloon Dilation 
KEVIN J. BEATT. MRCP, HANS E. LUUTEN. MD. P!M J. DE FEYTER, MD. 
MARCEL VAl< DEN BRAND, MD, JOH.'\.N H.C. REIBER, PHD, PATRICK W. SERRUYS. MD. 
FACC WITH THE STATISTICAL ASSISTA:-<"CE OF HA.RALD J. TEN KATEN AND GERRIT A. VANES 
Rotterdam. The Netherl.an.ds 
To determine the changes in stenotic and nonstenotic 
segments of a dilated coronary artery • detailed quantitative 
angiographic measurements were perfonned in 342 pa-
tients (398 lesions) immediately after angioplasty and at a 
predetermined follow-up time of 30, 60, 90 or UO days 
after the dil3tion. Measurements of the stenotic segments 
were expressed as minimal luminal diameter, and the 
adjacent nonstenotk segments were expressed as interpo-
lated reference diameter (both in millimeters). A follow-up 
rate of 86% was achieved. 
In the patients followed up at 30 and 60 days, there was 
no significant change in either the mean minimal luminal 
diameter or the mean reference diameter. However, at 90 
The incidence of restenosis after coronary angioplasty has 
become an important index for defining the long-term suc-
cess rate of the procedure. The relatively high incidence rate 
(range 12 to 48% [1-5]) ofrestenosis. as defined by a number 
of arbitrary criteria, is regarded as the predominant limiting 
factor to the long-tenn success rate of angioplasty. 
The usual definition of restenosis (2) is based on changes 
in percent diameter stenosis. This value is used to reflect the 
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and 120 days. there was significant deterioration in both the 
mean minitoal luminal diameter ( -0.37 and -0.42 mm., 
respectively) and the mean reference diameter (-0.17 and 
-0.26 mm, respectively), all of the changes being highly 
significant (p < 0.00001). The reference diameter is in-
volved in the dilation process and may be subject to the 
same restenosis process that takes place in initially stenotic 
segments. Percent diameter stenosis measurements, which 
are conventionally used to express the change in tbe severity 
of a stenosis after angioplasty. will tend to underestimate 
the change when there is a simultaneous reduction in the 
reference diameter. 
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changes in minimal luminal diameter in relation to the 
scrcalled normal diameter of the vessel in the immediate 
vicinity of the obstruction. It assumes that this ··normal" or 
reference diameter of the vessel proximal or distal to the 
obstruction does not change as a result of angioplasty or 
during the immediate follow-up period when restenosis of 
the dilated lesion is a well recognized phenomenon. With 
this criterion for restenosis, which depends on changes that 
occur in two independent variables (namely. minimal lumi-
nal diameter and ··normal" luminal diameter). it is not 
possible to independently examine the absolute changes in 
either variable. each of which may be important in its own 
right. In addition. the selection of an arbitrary reference 
diameter may introduce a further source of error because the 
selection procedure is not always well standardized and. in 
practice. is difficult to reproduce reliably during sequential 
analysis. 
Animal experiments (6) have suggested that balloon dila-
tion of a normal coronary artery is capable of inducing the 
same fibrocellular response seen after dilation of atheroscle· 
Table 1. Clinical Characteristics of 342 Patients With Successful Coronary Angioplasty 
Follow-Up Period 
30 Days 60 Days 90 Days 120 Days 0"""' 
No. of patients 93 79 82 ss 
'" No. of lesions 110 89 93 106 J9S
Mean no. of lesions dilated per p;1tient LIS 1.13 1.13 }.20 1.16 
.'1ge (yr) 
Mean= SD 57=- 9 57:!: 9 56= 9 57= 9 57:!: 9 
"""' 
35 to 75 31 tO 75 32 to 74 31 to 74 31 to 75 
Gender ratio (M/FJ 5.6 (79/14) 5.1 (66/13) 3.3 (63/19) 3.9 (70/18) 4.3 CJS/6:.} 
TIIIIefrom PTCA to FfU (days) 
Mean: SD 4(1:!: 7 61:!: 12 10:!: IS 1:!0 = 32 so:!: 38 
"""' 
18 to 62 11 to SO 33 to 164 4 to 226 4 to 226 
Extent of CAD (no. [%]) 
One vessel disease 62 (67) 56 (71) 52 (63) 62 (70) 232 (68) 
Two vessel disease 25 (}.7) 20 (25) 21 (}.6) 16 (18) 74 (::;2) 
Three vessel disease 5 (~ 4 (5) 5 {6) 10 {11} 36 (II) 
Previous coronary bypass grafting (no. [%]) 9 (10) 7 (9) 6(7) 8 (9) 30 (9) 
Previous myocardial infarction (no. [%)) 40 (43) 39 (49) 32 (39) 30 (34) 13S (40) 
Previous coronary angioplasty (no. [%]) 10{11) 2 (3) 11 (13) 12 (14} 35 (10) 
CAD= coronary artery disease: F- female: Fft:- follow-up ;).Dgiogr:aphy: M- male: PTCA"' percutaneous tr.l.nsluminal corooary angioplasty. 
rotic vessels. However. no data exist to show whether this is 
important in the clinical setting. where the dilating process 
frequently involves relatively normal coronary anery seg-
ments. To determine the changes in stenotic and nonstenotic 
segments in the period immediately after angioplasty and to 
assess their importance in relation to the change in diameter 
stenosis occurring in the same period. we used a computer-
generated angiographic measurement system in a detailed 
follow-up srudy of patients who had undergone successful 
angioplasty. 
Methods 
Study patients. Four hundred consecutive patients who 
undenvent successful coronary angioplasty and agreed to 
have a follow-up angiogram were entered into an ongoing 
study on restenosis. Successful coronary angioplasty was 
defined as: 1) <50% diameter stenosis on visual inspection 
of the postangioplasty coronary angiogram performed in 
multiple views; and 2) no in-hospital complications (namely. 
recurrence of angina. coronary bypass grafting. repeat 
coronary angioplasty, acute myocardial infarction or 
death). Patients with stable and unstable angina pectoris, as 
defined previously (7). were included. Patients with acute 
myocardial infarction receiving a thrombolytic agent who 
subsequently had immediate coronary angioplasty were ex-
cluded. 
Allocation of patients at the time of angioplasty to one of 
four predetermined times for follow-up angiography was 
made sequentially according to the study period in which 
the dilation was performed; patients undergoing angio-
plasty in the first study period were reinvest:igated at 30 
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days. the second group at 60 days. the third group at 90 
days and the fourth group at 120 days. Oi the 400 patients 
who met the inclusion criteria. 342 had repeat angio-
grams suitable for quantitative analysis. Reasons for fail-
w-e to complete the study were late death (2 patients). 
recatheterization contraindicated or refused (38 patients) 
and angiograms unsuitable for quantitative analysis (18 
patients). 
Oi the total study group of 342 patients (398 lesions). 93 
patients undenvent repeat catheterization at 30 days (110 
lesions), 79 at 60 days (89lesions). 82 at 90 days (93lesions) 
and 88 (106lesions) at 120 days after angioplasty. 
The baseline clinical characteristics in the four groups 
were comparable for the variables shown in Table 1. The 
mean time from angioplasty to follow-up angiography in 
the four study groups was 40, 61, 102 and 120 days. respec-
tively. 
When clinically indicated (early recurrence of symp-
toms). patients were reinvestigated before their preset time. 
but analysis was performed according to that for their 
original allocation group. This was done to allow a valid 
statistical comparison of the changes occurring among the 
individual groups. We assume that changes seen at the early 
investigation would be present if a further investigation was 
performed at the original preassigned time. Most patients 
restudied early had a further intervention (coronary angio-
plasty or bypass surgery) and. thus. a further investigation 
was not appropriate. This method was chosen to avoid 
biasing the early groups with patients who underwent early 
investigation because of symptoms and who were thus more 
likely to show a deterioration in the dilated lesion. Table 2 
shows the tYPe of vessel. the number of patients with tandem 
Table 2. TYPe of Vessel Dilated and Number of Patients in the Four Study Groups With Tandem 
Lesions and More Than One Lesion Dilated 
Follow-Up Period 
30 ., 90 120 
Days Days Days 
"'" 
Ov"" 
Vessel dilated (no.[%)) 
LAD 61 (56) 61 (69) 55 (59) 62 (58) 239 (60) 
LCx IS (16) 16 (18) 19 {:!0) 16 (15) 69 (17) 
RC.' 26 (:!4) 11 {12) 16 (17) 23 (22) i6 (19) 
Bypass graft 4 (4) 0 (0) :!(:!) 4 (4) 10 (3) 
LMCA 1(1) 1(1) J(l) I (I) 4 {I) 
No. of patientS with tandem 6 (6) 2 (3) 2 (2) 5 (6) 15 (4) 
lesion (no. [%]) 
No. of patientS with (no. {%)) 15 (16) 10 {13} 10 {12) IS (:!0) 53 (J5) 
>I lesion dilated 
LAD'"' left anterior descending artery: LCx "' left circumflex artery: LMCA = left main coronary artery:RCA 
= right coronary artery. 
lesions and the number of patients with more than one lesion 
dilated for each study group. 
AngiopJasty protocol. Coronary angioplasty was per-
formed with a steerab!e movable guidewire system by means 
of the femoral route. Details regarding the procedure used in 
our laboratory have been described previously (J). At the 
beginning of the procedure. all patients received infusions of 
heparin. 10.000 IU and aspirin. 500 mg. and a continuous 
infusion of Rheomacrodex (low molecular weight dextran) 
was started. After dilation. 10 mg of nifedipine was given 
orally every 2 h for the first 12 h. and then three to six times 
a day together with 500 mg/day of aspirin orally until repeat 
angiography. Beta-adrenergic blocking agents were with-
drawn unless indicated for hypertension. 
Quantitative coronary angiography. The quantitative 
analysis of the stenotic coronary artery segments was car-
ried out with the computer-assisted Cardiovascular Angiog-
raphy Analysis System (CAAS). which has been described 
in detail (8.9). In summary. to analyze a coronary artery 
segment in a selected frame of 35 mm cinefilm. an optically 
magnified portion of the image encompassing that segment is 
converted into video format by means of a cine-video 
converter. The region of interest is defined and the contours 
of the vessel are detected automatically on the basis of the 
weighted sum of first and second derivative functions ap-
plied to the digitized brightness information. Calibration of 
the diameter data of the vessels in absolute values (in 
millimeters) is achieved by using the contrast catheter as a 
scaling device (10). To this end. the contours of a user-
defined portion of the opti,mally magnified catheter (optimal 
magnification factor 2 V2) are detected automatically and 
corrected for pincushion distortion caused by the image 
intensifiers. From the contours. the vessel diameter func-
tions are determined by computing the shortest distances 
between the two contour positions. All aspects of this 
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process apart from the selection of angiograpbic frames for 
analysis are independent of the user and were performed 
without knowledge of previous results. 
A represen.rarive analysis, with the detected contours and 
the diameter functions superimposed on the original video 
image, is shown in Figure 1. The reference diameter is 
difficult to define and is usually selected visually as the 
nearest coronary artery segment that appears normal. To 
standardize this measurement and minimize potential errors. 
we used an "interpolated .. reference diameter measure-
ment. This method has the advantage of eliminating the 
arbitrary choice of a reference diameter. which will vary 
among individual observers. and also provides a smoothing 
effect for the segments adjacent to the stenosis so that 
extreme irregularities in the vessel have little influence on 
the reference diameter. The principle behind this technique 
has been described previously (11-13). as have the precision 
and overall accuracy of the system (13). The method of 
obtaining angiograms and the precautions taken to reduce 
error were recently reported (14). 
A change 2:0.72 rom was taken to represent a significant 
change. This is based on twice the variability (0.36 rom) of 
the minimal luminal diameter measurement (in millimeters) 
when coronary angiography is repeated over an interval of 
90 days (8). 
Statistical methods. To test for differences in mean values 
and proportions among the four follow-up groups with 
respect to the baseline characteristics (Tables 1 and 2). 
univariate analysis of variance was performed for the con-
tinuous variables. and multiway chi-square analysis for the 
discrete variables. For the quantitative variables listed in 
Table 3. univariate analysis of variance was performed 
(BMDP statistical software. University of California Press. 
Berkeley. CA. 1985). All statistical tests were two-tailed. A 
A 
c 
probability (pl value <0.05 was regarded as indicating sta-
tistical significance. 
Results 
Changes in mean minimal luminal diameter and reference 
diameter. The mean results of quantitative angiography for 
the 342 patients who completed the study. divided into four 
follow-up groups. arc shown in Table 3 along \vith the 
changes that occurred between angiopla::;ty and follow-up 
study. The changes in mean minimal luminal diameter and 
mean reference diameter that occurred between postangio-
plasty and follow-up study are shown in Figure 2. In the 
30 
8 
Figure n. A series of single frame angiogram~ of the same left 
anterior descending coronary lesion. before dilation (A). n.fter dila-
tion (BJ and at 60 days follow-up study {C). The interpolated 
reference diameters (!RDJ are shown to the right of the diameter 
function curve. and the corresponding percent di:lmett'r steno>is 
(O-STEN) and percent area stenosis 1.'\-STEJ\"J at the top left ofcaeh 
frame. The anerial boundary of the segments of interest is defined 
by the :J.Utomated edl;e detection process. and the length of the 
lesion is defined autom:J.tically by curvature analysis :J.s shown by 
the lines (a.a) proximal and distal to the stenosis and the wrtical lines 
{b.bJ on the diameter function plot. The interpolated reference 
contour line (c) is computed from the contours proximal and distal to 
the lesion. and the rdt-rence diameter value is taken at the point 
coincident with the point of maximal narrowing. ~hov.n by the line 
(s). The postangiogr.r.phic a.nalysis (B) shov.; a sutisfacwry result. 
The follow-up analysis (CJ shows that a significant restcnosi:. has 
taken plucc. anU the lesion is longer as ddlned by the computer. 
However. the adjacent contours outside the \xlundaries huw ;tl~l) 
become narrower. resulting in a reduction in the reference diam.:ter. 
This result~ in an erroneously low percent di;Jmeter stenosis of ~2r:r. 
r;Jthcr than 70';·i if the measurement had been based on the r.:fen:nce 
diameter immediately after angioplusty. The choice of a sin:;k 
ref.::rence diameter in such a dy-namic sening would be inappropri:~te 
anJ rc~ult in mislcuding errors. 
groups who undenvent follow-up angiography at 30 and 60 
days. there were small nonsignificant changes in both mini-
mal luminal diameter and reference diameter. with a sm:.tl! 
improvement in minimal lumina! diameter and a reduction in 
reference diameter at 30 days and a reduction in both values 
at 60 days. However. at 90 and 120 days. both minimal 
luminal diameter and reference diameter show a highly 
significant fp < 0.00001) deteriomtion, with the values at 120 
day~ being greater than those at 90 days. 
Distribution of individual changes in luminal diameter. The 
individual changes in reference diameter and minimal lumi-
nal diameter are represented in Figures 3 and 4, respectively. 
The progressive shift of the distribution of the minimal 
Table 3. Quantitative Coronary Ang:iographic Findings Postcoronary A.ng:ioplasty and at Follow-Up 
in the Four Study Groups 
Follow-up Period 
30 Days 60 Days 90 Days 120 Days pV:llue 
:Minimal luminal diameter (rnm) 
Pom 2.06:;: 0.46 2.00 !:: 0.42: 2.14:;: 0.42: :2:.10:;: 0.40 O.li 
Follow-up 2.ll ::: 0.56 1.93:;: 0.64 1.77::: 0.58 1.68 = 0.55 <0.0004 
Post to follow-up -0.04 -0.06 -0.37 -0A2 <0.00001 
Reference diameter (mm) 
Post 2.92 = 0.63 2.91 = 0.50 3.02:;: 0.56 2.86 ::: 0.49 0.34 
Follow-up 2.90 = 0.60 2.92 = 0.54 2.86 = 0.55 2:.62:;: 0.51 0.84 
Post to follow-up -0.02 -0.01 -O.li -0.26 <0.0000! 
Diameter stenosis {%) 
Poo ::s.s = 12.0 31.0 = 12:.0 :S.J:: ll.O 2:6.3 = 9.5 0.20 
Follow-up 2:6.9 = 14.7 33.5 = 19.8 37.1 ::: 18.4 35.4 = 16.7 <0.0002: 
Post to follow-up -1.6 +2.5 -9.0 +9.1 <0.00001 
Variables :u-e expressed as mean = SD. The Post to follow-up values are the mean of the individual differences: 
the p values :u-e derived from the analysis of variance comparing the four groups. 
luminal diameter with time to follow-up is evident and shows 
that it is not just a limited number of lesions that 
""restenose:· but rather almost all lesions deteriorate to 
some extent by 120 days after angioplasty. The degree of 
change is normally distn"buted about the mean value ( -0.42 
mm at 120 days). and the number of lesions that undergo 
'"restenosis"' will depend on the criterion chosen. Figure 4 
shows the percent of lesions that undergo change {either 
progression or regression) if 0.72 rom is used as the criterion 
for change. For patients who were reinvestigated at 30 days. 
the percent of individual lesions that achieved the 0.72 mm 
criterion for regression was 6%, with 1% showing progres-
sion. At 60 days. a similar percent showed regression. but 
the number showing progression had increased to 12%. The 
rate of progression then increased to 23 and 26%. respec-
tively. in the subsequent t\\·o follow-up groups. with vlltu-
ally no lesions showing regression. The pattern of change for 
Figure 2.. Change in reference diameter and minimal luminal diam-
eter for the four follow-up groups. At 90 and 120 days. both these 
~hanges are significant (p < 0.00001) and are different from tl!e 
changes ar 30 and 60 days (p < 0.00001). 
FOU.OW-UP GROUPS (OAYS) 
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the reference diameter was very similar to that of minimal 
luminal diameter, although the degree of change was less 
(Fig. 3 and 4). 
Discussion 
Change in minimal luminal diameter: mechanism and 
timing. Early changes. The design of this srudy allows some 
insight into the course of a dilated coronary lesion after 
angioplasty. Many of the previously published studies re-
poned mean results for patients with a wide range of 
follow~up times. so that little infonnation on the behavior of 
the lesion with time is available. The published data are 
further distorted by preferential recatheterization of symp-
tomatic patients. who can be expected to show a higher 
incidence of restenosis. To determine a significant change 
within individuals. we have taken 0.72 mm. two times the 
variability for duplicate measurements. as the criterion for 
change. The variability (0.36 mm) r~resents 1 SD of the 
mean difference between duplicate measurements on the 
same lesion and would result. if used as a criterion for 
change, in a 16%false positive rate. whereas the use of2 SD 
(0.72 mm) as a criterion results in a false positive rate of only 
2.5%. 'When this value is used as the criterion for change. it 
can be seen that, in patients reinvestigated at 30 and 60 days, 
the immediate response is variable. with more lesions ini-
tially showing regression than progression (Fig. 4). A 30% 
rate of lesion regression after angioplasry was previously 
described (14). but only in a small group of patients, with use 
of different criteria and without specific reference to the time 
after angioplasty in the selected subgroups. Spontaneous 
lesion regression may occur as part of the atherosclerotic 
process (15-18) in undilated coronary artery lesions, but the 
rapid improvement of 6% of the dilated lesions in our study 
suggests that some lesions may undergo a remodeling proc-
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Flgllre 3. Histograms for the four follow-up groups. A. Distribution 
in the change of reference diameter "With time. The vertical inter-
rupted line represents no change. The mean value for eac:h follow-up 
group:!: 1 SD is also shown. B. Distribution in the change of minimal 
luminal diameter for the four follow-up groups. FU =- follow-up 
study; nr '= number: POST PCTA = postangioplasty. 
ess early after dilation that is different from the normal 
atherosclerotic process. 
Late changes. At 90 and 120 days. there were virtually no 
lesions showing regression. Indicating that. even after initial 
improvement. significant progression of stenosis may occur. 
The more well established trend of lesion progression starts 
tb become evident between 30 and 60 days. but it is not 
confirmed statistically until 90 days. with some funher 
deterioration at 120 days. 
In the pig model. Steele et al. (6) found evidence of 
smooth muscle proliferation as early as 7 to 14 days after 
dilation. This same process was identified in at least seven 
postmonem hearts (19-22) that were examined over a time 
period (l7 to 150 days after dilation) similar to that used in 
our study. It seems likely that the process also begins early 
in human patients. but because of the limitations in recog-
nizing small changes even with an accurate system of 
analysis. we do not see highly significant deterioration until 
90 days. Our data suggest that the restenosis process takes 
place to some extent in virtually aU lesions dilated. 
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Change in reference diameter: response of nonstenotic 
segments to intraarterial balloon injury. Animal studies 
(6.23.24) have shown that, after angioplasty of normal ca· 
rotid arteries. there is initially significant platelet deposition. 
particularly if a deep intimal tear has occurred. and subse-
quent proliferation of smooth muscle cells. During angio-
plascy. the relatively normal coronary artery segments adja-
cent to the stenosis are inevitably involved in the angioplasty 
process because the balloon is usually longer than the 
Flgllre 4. Percent of patients within each of the individual follow-up 
gtoups who fulfilled the 0.72. mm criterion for change. D =days to 
follow-up study. 
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stenosis and positioning of the balloon across the stenosis 
cinnot always be done precisely. The diameter of these 
adjacent segments (considered to be relatively normal coro-
nary aneries) is conventionally used as the reference diam-
eter because the use of segments at a distance from the 
steriosis. which are not involved in the dilation process. will 
no longer reflect the ··normal" diameter at the site of the 
stenosis. In the previously mentioned postmortem studies 
(19-22). the authors made the distinction benveeo dilated 
and nondilated segments. but did not differentiate betv.reen 
those having changes within stenotic segments and those 
who did not. More recently. Waller et aL (21) obser"l.ced 
fibrocellular proliferation in the left main stem coronary 
artery. which was not targeted for angioplasty. but was 
involved in the dilation process because of the proximity of 
a lefi: anterior descending coronary anery stenosis. The 
proliferation was limited to the segments dilated by the 
ballOon whether or not they were stenotic. Otl:ier case repons 
(26-28) also implicated inrraarcerial trauma as the cause for a 
new stenosis in segments not targeted for angioplasty. 
Rationale for choosing variables to be measured. Conven-
tionally. the severity of a coronary artery stenosis is ex-
pressed as percent diameter stenosis (that is. the diameter of 
the stenotic lumen as a Percent of the norn:lallumen of the 
vessel). The so-called normal lumen has to be selected 
ind.ividuaJly from a segment of the coronary anery immedi-
ately adjacent to the stenosis. that appears to the angio-
Ftgnre 5. Acrua! time to follow-up according to predetermined 
follow-up groups. comparing lesions with restenosis (5;0.72 mm) 
(left) with those without (right). See text for details. 
grapber to be normal. This approach has several limitations 
(29.30). The :first is that we now know that it is not possible 
with cinean...ciography to identify reliably the normal diame-
ter of a coronary anery because of the general compensatory 
dilation associated with coronary artery disease (31). Also. 
the presence of diffuse atherosclerotic narrowing may give 
rise to a normal regular appearance (32). leading to an 
underestimation of the diameter of the normal arterial seg-
ment. Second. because of the normal variation in diameter of 
diseased coronary aneries composed of stenotic and ectatic 
segments. the selected normal segment is subject to consid-
erable individual variation; this problem is compoui:tded 
when sequential analyses are performed on the same lesion. 
Third, between two analyses the selected normal segment 
may undergo a significant change that will not be recognized 
unless the segment is measured quantitatively. The use of 
the interpolated reference diameter minimizes these poten-
tial errors because it is not arbitrarily selected by the 
angiographer and it is based not on how an artery behaves at 
one point alone. but reflects the change in the segments 
adjacent to the stenosis both proximally and distally. 
Factors contributing to variability of measurement. De-
spite these considerations. serial analysis of a dilated lesion 
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still presents significant methodologic problems. Figure 1 
shows single frame angiograms analyzed before dilation. after 
dilation and at 60 day follow-up. The vessel concerned is the 
~eft anterior ·descending coronary artery. Before dilation. 
there is a discrete stenosis at the origin of a diagonal branch. 
Angioplasry achieves a satisfactory result. but there is a long 
restenosis at follow-up. The length of the lesion is defined 
automatically on the basis of the derivative of the diameter 
function curvature analysis and dem.arcated by the lines on 
either side of the lesion on the al!giogram and by the vertical 
lines on the plot. The interpolated contour is then superim-
posed on the plot on the basis of the contours to either side of 
the lesion, and the reference diameterfor the lesion is taken as 
the value coincident with the site of maxim.aJ. narrowing. In 
such analyses. the reference contour is computed from the 
same segments of the coronary artery, but excluding the 
l~gth of the stenosis. w~ch is auto~tically defined by the 
computer. In this \V3.y. any real change in these contours \Vill 
be reflected in the ~hange in reference ~eter. 
Like· the change in the minimallun¥nal diameter. the 
change in interpolated reference diameter (Fig.. 3) constitutes 
a normal distribUtion about the mean v~ue for each of the 
follow-up groups. with a trend to deterioration with time. 
The greatest deteri.oraqon is seen berw~en 60 and 9(1 days. 
but the trend is still evident betWeen 90 and 120 days. The 
possibility that this change in reference diameter is anifu.c-
tual has· been addressed: there are reasons why t:l;is is 
unlikely. The first is that the change follows the same trend 
as that of the minimal luminal diameter. suggesting the 
underlying causative mechanism is the same. SecOnd. if 
there was a factor (such as the degree of pbarmocologic 
vasodilation) causing the change, it would be expected that a 
similar change would be seen in all the follow-up groups and 
not just in the latter wo. 
The i!z.cidence of restenosis and the timing will be influ-
enced by the selection of patients for reinvestigarion. and the 
selection of symptomatic patients has certainly been rele-
vant to other studies (1;2). It is inevitable that not all patients 
will be restudied at their originally allocated time, usually 
because recurrent symptoms dictate early investigation. 
Figure 5 shows the actual time from angioplasty to follow-up 
study. comparing those !esions that undenvem restenosis 
with those that did not. Most patients were restudied at or 
near thei! preset time. Analysis of the data according to 
actual time to follow-up study rather than allocated time to 
follow-up study does not materially alter the results. 
R~osis: implications for foUow-up studies. All of the 
larger follow-up studies after coronary angioplasty have 
expressed the results in terms of the changes in percent 
diameter stenosis. Thus. there is little inform."ation available 
on the change in minimal luminal diameter independent of 
the change in reference diameter. Any change in the refer-
ence diameter, as one of the variables on which percent 
diameter·stenosis measurement is based. will influence the 
rate of restenosis. A reduction in reference diameter '.VilJ. 
tend to underestimate any coincident reduction in the vessel 
lunllnal diameter expr~ssed as a percent of this diameter. As 
a consequence. a restenosis rate based entirely ·on the 
change in percent diameter stenosis will tend to underesti-
mate the incidence ofrestenosis after angioplasty. 
Conclusions. The use of a comPuter-assisted syStem for 
the measurement of coronary artery lesions bas enabled the 
accurate determination of the changes that oc~ur in these 
lesions after balloop. dilation. Early after the procedure, 
thefe is a variable response. some lesions showing improve-
:;nent and thus detezioration of the minimal luminal. diameter. 
Between 60 and 90 days. there is a signihca:nt deteriora~on 
that is maintained at 120 days. The reference diameter 
obtained from the adjacent ··normal" segment. also shows a 
similar late deterioration. presumably because this segment 
is involved in the ~tion process. This change in reference 
diameter will lead to an underestimation of changes in the 
dilated. lesion if, as is the convention; the percerlt diameter 
stenosis is used aS the sole measurement. 
We gratefully acknowledge tbe help of Gusta Koster. Anja van Huuksloot and 
Claudia Spm.ger de ~over in the preparntion of this manuscript · 
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the first three months following angioplasty. New Developments in 
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11. Early regression and late progression in coronary 
artery lesions in the first 3 months following 
coronary angioplasty 
KEVIN J. BEATT. H. E. LUUTEN. J. H. C. REIBER and 
P. W. SERRUYS 
SUM:MARY. In order to determine the changes in stenotic lesions follov.ring coronary angio-
plasry. detailed quantitative angiographic measurements were performed in 254 patients (292 
lesions) immediately post-angioplasty and then at one of three predetermined follow-up times. 
at 30. 60 or 90 days. The absolute changes in mm of the minimal lumen diameter were 
compared for the three groups, and a relatively high follow-up rate of SS% was achieved. In 
the groups of patients followed-up at 30 and 60 days. the response was variable with 6°/o of the 
lesions sho'Ning a significant improvement in both groups and 1% and 12% respectively, 
showing a deterioration. At 90 days no lesions were seen w improve with 23% deteriorating. 
Early following angioplasty lesions e..xhibit a variable response with more improving than 
deteriorating. At 60 days the restenosis process is evident. with the number of lesions 
deteriorating almost doubling ber.veen 60 days and 90 days. 
Introduction 
The incidence of restenosis follo'Wing PTCA has become an important index 
for defining the longterm success rate of the procedure. However, despite a 
number of studies, some involving relatively large numbers of patients, the 
incidence of restenosis in the overall PTCA population remains poorly 
defined. Tbis is due to a number of factors, which alon~ or in combination 
may lead to distortion of the data. The first of these is the failure to use a 
reproducible quantitative angiographic measurement system for defining the 
vessel diameter. Visual estimation of stenosis severity alone yields unaccept-
able errors in the assessment of changes in the coronary lesion [1-4], and an 
automated edge detection system will further enhance the accuracy of a 
quantitative system [ 5]. 
Secondly, the rate of restenosis varies considerably according to the 
definition used. Restenosis rates are conventionally based on the change in 
percentage diameter stenosis; the criteria used are arbitrary and may not 
reflect_ the true changes occurring in the vesseL 
Thirdly. follow-up studies addressing restenosis should be performed 
prospectively, with all or as many patients as possible undergoing repeat 
angiogtaphy at preset follow-up times. Reinvestigation determined predomi-
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nantly by the recurrence of symptoms, "'ill bias the results so that they do 
not reflect the outcome of the PTCA population as a whole. 
In order to better define the true incidence of restenosis, and to determine 
the change of lesion characteristics with time, we performed an angiographic 
study in patients who had undergone a successful PTCA Patients were 
reinvestigated at 30, 60 and 90 days (following the dilatation procedure) and 
measurements were performed using a computer based quantitative angio-
graphic system (CAAS). 
Study population 
Initially 290 patients were entered into the study having undergone success-
ful coronary angioplasty, defined as: (1) less than 50 percent diameter 
stenosis on visual inspection of the post-angioplasty coronary angiogram 
performed in multiple views; (2) no in-hospital complications, namely recur-
rence of angina, coronary bypass grafting, repeat percutaneous transluminal 
coronary angioplasty (PTCA), acute myocardial infarction, or death. 
Both patients with stable and unstable angina pectoris, as defined previ-
ously [6], were included. Patients with acute myocardial infarction receiving 
a thrombolytic agent who subsequently had immediate coronary angioplasty 
were excluded. 
Allocation of patients to one of three predetermined times for follow-up 
angiography was made sequentially according to the study period in which 
the dilatation was performed; those falling in the first study period being 
reinvestigated at 30 days, the second at 60 days, the third at 90 days. Of the 
290 patients who met the inclusion criteria, 254 patients had repeat angier 
graphy suitable for quantitative analysis. The reasons for failure to complete 
the study are detailed in Fig. 1. 
Recatheterization ;vas considered to be contra-indicated for the following 
reasons: severe concomitant disease (e.g. renal failure, lung cancer), peri-
pheral vascular disease, or multiple ( > 4) prior angiographic investigations. 
Of the total study group of 254 patients (292 lesions), 93 patients were 
recatheterized at 30 days (110 lesions), 79 patients at 60 days (89 lesions) 
and 82 patients at 90 days (93lesions). 
The baseline clinical characteristics in the three groups were comparable 
for the variables shown in Table l The mean time from PTCA to follow-up 
angiography in the three study groups was 40 days, 58 days and 102 days, 
respectively. 
Where clinically indicated (early recurrence of symptoms), patients were 
re-investigated before their preset time, but in order not to adversely bias 
the earlier groups and so allow valid statistical comparison of the individual 
groups, analysis was performed according to their original allocation group. 
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PATIENTS WITH SUCCESSFUl PTCA 
(<50% OSTEN POST-PTCA) 
'---11 recath. 
contra-indicated 
'----11 angiogram not suitable 
for analysis 
PATIENTS WITH lATE F/U 
(QCA in 88%) 
:# of lesions 
Figure 1. Flow chan of the total number of patients who met the inclusion criteria. and the 
reasons for failure to complete the srudy. FlU = follow-up; QCA = quantitative coronary 
angiography~ Recath. = recatheterization. 
Prior myocardial infarction was defined according to the Minnesota code, 
[7] and in the case of an electrocardiographic conduction abnormality mak-
ing interpretation difficult, the presence of regional akinesia or dyskinesia on 
the left ventriculogram was used as the criterion for a pre,ious infarction. In 
Table II are shown for each study group the type of vessel dilated, the 
number of patients with tandem lesions, and the number of patients -.,ith 
more than one lesion dilated. 
Methods 
Coronary angioplasty- .was performed with a steerable, movable guide-wire 
system via the femoral route. Details regarding the procedure used in our 
laboratory have previously been described [6]. At the beginning of the angio-
plasty procedure all patients received 10,000 LU. of heparin i.v., 500 mg of 
acetylsalicylic acid i.v, and a continuous infusion of Rheomacrodex"' (low 
molecular weight dextran) was started. After dilatation 10 mg of nifedipine 
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Table I. Clinical characteristics of 290 patients v.'ith successful percutaneous rransluminal 
coronary angioplasty entered into the study. 
Characteristics 
No. of patients 
No. of lesions 
Mean no. of 
lesions dilated/pt. 
Age (mean ± s.d.) 
Sex ratio (MJF) 
TUDe from PTCA 
to FlU (days) 
Extent of CA.D. 
(No. of vessels) 1 
2 
3 
Previous coronary 
bypass grafting 
Pre-.'ious myocardial 
infarction 
Pre-.'ious coronary 
angioplasty 
Follow-up period 
30Days 
No.(%·) 
93 
110 
1.18 
-57±9 
(~ge, 35-75) 
5.6 (79/!4) 
40±7 
(range. I 8-62) 
63 (68) 
25 (27) 
5 (5) 
8 (9) 
25 (27) 
10 (11) 
60Days 
No.(%) 
79 
89 
1.13 
57±9 
(range,31-75) 
5.1 (66/13) 
61 ±12 
(range.11-80) 
55 (70) 
20 (25) 
4 (5) 
4 (5) 
24 (30) 
2 (3) 
90Days 
No.(%) 
82 
93 
1.13 
56±9 
(range, 32-74) 
3.3 (63119) 
overall 
No.(%) 
254 
292 
1.15 
57±9 
(range. 31-7 5) 
4.5 (208/46) 
102±18 80±38 
(range,33-164) (range, 11-164) 
59 (72) 
18 (22) 
5 (6) 
3 (4) 
20 (24) 
11 (13) 
177 (70) 
63 (25) 
14 (6) 
15 (6) 
69 (27) 
23 (9) 
CAD.= coronary artery disease; F =female sex: FlU= follow-up angiography; M =male 
sex: s.d. =standard deviation. 
was given orally every two hours for the first twelve hours after PTCA, and 
then three to six times a day together with 500 mg of acetylsalicylic acid 
orally once a day until repeat angiography. Beta-blockers were withdrawn 
unless hypertension was present. 
Quantitative coronary angiography 
The quantitative analysis of the stenotic coronary segments was carried out 
with the computer-assisted Cardiovascular Angiography Analysis System 
(CAAS), which has been described in detail [8, 9]. In summary, to analyze 
a coronary arterial segment in a selected frame of 35 mm cinefilm, an 
optically magnified (magnification factor 2) portion of the image encom-
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passing that segment is convened into video fonnat by means of a cine-video 
convener. The contours of the vessel are detected automatically on the basis 
of the weigbted sum of first- and second-derivative functions applied to the 
digitized brightness infonnation. Calibration of the diameter data of the 
vessels in absolute values (mm) is achieved by using the contrast catheter as 
a scaling device. To this end, the contours of a user-defined portion of the 
optically magnified catheter (optical magnification factor 2./2) are detected 
automatically. Both the arterial segment and catheter contours ·are corrected 
for pincushion distortion caused by the image intensifier. From the arterial 
contours, the vessel diameter function, in millimeters, is detennined by 
computing the shortest distances between the two contour sides. A represen-
tative analysis, with the detected contours and the diameter function super-
imposed on the digitized video image, is shown in Fig. 2. 
The reference diameter or the normal diameter of the coronary artery 
at the site of obstruction is difficult to standardize and is usually defined 
visually using the nearest coronary artery segment that appears nonnal. 
A number of errors may be produced in this way: firstly, there is a large 
individual variation in the choice of the segment used, and secondly, because 
of the variation in the vessel diameter, typical of atherosclerotic vessels, 
adjacent segments will not always represent the normal diameter of the 
vessel at the site of the obstruction. To avoid these potential errors we have 
used an intetpolated' reference diameter measurement. The principle behind 
this technique is the computer estimation of the original diameter within the 
obstructed region assuming that no local coronary disease is present. This is 
calculated from the computed reference diameters of the proximal and distal 
segments, and after the vessel has been reconstructed the intetpolated 
reference diameter is taken as the value coincident with the site of maximal 
narrowing [10-11]. The precision of the contour detection process has 
previously been validated using plexiglass phantoms filled with contrast 
medium [12]. We have found that using our measurement system, the overall 
ac=acy (average difference between true and measured values) and the 
precision (pooled standard deviation of the differences) of the obstruction 
diameter is minus 30 and plus 90 microns, respectively [8]. 
In order to standardize the method of analysis of the PTCA and follow-
up angiograms, the following four measures were undertaken: first, multiple 
matched views, orthogonal if possible, were aualyzed for each patient and 
the results averaged; second, the X-ray system was repositioned in the 
settings corresponding as much as possible to the projections used during 
the previous angiographies. For this pntpose, the angular setrings of the 
X -ray gantry and the various heigbt levels were readjusted according to the 
values previously documented with the on-line registration system. Third, 
for all studies cinefrarnes to be analyzed were selected at end-diastole to 
minintize any possible foreshortening effect. Fourth, the user-detennined 
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Figure 2. A single frame angiogram of a left coronary anery with superimposition of the 
automated contours at the coronary artery segment of interest. Beneath this is shown the 
diameter function of !he detected contours of the left anterior descending coronary artery. The 
minimal lumen diameter (0.91 mm) and the interpolated diameter function line (i) from which 
the reference diameter is derived, are sho\Vfi on the diameter function plot. 
beginning and end-points of the major coronary segments between side 
branches, where possible, were identified according to the definitions of the 
American Hean .-"ssociation. Finally, Polaroid pictures were taken of the 
;ideo image with the detected contours superimposed, to ensure that the 
analyses were performed on the same coronary segment in the consecutive 
angiograms. 
Absolute measurements of the reference diameter and minimal obstruc-
tion diameter were recorded in millimeters. A change of greater than 
0.72 rom was taken to represent a significant change. This is based on twice 
the variability of the obstruction diameter (036 rom) when coronary angio-
graphy is repeated over an interval of 90 days [8]. 
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Statistical analysis 
To compare the three follow-up groups with respect to baseline charac-
teristics (Tables I and II), univariate analysis of variance was performed for 
the continuous variables, and chi-square analysis for discrete variables. 
Univariate analysis (BMDP statistical software, University of California 
Press, Berkeley, California 1985) was performed on the quantitative angie-
graphic data. 
Table II. Type of vessel dilated, number of patients v.ith tandem lesions. and number of 
patients "With more than one lesion dilated for each of the four study groups. 
30Days 60Days 90 Days overall 
No.(%) No.(%) No.(%) No.(%) 
Vessel dilated 
LAD 61 (56) 61 (69) 55 (59) 177 (61) 
LCX IS (16) 16 (18) 19 (20) 53 (IS) 
RCA 26 (24) 11 (12) 16 (17) 53 (IS) 
Bypass 4 (4) 0 (0) 2 (2) 6 (2) 
LMCA (I) (I) I (I) 3 (1) 
No. of patients with tandem lesion 6 (6) 2 (3) 2 (2) 10 (4) 
No. of patients v.rith more than I 
lesion dilated 15 (16) 10 (13) 10 (12) 35 (14) 
Bypass = aortocoronary bypass grate LAD = left anterior descending artery; LCX = left 
circumflex artery~ LMCA = left main coronary artery: RCA= right coronary artery. 
Results 
In the three follow-up groups 254 patients completed angiographic follow-
up. As a result of PTCA there was an expected significant improvement in 
the minimal lumen diameter and diameter stenosis in each of the 3 groups 
(p < 0.0001 ). The changes in the mean minimal lumen diameter and the 
mean reference diameter occurring between post-PTCA and follow-up are 
shovm in Fig. 3. In the groups that had follow-up angiography performed at 
30 and 60 days, there were small nonsignificant changes in both these. 
values. However, at 90 days there was a highly significant decrease in not 
only the minimal lumen diameter, but also in the reference diameter. 
The changes in the individual minimal lumen diameters (mm) of all the 
lesions divided into the 3 follow-up groups are represented in Fig. 4. Individ-
ual lesions that have undergone a change greater or equal to 0.36 mm are 
distinguished by a closed circle. Regression is defined as an increase, and 
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Figure 3. Change in reference diameter and mini.mallumen diameter for the three follow-up 
groups. For the 90 days group both these changes are significantly greater than in the two 
previous follow-up groups (p < 0.0001 ). 
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'· ........... ~~ 
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Figure 4. Individual minimal lumen diameter (mm) post-PTCA compared with that at control 
angiography for the three groups. The two solid lines on either side of the identity line 
correspond to the long-term variability (0.36 mm) of repeated measurements for this para-
meter. This variability is one standard deviation of the differences of the duplicate angie-
graphic measurements. Here two standard deviations were used (2 X 0.36 = 0.72 nun; dashed 
lines) as a criterion for lesion progression or regression. Based on this criterion the percentage 
of lesions showing progression or regression (outside of dashed lines) are shovm within the 
relevant brackets. 
progression as a decrease of at least 0.72 mm (twice the variability) and 
these values fall outside the dotted lines. It can be seen that the mean 
change for each group does not reflect the number of individual lesions 
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undergoing a significant change. In the group followed up at 30 days there 
were a greater number of lesions undergoing regression than progression. At 
6 0 days the percentage of patients showing progression was twice that of 
regression and at 90 days this percentage had doubled v;ith virtually no 
lesions exhibiting regression. 
Figure 5 illustrates the incidence of restenosis according to a number of 
commonly used criteria, and to the criterion for a change of greater than 
0. 72 mm. There is a vlide variation in the incidence according to the criteria 
used, although the incidence of restenosis increases progressively up to at 
least 90 days, irrespective of the criteria chosen. 
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Figure 5. Sho"-n are the percentages of lesions that fulfil three of the restenosis criteria: 
NHLBI IV. defined by a loss of gTeater than 50% of the gain achieved at PTCA; ~ 0.72 mm, 
defined by a change of ~ 0.72 mm between post-PTCA and follow-up; and thirdly. ;<!::50% 
stenosis at follow-up. Using these three criteria the incidence of restenosis increases up to ai 
least 90 days. 
Discussion 
Method of assessment 
Percutaneous transluminal coronary angioplasty has developed into a well 
accepted method of revascularization. Although the immediate benefits of 
the procedure are well established and often striking, the longterm outcome 
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is less well defined; undoubtedly, the feature that most limits the usefulness 
of this procedure is the incidence in restenosis of the dilated lesion in the 
months following the procedure [14-17]. Various methods of assessing the 
results of angioplasty have been addressed by Serruys and others [10, 18]. 
The absolute measurement of a coronary stenosis based on a series of single 
frame angiograms remains the most direct method of assessing the degree of 
coronary artery obstruction. Accurate measurement of any change in the 
coronary artery stenosis must be based on reproducible quantitative mea-
surements. The use of computer assisted automatic edge detection of the 
lesion contours is also important, particularly in the situation post-angio-
plasty when the contours of the dilated lesions tend to be irregular and 
are subject to a ·greater inter- and intra-observer variability [5]. Using an 
automatic edge detection measurement system in combination v..ith a strict 
protocol, both for the timing of repeat follow-up measurements and for the 
angiographic projections studied, will allow a high degree of accuracy to be 
obtained. The variability of the mean ntinimal lumen diameter for repeat 
short (5 min.), medium (60 min.), and long tertn (90 days) observations was 
found to be 0.34mm, 0.22 mm and 0.36 mm, respectively. We have taken 
the long term variability, the value for the least well controlled group, as the 
basis of our criteria for lesions that undergo a significant change. The 
variability represents one standard deviation of the differences between the 
paired measurements from the first and second angiograms, and would 
result in a 16% false positive rate, while the use of two standard de,iations 
as a criterion (0. 72 mm) results in a false positive rate of 2.5%. It provides 
an index of restenosis based on the absolute change in the lesion rather 
than a change relative to the reference diameter; by using this value we are 
able to obtain a better insight into the changes in coronary anatomy that 
occur following PTCA. 
Early rer;zodeling of dilated lesion 
The data of patients followed up at 30 days suggest that the early response 
following PTCA is extremely variable with more patients exhibiting a regres-
sion of the stenosis than those exhibiting progression. This is well shown 
in Fig. 4. The lack of uniformity in response following PTCA has been 
documented in the past [16, 17], but no factor has been identified that can 
predict -.,ith any reliability or consistency the lesions that will show either 
progression or regrJ;ssion. 
Lesion regression rates of 30% have previously been described follo"ing 
angioplasty, but in a small group of patients, using different criteria and 
without specific reference to time following angioplasty of the selected 
subgroups. Spontaneous lesion regression may occur as part of the athero-
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sclerotic process [19-22] in undilated coronary artery lesions; however, we 
cannot exclude further changes following our_ last observation point at 90 
days. It may be that the irregular nature of the lesion post-angioplasty does 
not allow accurate baseline measurement, particularly if a dissection has 
occurred, but our system using automatic detection of the vessel contours 
will minimize the variability of this measurement. Distortion of the baseline 
value \\ill mean that any consequent measurement based on this will be 
inaccurate. 
An alternative explanation for the early variable response is that of 
platelet deposition or dissolution. Thrombus may be present at the site of the 
stenosis prior to dilatation, or alternatively deposition may occur early after 
dilatation as has been demonstrated in animal models [23]. Therefore, 
behavior of platelets at the site of dilatation following angioplasty may 
account for the early variable response seen. 
Laze progression 
In the group of patients followed up at 60 days the variability in response is 
again exhibited, but at 90 days there is a distinct change in the pattern. 
There are fewer patients exhibiting a regression in the minimal lumen 
diameter, with many more patients showing a deterioration. Tills general 
trend towards deterioration is responsible for the relatively large change 
in the mean minimal lumen diameter and the highly statistical difference 
between this group and the 2 groups followed up earlier at 30 and 60 days 
(p < 0.0001). 
Tills progression of the minimal lumen diameter reflects the well known 
deterioration in percent diameter stenosis in studies where the mean follow-
up time post-angioplasty was greater than two months [14-17]. Animal 
studies have shown that following angioplasty of normal arteries there is 
initially significant platelet deposition, particularly if an intimal tear has 
occurred, and subsequently proliferation of smooth muscle cells. In the pig 
model [23] it has been shown that intimal proliferation occurs between 7 and 
14 days and this same process has been identified in at least 7 posttnonem 
heans that were examinated over a similar time period to that involved in 
our study (17-150 days) [24-28]. These repons comment on this dif-
ference between the dilated segments and nondilated segments, but do not 
differentiate between changes within stenotic segments and those without. 
More recently, Wallar et aL [29] has reponed fribrocellular proliferation in 
the left main stem coronary artery which was not targeted for angioplasty, 
but may have been traumatized by either the balloon dilatation or guiding 
catheters. However, the former seemed the more likely as there was evidence 
of the restenosis process along the entire segment occupied by the dilating 
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balloon. The histological evidence suggests that the restenosis process found 
in animals is the same as that responsible for the deterioration in the 
minimal lumen diameter and the reference diameter sho'-'11 in our study. 
Kaltenbach et al. [13] in one of the few studies with a high percentage 
follow-up rate showed, that almost all patients who develop restenosis do so 
within the first three months. We are able to show that a restenosis process 
takes place predominantly between two and three months, but at this time 
we are unable to comment on the possibility of the process continuing 
beyond this period. 
There is very little data conceruing the change in the reference diameter 
following angioplasty, which is perhaps surprising as animal studies would 
suggest that coronary anery segments involved in the dilatation procedure 
would also expect to be involved in the intimal proliferation process [23]. 
The fact that, in our study, the acceleration of deterioration in the reference 
diameter occurs at the same time as that in the minimal lumen diameter 
.suggests that the underlying process is the same. The change has an impor-
tant effect on the percentage diameter stenosis measurement and will tend to 
underestimate the restenosis process. It further reinforces the imponance of 
using an accurate measurement system in this type of srudy. 
Conclusion 
The use of an accurate computer-assisted system for the measurement of 
coronary anery lesions has enabled a more accurate determination of the 
changes that occur in coronary anery lesions following dilatation. Early 
following the procedure there is a variable response with both improvement 
and deterioration of the minimal lumen diameter, whereas by 90 days the 
response is more uniform with a significant deterioration being evident The 
change in reference diameter follows a similar pattern to that of the mean 
minimal' lumen diameter, presumably because it is also involved in the 
dilatation process, and will lead to an underestimation of changes that occur 
if percentage diameter stenosis is used as the sole measurement. 
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Chapter 4 
Restenosis following coronary angioplasty. The paradox of initial 
improvement in lesion geometry and poor long term result. Journal 
of the American College of Cardiology 1992 
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CLINICAL STUDIES 
Restenosis After Coronary Angioplasty: The Paradox of Increased 
Lumen Diameter and Restenosis 
KEVIN J. BEATT. MB. BS. PATRICK W. SERRUYS. MD. PHD. FACC. HANS E. LUDTEN. MD. 
BENNO J. RENSING. MD. HARYANTO SURYAPRANATA. MD. PHD. 
Pil\1 DE FEYTER. MD. PHD. MARCEL YAK DEN BRAND. MD. GERT JAN LAARMAN. MD. PHD. 
JOS ROELANDT. MD. PHD. FACC. WITH THE STATISTICAL ASSISTANCE OF GERRIT ANNE VANES 
Rotterdam, The Netherlands 
Restenosis after coro~· angioplasty is the single complication 
that most limits this revascul:uization procedure in clinical prac-
tice. The process is largely unpredictable and the lesion-related 
factors predisposing to resteoosis are poorly understood. with 
little consensus in published reports. In this study using detailed 
quantitati,·e angiographlc measurements to assess 490 lesions. the 
simple lesion characteristics associated with restenosis were de-
fined and the relation to the restenosis process documented. 
Restenosis was defined as an absolute deterioration in the minimal 
lumen diameter by 2:0.72 mm. a criterion based on the 95% 
confidence intervals for repeat angiographic: measurements. This 
was chosen in an attempt to separate spurious changes due to a 
poor angiograpbic result and tbe variability of angiographic 
measurements from significant changes due to the restenosis 
process. 
The principal determinants of restenosis were found to be a 
large improvement in the minimal. lumen diameter at the time of 
dilation (1.13 mm for tbe restenosis group compared witb 
0.86 mm for the no rest:enosis group [p < 0.0001] and an optimal 
Restenosis after angioplasty is conventionally detennined by 
the angiographic restenosis rate .• 4J.though this is known to 
be an inaccurate reflection: of "clinical restenosis .. (l-6). it is 
the most objective and reproducible form of assessment and 
consequently it remains the index by which the long-term 
success of angioplasty (J-9) as well as other nonsurgical 
revascularization procedures is judged. 
This index. however. is signjficantly influenced not only 
by the definition of restenosis employed. but also by a host 
of other factors such as incomplete dilation. method of 
angiographic analysis. low follow-up rates and biased patient 
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postangioplasty result (minimal lumen diameter 2.28 mm in the 
restenosis group compared with 2.05 mm [p < 0.001] in the no 
restenosis group. corresponding to a 25% and a 30% diameter 
stenosis. respectively [p < 0.0001]). 
These observations reported for the first time suggest that the 
distinction needs to be made between a "clinical restenosis'' of 
2:50% diameter stenosis and the "restenosis process·' as mea-
sured by the absolute changes occurring during and after angio-
plasty. They lend support to tbe hypothesis that the degree of 
mechanical stretch produced by the dilating balloon on the vessel 
wall may be important in stimulating the restenosis process. This 
is in contradiction to deductions obtained if restenosis is based on 
"clinical restenosis •• , whicb suggests that restenosis is associated 
primarily with a poor angioplasty result. More important. it 
indicates that there is potential for misinterpreting the results of 
restenosis studies if the obsen·ations are based solely on conven-
tional restenosis criteria without knowledge of the absolute 
changes occurring during and after the angioplasty procedure. 
(]Am Coli Cardiol1992;19:258-66) 
study groups. The failure to adopt a standard method of 
assessment has led to varying reports concerning the factors 
that influence the restenosis process. 
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The current lack of information means that the optimal 
angioplasty result necessary to achieve good long-tenn suc-
cess is not known. Overdilation is associated with an in-
creased incidence of acute dissection (10) and may stimulate 
the restenosis process by the extent of deep arterial injury. 
which in tum is associated with increased platelet activation 
(II). Alternatively. as suggested in the animal model (12). 
the injury due to stretching itself. independent of platelet 
accumulation. may be an im.ponant stimulant for restenosis. 
Conversely. underdilation may leave a significant residual 
stenosis. resulting in increased turbulence (5.13). increased 
platelet activation and subsequent restenosis by the same 
common pathway. More recently. the important association 
of residual stenosis. a positive stress test and their relation to 
"'restenosis"' have been reported (14). 
In this study. simple lesion variables (minimal lumen 
diameter. reference diameter and percent diameter stenosis) 
Table 1. Clinical Characteristics of 424 Patients 
No. of!esions 
Lesions/patient 
Patient age (mean} (yr) 
Malelfel!'.ale ratio 
Time from an&:ioplasty to follow-up (days} 
Vessels v.ith CAD (no. of patients} 
1 
3 
Previous CABG {no. of patients} 
PreviollS <mgioplasty (no. of patients} 
Previous Ml (no. of patients) 
Dilated vessel {no. of patients} 
LAD 
LC> 
RCA 
Bypass graft 
No. of patients with more than one ksion 
dilated 
490 
1.16 
57:::+:: 9 (range31 to 79} 
346178 
94 :!: 43 (range 3 to .2.26) 
.288(68%) 
97 (23%) 
39 (9%) 
31 (7%) 
176 {4.2%) 
44 (109C) 
.239 (57%) 
80 (17%) 
97 (.20%} 
10 (.29C} 
63 (15%) 
CABG = coronary artery bypass graft: Lill =left anterior descending 
coronary artery: LCx = left circumflex coronary artery; Ml = myocardial 
infarctioc: RCA= right coronary artery. 
were measured and the changes in each of these during and 
after the procedure assessed. The influence of the simple 
lesion morphology and changes occurring at angioplasty on 
the restenosis process have been determined and the distinc-
tion made between this process and '"clinical restenosis" as 
assessed by more conventional restenosis criteria. 
Methods 
Study patients (Table I). Five hundred consecutive pa-
tients who underwent successful angioplasty and agreed to 
have a follow-up angiogram were studied (J). Successful 
coronary angioplasty was defined as 1) <50% diameter 
stenosis on visual inspection of the postangioplasty coronary 
angiogram performed in multiple views: and 2) no in-hospital 
complications (namely. recurrence of angina. coronary by-
pass grafting. repeat percutaneous transluminal coronary 
angioplasty. acute myocardial infarction or death). 
Patients with stable and unstable angina pectoris. as defined 
previously (15). were included. Patients with acute myocardial 
infarction receiving a thrombolytic agent who subsequently 
had immediate coronary angioplasty were excluded. 
Patients were allocated at a predetermined time for fol-
low-up angiography at the time of angioplasty. Of the 500 
patients who met the inclusion criteria. 424 patients (with 
490 lesions) had repeat angiograms suitable for quantitative 
analysis. with a mean time to follow-up angiography of 94 :::: 
43 days. The reasons for failure to complete the study were 
late death (2 patients). recatheterization contraindicated or 
refused (52 patients) and angiograms unsuitable for quanti· 
tative analysis (22 patients). 
\Vhen clinically indicated (early recurrence of symp-
toms). patients were reinvestigated before the original preset 
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time. Table I shows the baseline characteristics of the 
patients included in the study. Data concerning patients 
followed·up within 4 months of angioplasty have previously 
been published (i). 
Coronary angioplasty. This was performed with a steer-
able. movable guide wire system by means of the femoral 
route. At the begiDlling of the angioplasty procedure. all 
patients received 10.000 IU of heparin and 500 mg of aspirin 
intravenously. After dilation. 10 rn.g of nifedipine was given 
orally every 2 h for the 1st 12 hand then 20 mg three times 
a day together with 500 mg of aspirin orally once a day until 
repeat angiography. 
Quantitative coronary angiography. The quantitative 
analysis of the stenotic coronary segments was carried out 
with the computer-assisted Cardiovascular .'-\.ngiography 
Analysis System (CAA.S). which has been described in detail 
(16.1 7). Calibration of the diameter of the vessels in absolute 
values (mm) was achieved by using the guiding/diagnostic 
catheter as a scaling device (16). 
A representative series of analyses. with the detected 
contours and the diameter functions superimposed on the 
original video image. are shov.n in Figure 1. To standardize 
the measurements and minimize potential errors. the "'inter-
polated" reference diameter measurement was used when-
ever possible. This method has the advantage of eliminating 
the arbitrary choice of a reference diameter that v.ill vary 
among individual obsenrers and provides a smoothing effect 
for the segments adjacent to the stenosis so that exrreme 
irregularities in the vessel will not artificially bias the refer-
ence diameter measurement. It also reduces the effect ofthe 
change in reference diameter at follow-up angiography that 
occurs as pan of the restenosis process (18). The principle 
behind this technique has previously been described (19-21). 
as have the precision and overall accuracy of the system. the 
method of obtaining angiograms and precautions taken to 
reduce error (7). 
Restenosis criteria. The restenosis group was defined as 
those patients with a deterioration in the minimal lumen 
diameter from postangioplasty to follow-up of ;:0.72 mm. a 
criterion based on the 95% confidence limits for determining a 
significant change using a quantitative angiographic system 
(CA.A.S) (i.16). The relevance of using this criterion and its 
comparison with the conventional cutoff criterion of z50% 
diameter stenosis at follow-up are addressed in the Discussion. 
Data analysis. All angiographic and procedural variables 
were entered into a relational data base and statistical 
analysis was performed with use of BMDP statistical soft-
ware (University of California. Berkeley. California. 1985). 
The tertile with the highest incidence of restenosis was 
identified for each variable. and the relative risk of restenosis 
in this group was compared with that in the remainder of the 
study group. An odds ratio for restenosis ;:2 v.ith 95% 
confidence limits ~I was considered to have clinical rele-
vance in this study group. 
The variables selected for analysis in this study were all 
continuous with gaussian distributions. The determination 
Figure I. Singk frame angiograms of a proximal left anterior descending 
:>rterv stenosis before dilltion ltop left). after dilation ltop rightl and at 
follo~·-up angiography lb<tttoml. Quantitative coronary analysis was per~ 
formed using the Cardiovascular Angiography Analysis System. The anerial 
boundaries detected by the sy5tem are shown on the angiogram. and the 
diameter function curve derived from these contours is below. The example 
is cho~en to illustr.;~.te a successfully dilated proximal left anterior artery 
lesion th(lt undergoes a severe restenosis at 4 months. 
of risk ofrestenosis for continuous variables is dependent on 
the arbitrary subdivision of data comparing the subgroup 
with the highest risk with the remainder of the study group. 
The risk may be artificially influenced by selecting small 
subgroups that vary from the population by chance and do 
not reflect the true nature of the population they arc drawn 
from. To define the groups. the data were classified into 
three groups according to convenient cutoff points, so that 
each group contained one-third of the overa!! swdy patients 
and the group with the highest restenosis rate was identified. 
The two remaining groups were then combined to form the 
group considered to be at ··normal risk'" and the odds ratio 
of restenosis determined by comparing the third of the 
patients in the high risk group with this reference group (the 
remaining two-thirds of the study patients). !The identifica-
tion of subgroups for postangioplasty percent diameter ste-
nosis is illustrated in Fig. 2.1 This method of subdivision has 
the advantage of being consistent for a!! variables and thus 
avoids any bias in selection of subgroups that might be 
undertaken to emphasize a particular point. The 95% confi-
fi~urc 1. Frequency histograms grouped by percent diameter ste· 
nosis :>ftcr angioplasty sho">ving how the group defined by the 
'2:0.72-mm criterion is divided to determine a relevant odds r;1tio. 
The top line shows the number of lesions in each third of the group 
with restenosis (l'\0 WITH RESTI. The wrtical arrows with the 
values beneath .;;how the points of subdivision. POST-PTCA =after 
coronary angioplasty. 
NO WITH REST 
" " 
.,_ 
'" 
v' 
" " 0 
0 
' 
: 0.7:> mm 
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Table 2. A.ngiographic Variables of Restenosis Subgrouped According to Two Criteria 
::::50% Diameter Stenosis• ..,0.72 mm• 
No No 
Restenosis Restenosis p Value Restenosis Reste:nosis p Value 
Minim:ll lumen diameter before ;:mgioplasty 1.18 !.21 NS 1.15 LIS NS 
Minimal lumen diameter after an£:ioplasty 2.02 2.10 NS 2.28 2.05 <0.001 
Minimal lumen diameter at follow-up 1.06 1.99 <0.0001 1.16 2.01 <0.0001 
%diameter stenosis before anpoplasty 62.6 57.7 <0.01 58.8 58.3 NS 
% diameter stenosis after angioplasty 32.7 28.3 <0.005 24:8 29.7 <0.005 
% diameter stenosis at follow-up 64 29.1 <0.0001 54.3 29.7 <0.0001 
Normal vessel diameter before angioplasty 2.95 2.8 NS 2.86 2.85 NS 
Normal vessel diameter after angioplasty 3.05 2.94 
" 
3.06 2.93 NS 
Normal vessel diameter at fol!o'W·UP 2.92 2.81 KS 2.60 2.93 <0.001 
Change in minimal lumen diameter at a.ngioplasty (mm) 0.93 0.91 NS l.13 0.86 <0.0001 
Change in% dia.meta stenosis at a.ngioplasty 30 29.4 NS ,, 28.6 <0.01 
Change in minimal lumen diameter at follow-up (mml 0.97 0.10 <0.0001 1.12 0.0-1 <0.0001 
Cha.nge in% diameter stenosis at follow-up 31.2 0.77 <0.0001 29.7 0.07 <0.0001 
*Criterion <i <:SO% diameter stenosis at follow-up angiography. tDeteriol<l.tion in minimal lumen diameter by <:0.72 mm after ;:mgioplasty to follow-up. 
dence intervals then provide an index of the degree of 
certainty for the result obtained. 
Results 
Pre- and postangioplasty coronary stenosis measurements. 
For the total study group. the mean minimal lumen diameter 
-was 1.18 mm before angioplasty. 2.09 mm after angioplasty 
and 1.85 mm at follow-up. The corresponding mean refer-
ence diameters were 2.85, 2.% and 2.83 mm. giving rise to a 
percent diameter stenosis of 58.4% before angioplasty. 
28.9% after angioplasty and 33.9% at follow-up. 
The mean values for the angiographic variables sub-
Table 3. Angiographic Variables Before Angioplasty 
Grouped by :::0.72-mm Change Criterion 
grouped according to the o::o. 72-mm criterion and the o::50% 
diameter stenosis criterion are shown in Table 2. emphasiz-
ing the differences ber-.<.:een the two criteria. The grouping of 
the data for statistical analysis. showing the numbers in each 
group and the odds ratio for restenosis. are shown in Tables 
3 to 5. again comparing the values obtained using the 
:::::0.72-mm criterion with the ::::50% diameter stenosis crite-
rion. 
Preangioplasty variables predictive of restenosis (Table 3). 
None of the preaogioplasty variables were found to be 
associated with restenosis. A severe >65% diameter steno-
sis before angioplasty was the most relevant factor. with an 
odds ratio of 1.63 and confidence intervals from 0.85 to 3.31. 
Grouped by 2::50% D~eter Stenosis 
Minimal Lumen Diameter Before Angiopklsty 
:Slmm >lmrn Total :Slmrn >1= Total 
No restenosis 129 (85) :!78 (82) 407 (33) No restenosis 12S (35) 295 {87) 4"23 (86) 
Restenosis 2"2. {15) 61 (IS} 33 {17) Restenosis 23 (15) 44 {13) 67 (13) 
To"' 151 339 "O Toto! 151 339 490 
Odds 1<1.tio"' 1.29 {0.76-2.19) Odds ratio"' 1.21 (0.70-2.08) 
%Diameter Stenosis Before Angioplasty 
::.:::65% >65% To<ol ::;65% ~5% Tom! 
No restenosis 31:!: (85) 94 liS) 4()7 (83) No restenosis 323 (89) 95 (79) 423 (86) 
Restenosis 57 {16) 26 ("2"2) 83 {17) Restenosis 42 {]]) ~{:!:!) 67 (14) 
ToW 370 120 '90 ToraJ 370 120 ,90 
Odds ratio= 1.63 {0.85-3.13) Odds ratio = !.42 (0.82-2.54) 
NorM.! Dian1eter Before Angioplasty 
::.:::3.2 mrn >3.2mm Total ::.:::3.:!: rnm >3.2 mm Tom! 
"t'o restenosis 289 (84) 107 (8:!:) 396 (33) No restenosis 301 (87) lll (85) 412 (87) 
Restenosis 57 {16) 23 (181 so (17) Restenosis 45 (13) 19 (15) 64 (13) 
Tom! 3'6 130 476 Total 
"' 
130 
"' Odds 1<1.tio"' 1.09 (0.64-1.86) Odds ratio "' 1.15 (0.64-2.04) 
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Table 4. Angiographic Variables After Angioplasty 
Grouped by ?.:0.72-mm Change Criterion Grouped by ?.:50% Diameter Stenosis Criterion 
Minimal Lumen Diameter After Angioplasty 
::s2.3mm >2.3 mm Tow <2.3 mm >2.3mm Toml 
No restenosis 304 (86) 103 {72) 107 (S3J No restenosis !85(il) 77 (89) 362 (74) 
Restenosis 42 (!4) 41 (28) 83 (17) Restenosis 119 (29) 9(11) 128 (26) 
Tow 3.\6 144 490 Tow 404 86 490 
Odds ratio= 2.88 (1.77-4.68) Odds ratio = 0.28 (0.!3-0.60) 
% Diameter Stenosis After ,-\ngioplasty 
::::25% >25% Tow :::25% >25% Toml 
No restenosis 139 (!5) 288 (89) -+07 (83) No restenosis 168 {8!) 254 (80) 422 {86) 
Restenosis 47 (25) 36 (ill 83 {17) Restenosis 17 (9) 50 C!OJ 67 (14} 
TotJ.l 186 3:!4 490 Tow 185 304 490 
Odds ratio = 2.60 0.40-4.821 Odds r:1tio"' 0.51 (0.28-0.95) 
Normal Diameter After Angiopla.sty 
:s:3.2 mm >3.2 ll'.JO Toml 
No restenosis 295 (86) 112 (76) 407 (83} 
Restenosis 47 (14) 36C4l 83 (17) 
Toml 340 148 490 
Odds ratio = 2.M (1.25-3.31) 
Postangioplasty Yariables predictive of restenosis (Table 4). 
The restenosis group had a significantly better postangio-
plasty result as judged by minimal lumen diameter (2.2S rnm) 
and percent diameter stenosis (24.S%) compared with the no 
restenosis group (2.05 mm and 29.7%: p < 0.001 and p < 
0.0001. respectively). A postangioplasty minimal lumen di-
ameter> 2.3 rom was significantly associated with restenosis 
(odds ratio "" 2.S8) as was a postangioplasty percent diam· 
eter stenosis ::S25% (odds ratio"" 2.60). A vessel::::3.2 rom in 
diameter was less clearly predisposed to restenosis accord-
ing to the 2:-0. 72-rnm criterion with an odds ratio of 2.04. 
Changes at angioplasty (Table 5). The factor most asso-
ciated with restenosis was a large change in the minimal 
lumen diameter at angioplasty: I. 13 mm for the restenosis 
group and O.S6 rnm for the no restenosis group (p < 0.0001), 
which corresponds to a change in percent diameter stenosis 
of 34% and 28.6%, respectively. The risk associated with a 
large improvement in the stenosis in terms of descend-
ing order of_ magnitude were: minimal lumen diameter 
2:"1.14 rnm, minimal lumen diameter adjusted for vessel size 
::::0.35 mm and percent diameter stenosis ::::35%. giving odds 
ratios of 3.30. 2.9S and 2.20. respectively. There was also a 
trend for a large change in reference diameter >0.36 mm to 
be associated with an increased risk of restenosis (::::0.72-mm 
criterion) with an odds ratio of l.S3. 
Discussion 
Criteria for postangioplasty restenosis. Soon after the 
introduction of coronary angioplasty as a revascularization 
procedure. it became clear that restenosis after the proce-
:::;3.2mm >3.2 mm Tow 
No restenosis 301 (88) 1:!2 (83) 4:3 (86) 
Restenosis 41 (]2) 26 (18) 61 (14) 
Tow 342 148 490 
Odds ntio = 1.58 (0.9.:?-2.691 
dure was a significant limitation (22.23) and with the im-
provement in acute results over the years, this limitation has 
assumed increasing significance. Despite intensive investi-
gation, there is as yet no known intervention that is able to 
reduce the incidence of restenosis. The reponed risk factors 
associated with restenosis are unsatisfactorily documented, 
with little agreement among the various studies. These 
differences are primarily due to the failure of investigators to 
adopt a suitable standardized methodology with a uniformly 
accepted definition of restenosis that is relevant to the 
restenosis process. It has frequently been pointed out that 
different restenosis criteria give rise to similar restenosis 
rates (5.24). Although this is true, these similar restenosis 
rates do not define the same groups of patients (with some-
times as linle as 50% overlap) and therefore risk factors may 
well be very different for different restenosis criteria (1). 
Figure 3 illustrates the distribution of the two restenosis 
groups in relation to the total number of lesions studied. Of 
the 104lesions fulfilling at least one of the two criteria (21% 
of the total group of 490 lesions) <50% fulfilled both criteria. 
and 24% and 33%, respectively, fulfilled the 2:"50% diameter 
stenosis and the ::::0.72-mm criteria. 
Risk factors for restenosis. There are as yet no prospec-
tive studies using quantitative coronary angiography that 
report on the risk factors for restenosis in large numbers of 
patients. However. a small number of factors relating to the 
restenosis process have been identified and confirmed in 
more than one study. These include dilation of a proximal 
left anterior descending coronary artery stenosis (5.25). a 
totally occluded vessel before angioplasty (26) and the 
presence of collateral vessels supplying the distal part of the 
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Table 5. Angiographic Variables: Change at .'\ngioplasty 
Grouped by e:O.T.!·mrn Change Criterion Grouped by e:50% Diameter Stenosis Criterion 
Change in Minimal Lumen Diameter at • .l,.ngioplasty 
:::;J.14 >1.14 Toml :::;1.14 >1.14 Toml 
No restenosis 314 (88) 93 (69) 4()7 (83) No restenosis 30S (85) 115 (86) 423 (86) 
Restenosis 42 (1:!.) 41 (31) 83 (17) Restenosis 48 (15) 19 (14) 67 (14) 
Toml 366 134 490 Toml 356 134 490 
Odds t:ltio = 3.30 (2.02-5.37) Odds ratio = Ul6 (0.60-1.881 
Adjusted Change in Minimal Lumen Diameter at Angioplasty 
:S0.35 >0.35 Toml :::;0.35 >0.35 Toml 
No restenos:is 260 (89) 147 (74) 407 (83) No restenosis 115 (89) 243 (86) 358 (86) 
Restenosis 31 (11) 5:!. (26) 83 (171 Restenos:is 23 (14) 44(14) 67 (14) 
Toml 291 199 490 Tot:U 178 
"' 
490 
Odds ratio= 2.98 (1.82-4.84) Odds m.rio = 0.40 (0.22-0.76) 
Change in Diameter Stenosis at Angioplasry 
:::;35% >35 Toml ,.-;35%- >35% Toml 
No restenosis 290 (15) 1l7 (75) 407 (83) No restenosis :!.88 (75) 135 (87) 423 (86} 
Restenosis 44 (25) 39 {25) 83(J7) Restenosis 46 {25) 21 (13) 67 (14} 
Total 234 156 490 Toml 334 156 490 
Odds ntio = ::!..20 (1.36-3.56) Odds ratio ::: 0.98 (0.67-1.70) 
Differences in Reference Diameter at Angioplasty 
::>0.36 >0.36 Total 
No restenosis 320 (85) 75 (76) 395 (83) 
Restenosis 56 (!5) 24 (24) 80 Oil 
Toml 376 99 475 
Odds ratio= 1.83 (1.07-3.14) 
dilated coronary artery (27.28). The most frequently identi-
fied risk factor for restenosis has been incomplete dilation or 
a variable directly related to a poor angioplasty result, such 
as a residual pressure gradient (5.9). In our study. a reste~ 
nosis criterion that is dependent solely on the changes 
occurring after angioplasty was chosen to avoid having the 
results influenced by factors other than the restenosis pro-
cess. The distinction between the restenosis process and a 
suboptimal result has been made by comparing the 
Figure 3. Of the 490 lesions analyzed. 386 were free of restenosis 
and 104-lesions (21%) had restenosis bv either of the two criteria for 
mtenosis. The column (right) illustrates how each criterion is 
associated with a substantial proportion of lesions that are exclusive 
to that criterion. with <50% of the lesions (43%) fu11illing both 
criteria. A similar lack of correlation exists with other convention-
ally used restenosis criteria. DS = diameter stenosis. 
Total Population Rootenosls 
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::>0.36 >0.36 Toml 
No restenosis 327 (87) 84184) 4!1 (86) 
Restenosis 49 (13) 15 (15) &: (14} 
Total 376 99 475 
Odds ratio= LJ9 (0.64-2.23) 
<=::0.72-mm criterion with that of :=:::50% diameter stenosis. 
The analysis has been limited to the simple pre~ and postan-
gioplasty morphology (minimal lumen diameter. reference 
diameter and percent diameter stenosis) and the changes 
occurring during the procedure. Analysis of data in this form 
represents a significant change from the convention and 
gives rise to conclusions that are at odds with some of those 
previously published. 
Predilati<m variables. Of the predilation variables analyzed. 
only the severity of the initial lesion has previously been 
reported (9) to be associated v.-ith restenosis although many 
studies have failed to find this association. Other predilation 
variables not analyzed in this study. such as eccentricity. bend 
point location and proximal left anterior descending artery 
stenosis. presence of collateral vessels and a totally occluded 
artery. have also been implicated (5.24.29). 
The initial stenosis severity rFig. 4) was not found to be 
associated with an increased risk as assessed with either of 
the two criteria: odds ratios = 1.29 and 1.21 when using the 
<=::0.72-mm criterion and the ;:::SO% diameter stenosis crite-
rion. respectively. Likewise. if the severity of the initial 
stenosis is expressed as a percent of the normal diameter. a 
severe initial stenosis >65% was not significantly associated 
with an increased risk and this observation is in broad 
agreement with most published reports. 
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Figure 4. Odds ratios and 95% confidence intervals for restenosis in 
the third of the study group at highest risk are shown for the 
2::0.72-mm criterion (bold lines) and for comparison the correspond-
ing group according to the 2::50% diameter stenosis (fine lines). The 
cutoff point defining the relevant group at highest risk is indicated. 
CHANGE MIN LUMINAL DIAM (adjusted) = change in minimal 
lumen diameter divided by normal diameter of vessel: DL-\;.\1 = 
diameter: MIN = minimal; other abbreviations as in Figure 2. 
Postdilation variables. A poor postangioplasty result (or 
incomplete dilation) and factors associated with incomplete 
dilation such as a residual pressure gradient are most fre-
quently reported to be associated with restenosis. The data 
from this study show that the associated risk is highly 
dependent on the restenosis criterion employed: essentially 
a good result ( <25% diameter stenosis) is associated with 
restenosis if the ;:!:Q. 72-rn.m criterion is used and. conversely. 
a suboptimal result (>35% diameter stenosis) is a risk factor 
if ;:!:50% diameter stenosis is used (Fig. 4). 
It is. perhaps. not surprising that incomplete dilation 
should be identified as a risk factor if the criterion for 
restenosis is a ~50% diameter stenosis. However. the ques-
tion remains as to whether a more severe residual stenosis 
actually induces the restenosis process or whether it reflects 
the use of a restenosis criterion that preselects lesions with 
less than optimal results. The answer to this question is 
crucial because some theories addressing the cause of reste-
nosis incorporate this concept but. more important. if this 
question is not critically addressed. studies that are designed 
to determine the effect of therapeutic interventions on reste-
nosis may be falsely interpreted. 
Our study suggests that the latter of these two possibili-
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Figure 5. Frequency histOgram of 490 lesions after successful an-
gioplascy (POST-PTCA) grouped according to the postangioplasty 
percent diameter stenosis (DS). The distribution for the tOtal study 
group is "normal" about a mean value of 29%. The lesions fulfilling 
each of the two criteria are also sh0\\'0 and the discrepancy between 
their distributions is clearly demonstrated: The group defined by the 
~0.72-mm criterion is distributed around a mean value of 25% and 
the group defined by the 2::50% diameter stenosis criterion is 
distributed around a mean value of 32%. 
ties is the more likely and the frequency histogram (Fig. 5) 
illustrates why the discrepancy occurs. showing the distri-
bution of the two restenosis groups. The lesions with reste-
nosis (:=::50% diameter stenosis criterion) tend to lie near the 
50% threshold immediately after the procedure. It seems 
that if a "cut-off" criterion is used to define restenosis. it will 
preselect those lesions that lie close to the cut-off value and 
this appears to be the most relevant factor for the ;:!:50% 
diameter stenosis criterion. The reason for this is twofold. 
First. it should be remembered that the variability of the 
measurement using a quantitative measuring system is in the 
region of 6.5% (95% confidence limits :::':: 13%) (16). which 
suggests that if a ~50% criterion is used. a signliicant 
number of lesions will be defined as restenosis due to 
methodologic limitations of the measurement system. when 
in reality no change has taken place between angioplasty and 
follow-up. The potential for this tYPe of error will be 
magnified many times if visual estimates for stenosis severity 
are used. Lesions with a better postangioplasty result will 
fall outside this error of measurement and therefore will not 
be falsely defined as restenosis due to methodologic limita-
tions. Second, after angioplasty. most lesions deteriorate to 
some extent (30). with the patients showing a normal distri-
bution around a mean deterioration of -0.22 mm: thus. if a 
deterioration in the lumen diameter is an integral part of the 
healing process. any "cut-off' criterion that lies in the 
direction of population shift can be expected to choose 
preferentially those lesions near to the "cut-off' point. 
Conversely. the lesions that meet the ;:!:Q, 72-rn.m criterion 
tend to be distributed at the opposite end of the histogram 
and as a group have a much bener result than those selected 
by the ;:!:50% diameter stenosis criterion. The mean postan· 
gioplasty percent diameter stenosis in this study was 25% for 
those lesions fuliilling the ::::0.72~mm criterion and 32% for 
the :::::50% diameter stenosis criterion. 
Variables of change at angioplasty. The factors found to 
be associated with an increased risk according to the 
::::0.72~mm criterion in ascendlng order were change in 
reference diameter. change in diameter stenosis. change in 
minimal lumen diameter and change in m.inimallwnen diam~ 
eter adjusted for vessel size by divlding by the nonnal 
diameter of the vessel (Fig. 4). It is clear that the more the 
lesion is improved at the time of the angioplasty procedure. 
the greater the subsequent deterioration in the months after 
the procedure. As one might expect. lesions that are im-
proved less than the norm tended to have a greater residual 
~tenosis after angioplasty. These lesions. although likely to 
meet the :::::50% diameter stenosis criterion becau-se they lie 
close to it-after-angioplasty. undergo less. deterioration ·than 
lesions that ha:ve a bener result. The distinction should 
therefore be made between the postangiOplasty result and 
the change in lumen diameter at angioplasty. Although the 
postangioplasty result is highly _relevant to the long~tenn 
outcome. it is the change occurring at angioplasty that is the 
strongest predictor of subsequent deterioration between 
angiQplasty and follow~up. This observation. which previ~ 
ously has not been generally recognized. is not entirely 
without rationale (10-14). 
Substantial improvements in lumen diameter during an~ 
gioplasty (from a severe stenosis to an optimal result) imply 
dispersion of large amounts of plaque into the vessel wall or 
alternatively a deeper dissection into the arterial wall to 
achieve the same effect. In either case. the degree of 
improvement is likely to correlate \v:ith the degree of trauma 
to the vessel wall. If the restenosis process is influenced by 
the degree of trauma. then the greater and deeper the 
trauma. the more the restenosis process \Vill be stimulated. 
These results suggest that those lesions that are likely to 
experience the largest deterioration after dilation are those 
severe initial lesions that have the optimal postangioplasty 
result. The frequency histogram (Fig. 6) of change in mini~ 
mal lumen diameter for the total study group and for those 
with restenosis according to the two criteria illustrates the 
discrepancy and relevance of the two criteria. 
Implications for clinicaJ practice. There seems to be a 
consensus among clinicians that the better the result at 
angioplasty. the Jess chance there is of restenosis. This 
premise is not supported by hard experimental evidence. 
although clearly if the lesion is not effectively dilated. the 
long~tenn result cannot be expected to be good. The data 
from this study suggest that there may well be a compromise 
result somewhere between a 20% and 30% postangioplasty 
diameter stenosis that has a good chance of a satisfactory 
long·term result and may avoid the increased risk of acute 
dissection and occlusion (9) incurred by using an oversized 
balloon tO achieve an optimal result. 
Perhaps more important: the postangioplasty result has 
imPlications for clinical restenosis studies. particularly when 
assessing the aft"ect of pharmacologic interventions. If the 
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Figure 6. Frequency histogram similar to that in Figure 5 grouped 
according to change in minimal lumen diameter at angioplasty 
(PTCA). Again. the distribution is ··normal." but with a skew·to the 
right. According to the ~0.72-mrn criterion. the lesions in the third 
of the group with the largest improvement in the minimal lumen 
diameter at angioplasty (n = 44) have the highest risk ofrestenosis. 
DS = diameter stenosis. 
criterion of a :::::50% diameter stenosis is used as the sole 
definition of restenosis. the preselection of poor postangio~ 
plasty results by this criterion may be of such influence that 
any effect produced by pharmacologic intervention may not 
be reaiized by statistical hypothesis testing. More subtly. as 
the lesions that fulfill the 2::50% diameter stenosis criterion 
undergo less change between angioplasty and follow~up. it 
will become statistically difficult to show the effect of a truly 
beneficial agent because of inadequate statistical power-a 
verdict of "'no benefit" being returned when in fact a benefit 
exists. It is interesting to note that almost universally the 
conclusions from these studies have been that no agent has 
a beneficial effect on restenosis. 
The use of restenosis criteria alone for assessing the 
long-term resuJts of coronary angioplasty has the potential 
for producing misleading results. A distinction shouJd be 
made between the postangioplasry result and the restenosis 
process as measured by the change in minimal lumen d.iam~ 
eter or minimal lumen area after the procedure. 
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Angioplasty for stable versus unstable angina pectoris: Are unstable patients 
more likely to get restenosis? 
A quantitative angiographic study in 339 consecutive patients 
Hans E. Luijten, K.J. Beatt, P.J. de Feyter, M. van den Brand. J.H.C. Reiber & P.W. Serruys 
Key words: recurrent stenosis, quantitative coronary angiography 
Summary 
Current evidence with regard to the possible association between clinical expression of coronary disease 
prior to the time of angioplasty, and the subsequent risk of restenosis follo..-ving successful dilatation, remains 
inconclusive. 
To prospectively compare the incidence of restenosis in stable versus unstable angina pectoris patients, 
follow-up angiography was performed in 85 percent of patients from a consecutive series with a successful 
PTCA, irrespective of presence or absence of recurrent ischemic symptoms. Furthermore, changes in lesion 
severity were assessed quantitatively by an automated edge-detection technique rather than visual analysis. 
Employing such a study--design and follow-up protocol, it was found that the incidence of restenosis in 
patients with stable coronary artery disease was similar to that of patients with unstable rest angina, 
irrespective of the type of angiographic definition used. 
Introduction 
Increasing operator experience and technical in-
novations have made percutaneous transluminal 
coronary angioplasty (PTCA) a safe and successful 
treatment modality for patients with symptoms of 
either stable or unstable angina pectoris [1-7]. 
However, the long-term outcome of PTCA is still 
significantly curtailed by the so far unpredictable 
progression to recurrent stenosis in 12 to 48 percent 
of patients [4, 5, 8-15). 
AJthough the exact pathophysiological mecha-
nisms involved in recurrent stenosis remain un-
solved, its development is most likely the result of 
the little understood, but apparent, interplay of 
growth factors and chemoattractants from each of 
the four cell types involved in atherosclerosis; 
namely, endothelium, platelets. smooth muscle 
cells, and macrophages [16]. 
Furthermore, current evidence with regard to 
the possible association between clinical expres-
sion of coronary disease prior to the time of angio-
plasty, and the subsequent risk of restenosis follow-
ing successful dilatation, remains inconclusive. 
Whereas some previous reports have indicated that 
angioplasty for unstable angina is associated with 
an increased risk of lesion recurrence as compared 
with stable angina [10, 17}, this has not been cor-
roborated by others [4, 5, 7, 9, 12, 18, 19]. 
In view of these discrepant results, and given the 
distinctly different coronary morphology observed 
by angioscopy in patients with stable exercise-in-
duced angina versus those with unstable rest angina 
[20, 21], elucidation of the question whether the 
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incidence of restenosis differs in these two ischemic 
coronary syndromes merits further attention. 
Since the incidence of restenosis appears to be 
influenced by the rate of follow-up angiography. 
and by the method of assessment of the coronary 
angiograms. a protocol was implemented in this 
study that involved repeat quantitative coronary 
angiography, irrespective of the presence or ab-
sence of recurrent ischemic symptoms. 
Study population 
During the period from January 1984 to September 
1985. PTCA was attempted in 282 patients v.rith 
stable angina and in 1n patients with unstable 
angina. Stable angina pectoris was defined as chest 
discomfort related to effort or emotion; these pa-
tients underwent elective coronary angioplasty. 
Unstable angina pectoris was defined as prolonged 
chest pain at rest v.rith documented reversible ST-
segment or T-wave changes, v..ithout subsequent 
myocardial necrosis as evidenced by a rise in cre-
atine phosphokinase to at least twice the normal 
level or by pathological Q-wave development 
( Q > 0.04 s). The ischemia-related coronary lesion 
was dilated in unstable angina patients in whom 
multivessel disease was present. The offending le-
sion was identified on the basis of recorded electro-
cardiographic changes and coronary anatomy. 
Electrocardiographic changes in leads VI to V5 
were associated with lesions of the left anterior 
descending artery, changes in La VL. and V6. with 
the marginal branch of the circumflex artery or the 
diagonal branch of the left anterior descending ar-
tery. and changes in inferior leads with either the 
right coronary artery or the circumflex artery. 
Two-hundred forty-two consecutive patients 
with stable angina pectoris, which represents a 
85.8% primary success rate, and 155 patients with 
unstable angina pectoris, which represents a V .6% 
primary success rate (p = NS). underwent success-
ful coronary angioplasty. defined by: 1) clinical 
relief of ischemic symptoms: 2) less than 50 percent 
diameter stenosis on visual inspection of the post-
angioplasty coronary angiogram performed in mul-
tiple views; 3) no in-hospital complications. such as 
recurrence of angina. coronary bypass grafting. re-
peat PTCA, acute myocardial infarction. or death. 
After obtaining informed consent all patients 
with a successful PTCA were requested to undergo 
follow-up angiography. Of the 242 patients with 
stable angina and the 155 patients with unstable 
angina who underwent a successful dilatation. 206 
stable patients (85.1% follow-up) and 133 unstable 
patients (85.8% follow-up) had repeat angiogra-
phy suitable for quantitative analysis. Coron~ 
angiograms that were technically inadequate be· 
cause of suboptimal visualization of the dilated 
segment. most commonly due to vessel overlap, 
and/or incomplete opacification were not included 
in the analysis. The reasons for failure to complete 
the study for the stable and unstable groups com· 
bined are detailed in Fig. 1. Recatheterization was 
considered contra-indicated in the event of dis· 
abling concomitant disease (e.g. renal failure.lung 
cancer). severe peripheral vascular diseases. or 
more than four prior angiographic investigations. 
The clinical characteristics of the study popula· 
tion v.rith subdivision into patients v.rith a history of 
stable and unstable angina pectoris prior to the 
time of PTCA. are detailed in Table 1. The extent 
of coronary artery disease was defined as the num· 
ber of vessels with a ;>-50% diameter narrowing. 
and prior myocardial infarction was diagnosed ac· 
cording to the Minnesota code [22}. 
Methods 
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Angioplasty procedure and medication 
Coronary angioplasty was performed with a steer· 
able, movable guide-wire system via the femoral 
route. At the beginning of the procedure all pa-
tients received 10.000 I.U. of heparin i.v .. 250mg 
of acetylsalicylic acid i.v., and a continuous in-
fusion of low molecular weight dextran (Rheoma-
crodex®) was started. To prevent coronary spasm, 
intracoronary nifedipine or isosorbide dinitrate 
was given. ECG and blood pressure were contin-
uously monitored. Initial balloon inflation pressure 
was 2.0 atmospheres, v.rith subsequent inflations 
ranging up to 12.0 atmospheres. Inflation was 
PATIENTS WITH SUCCESSFUL PTCA 
(<50% DSTEN POST·PTCA) 
Total 
~21atet 
T-13 cecath. cootca-lodlcated 
c$L_ 
: 25 recath. retused 
PATIENTS WITH LATE F/U (0CA IN 85 %) 
~ " of lesions 
Fig. 1. Flow chan of the total number of patients who met the 
inclusion criteria. and the reasons for failure to complete the 
StUdy. OSTEN"" diameter stenosis; FlU= follow~up; QCA = 
quantitative coronary angiography; Recatb. = recatheteriza-
tion. 
maintained according to ECG changes, degree of 
blood pressure drop or induced pain. Balloon dila-
tations were repeated until the severity of the ob-
struction was at least below 50% luminal diameter 
narrov.ring, as judged from repeat coronary angie-
grams obtained in multiple views immediately after 
the dilatation. Following the procedure all patients 
were monitored for at least 24 hours, by means of 
electrocardiography, and serial cardiac enzyme 
levels when necessary. Following coronary angio-
plasty 10 mg of nifedipine was given orally every 
two hours for the first twelve hours, and thereafter 
three to six times a day together with 500 mg of 
acetylsalicylic acid orally once a day for a period of 
six months. Beta blockers were withdrawn unless 
hypertension was present. 
Quantitative coronary angiography 
The quantitative analysis of the stenotic coronary 
segments was carried out with the computer-assist-
ed Cardiovascular Angiography Analysis System 
(CAAS), which has been described in detail else-
where r23, 24]. To analyze a coronary arterial seg-
ment in a selected frame of a 35 mm cinefilm. an 
optically magnified portion of the image encom-
passing that segment is converted into video format 
by means of a cine-video converter. The region of 
interest is defined and the contours of the vessel are 
detected automatically on the basis of the weighted 
sum of first and second derivative functions applied 
Table 1. Clinical characteristics of the 206 stable and the 133 
unstable angina pectoris patients with successful PTCA entered 
into the study. 
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Characteristics StableAP UnstableAP 
DO(%) no(%) 
No. of patients 206 133 
No. of lesions 239 155 
Mean no. of lesions dilated 
per patient 1.16 1.17 
Age (mean±s.d.) 56±9 58±9* 
(range) (31-75) (31-75) 
Male sex 171 (83) 104 (73) 
Time from PTCA 81±38 79±37 
toFU (days) (11-194) (4-226) 
Extent of CAD 
1 140 (68) 89 (67) 
2 44 (21) 30 (23) 
3 22 (11) 14 (11) 
Previous coronary bypass 
grnfting 22 (11) 8 (6) 
Previous coronary a.ngioplasty 24 (12) 11 (8) 
Previous myocardial infarction 82 (40) 56 (42) 
Vessel dilated 
LAD 138 (58) 97 (63) 
LCX 43 (18) 26 (17) 
RCA 48 (20) 2S (18) 
Byp,; 7(3) 3 (2) 
LMCA 3 (1) 1 (1) 
Bypass= aonocoronary bypass graft; CAD= coronary artery 
disease; FU = follow-up angiography; LAD= left anterior 
descending coronary artery; LCX = left circumflex coronary 
artery; LMCA = left main coronary artery; RCA= right coro-
nary artery; s.d. = standard deviation. 
* p = 0.047 for difference with stable angina patients. 
A. 
C. 
to the digitized brightness information. Calibration 
of the diameter data of the vessels in absolute val-
ues (rom) is achieved by using the contrast catheter 
as a scaling device [25]. To this end. the contours of 
a user-defined portion of the optimally magnified 
catheter (magnification factor 2v'2) are detected 
automatically and corrected for pincushion distor-
tion caused by the image intensifiers. From the 
vessel contours the 'interpolated' reference dia-
meter Dr and the minimal lumen diameter· Do -
both in absolute mm - are then determined at the 
site of the shortest distance between the two con-
tours. The 'interpolated' percentage diameter ste-
B. 
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Fig. 2. Series of single frame angiograms, '.vith superimposition 
of the automatically detected contours. of the same left anterior 
descending artery lesion pre-dilatation (A). post-dilatation (B) 
and at follow-up (C). The interpolated percentage diameter 
stenosis (D<>Sten) and percentage area stenosis (A<>Sten) .,'3.lues 
are shov.n at the top left of each frnme. The post-PTCAanalysls 
shows a satisfactory result. The follow-up analysis shows that a 
significant restenosis bas taken place. 
nosis is then calculated according to the well known 
formula: 
interpolated %- D stenosis= (1- ~~) * 100%. 
A representative analysis pre- and post-PTCA and 
at follow-up. with the detected contours and the 
diameter function curves superimposed on the 
original video images, is shown in Fig. 2. 
In order to standardize the quantitation tech-
nique and to minimize potential errors, 'interpolat-
ed' reference diameter and percentage diameter 
stenosis measurements were used. This method has 
the advantage of eliminating the arbitrary choice of 
a reference diameter, which will vary between indi-
vidual observer::;. The principle behind this tech-
nique is the computer estimation of the original 
diameter values of the segment \Vithin the obstruct-
ed region (reference diameter function). assuming 
that no coronary disease is present. The interpolat-
ed reference diameter is then taken as the value of 
the reference diameter function at the site of maxi-
mal narrowing [26-28]. 
The automatic contour detection technique ap-
plied in this study has previously been validated 
using plexiglass phantoms filled with contrast me-
dium [28]. The overall accuracy (average differ-
ence) and the precision (pooled standard deviation 
of the differences) of minimal lumen diameter 
measurements are minus 30 and plus 90 microns, 
respectively. 
In order to standardize the method of acquisition 
and analysis of the pre- and post-dilatation and the 
follow-up angiograms, the following five measures 
were undertaken [24]. Firstly, the X-ray system 
was repositioned to correspond as much as possible 
to the projections and settings used during the pre-
vious angiographies. For this purpose, the angular 
settings of the X-ray gantry and the various height 
levels were readjusted according to the values pre-
viously documented with an on-line registration 
system. 
Secondly, all cine frames to be analyzed were 
selected at end-diastole, to minimize any possible 
blurring effect as a result of vessel motion during 
systole. 
Thirdly, the user-determined beginning and end-
points of the major coronary segments between 
side branches were identified according to the defi-
nitions of the American Heart Association [29]. 
Fourthly, multiple matched views, orthogonal if 
possible, were analyzed for each dilated lesion and 
then the results were averaged. 
Finally, Polaroid pictures were taken of the vid-
eo image with the detected contours superim-
posed, to ensure that the analyses were performed 
on the same coronary segment in the serial angie-
grams. 
Definitions of restenosis 
In order to allow comparison of our results with 
those of other published studies and to evaluate the 
various criteria, three previously proposed angie-
graphic definitions of restenosis (Fig. 3) were ap-
plied: 1) a loss of at least 50% of the gain in luminal 
diameter achieved at PTCA (NHLB!!V) [9]; 2) an 
% 
DST 
% 
DST 
50 
mm 
MLD 
PRE POST FU 
i---: 
' ' 
' ' I ' -~--;·--·--·----~ 
PRE POST FU 
PRE POST FU 
oss > half 
of the gain 
from 
> 50% 
MLD 
Fig. 3. Angiographic restenosis criteria employed (as explained 
in Methods section). DST= diameter stenosis(%); pre= pre-
PTCA; post= post-PTCA; FU = follow-up; MLD = minimal 
lwnen diameter (mm). 
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increase of the diameter stenosis from less than 50 
percent post-PTCA to greater than or equal to 50% 
at follow-up, and finally; 3) a decrease in minimal 
lumen diameterofgreaterthan or equal to 0.72mm. 
with respect to the post-PTCA situation. This last 
definition is based upon twice the variability (one 
standard deviation of the differences of duplicate 
measurements of the same lesion) of minimallu-
men diameter measurements in mm (2 x 0.36 
mm), when coronary angiography was repeated 
over a time interval of 90 days [23]. 
Statistical analysis 
To test for differences between the stable and un-
stable angina patients with respect to their baseline 
clinical characteristics (listed in Table 1), the un-
paired t-test was performed for the continuous var-
iables, and the chi-square test for discrete varia-
bles. Univariate analysis of variance was also per-
formed on the quantitative angiographic data ob-
tained (Tables 2 and 3) (BMDP statistical software. 
University of California press, Berkeley, Califor-
nia.1985). 
Results are presented as mean ± one standard 
deviation. unless stated otherwise. All statistical 
tests were two-tailed. A probability (p) value be-
low 0.05 was regarded as indicating statistical sig-
nificance. 
Results 
The clinical characteristics of the 339 patients (206 
with stable angina, and 133 with unstable angina) 
with a successful YTCA who completed angie-
graphic follow-up are detailed in Table 1. 
Comparison between the stable and unstable pa-
tient groups revealed a slightly higher overall mean 
age for unstable patients (56±9 versus 58±9, 
p = 0.047). Apart from this difference the stable 
Table 2. Comparative results of quantitative coronary 3llgiograph y. expressed as mean ± one standard deviation. for the 206 stable and 
133 unstable angina pectOris patients. Variance analysis. between the two groups was. perlormed. for which the p-values are given. 
Variable Tune StableAP Unstable AP p-value 
( n = 239 lesions) (n= 155 lesions.) 
reference: pre-PTCA 2.80±0.64 2.85±0.65 0.49 
diameter post-PTCA 2.93±0.54 2.92 ±.0.56 0.96 
(mm) follow-up 2.81 ±0.56 2.82±0.58 0.91 
minimal lumen pre-PTCA 1.17±0.41 1.14± 0.39 0.52 
diameter post-PTCA 2.09±0.42 2.05±0.44 0.32 
(mm) follow-up 1.86± 0.61 1.89 ± 0.59 0.66 
diameter pre-PTCA 58.3± 13.4 59.3± 12.3 0.44 
stenosis post-PTCA 28.0±11.3 28.9± 11.3 0.44 
(%) follow-up 33.4± 18.1 32.4± 17.4 o.ss 
AP = angina pectoris. 
Table3. Absolute change in stenosis geometry as a result of PTCA (pre to post). and from post -PTCA to time offollow-up angiography 
(post tofu), comparing the stable and unstable angina patients. Differences. are not statistically significant. 
Variable Tune StableAP Unstable AP 
Reference pre to post +0.13 +0.08 
diametermm post tofu -0.12 -0.11 
Minimal lumen pre to post +0.92 +0.91 
diametermm post tofu -0.23 -0.16 
Diameter pre to post -30.3 -30.5 
stenosis% post tofu + 5.4 + 3.5 
AP = angina pectoris. 
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and unstable patients were comparable with re-
gards to mean number of lesions dilated per pa-
tient, time to follow-up angiography (81 ± 38 days 
versus 79 ± 37 days, respectively), extent of coro-
nary artery disease, prior coronary bypass grafting, 
prior coronary angioplasty, prior myocardial in-
farction and vessel dilated (Table 1). 
The results of quantitative coronary angiography 
in the 206 patients (239lesions) with stable angina 
and the 133 patients (155 lesions) with unstable 
angina who completed angiographic follow-up are 
detailed in Table2. When collating the quantitative 
data for all the stable and unstable patients com-
bined, the reference diameter and the severity of 
the dilated stenoses pre- and post-PTCA, and at 
follow-up, were not significantly different. 
The changes in reference diameter, minimal lu-
men diameter, and the percentage diameter steno-
sis as a result of PTCA, and from post-PTCA to 
follow-up, are listed in Table 3. Following PTCA 
there was, as expected, a significant improvement 
in minimal lumen diameter and diameter stenosis 
for both groups of patients (p < 0.0001). Contrast-
ing the changes in stenosis geometry in the stable 
and unstable patients occurring between post-
PTCA and time of control angiography, reveals 
that both showed a comparable deterioration in 
lesion severity, as reflected by an increase in per-
centage diameter stenosis, and a decrease in mini-
mal lumen diameter; similarly, a comparable de-
crease in reference diameter was observed (Fig. 4). 
Table 4 delineates the incidence of restenosis in 
stable versus unstable angina patients according to 
three previously proposed angiographic criteria. 
STABLE UNSTABLE 
ANGINA ANGINA 
0 
mm 
-0.10 
-0.16 
-0.2.0 
-0.2.3 
-0.30 
Ftg. 4. Changes in reference diameter and minimal. lumen dia-
meter (xnm) occurring between post-PTCA and time offollow-
up angiography. Differences are not statistically significant. 
Also listed in Table 4 are the percentages of pa-
tients experiencing recurrent ischemic symptoms at 
the time of repeat angiography (Fig. 5). The so-
called 0. 72 mm restenosis criterion identifies le-
sions with a decrease in minimal lumen diameter of 
at least 0. 72 mm, corresponding to a change greater 
than or equal to two times the long-term variability 
of this type of measurement. 
Looking at the patient restenosis rates (Table 4 
and Fig. 4} several observations can be made. Frrst 
of all, the percent restenosis varies considerably 
depending upon the angiographic definition cho-
sen. Secondly, the incidence of restenosis in stable 
and unstable angina patients proved to be similar, 
irrespective of which restenosis definition is em-
ployed (Table 4). 
Table 4. Patient restenosis rates (percent) in stable versus unstable angina patients according to three different angiograpbic definitions 
of restenosis. The percentage of patients with recurrent angina at the time of repeat angiography is shown. in the bottom row_ 
Differences are not statistically significant. 
Restenosis definition Sta.bleAP UnstableAP 
(n~206) (n= 133) 
n % n % 
NHLBIIV 55 26.7 33 24.8 
~50% OS 31 15.0 16 12.0 
~0.72mm 37 18.0 24 18.1 
Recurrent angina. 46 22.3 33 24.8 
AP = angina pectoris; DS = diameter stenosis. 
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Discussion 
Baseline clinical characteristics and quantitative 
angiographic data pre- and post-PTCA 
Existent differences in pathophysiology of effort 
angina and angina at rest, as evidenced by recent 
angioscopic findings that each of these clinical cor-
onary syndromes appears to have its ovm specific 
underlying endothelial pathology [20-21], leads to 
the hypothesis that the early and 'late" vessel wall 
response to dilatation injury may be dissimilar in 
mechanism and/or magnitude. 
To gain insight into the early and late changes in 
vessel caliber and hence determine the true in-
cidence of restenosis, 85% of patients with a suc-
cessful PTCA underwent repeat quantitative coro-
nary angiography, irrespective of presence or ab-
sence of recurrent ischemic symptoms. In addition, 
in order to standardize the method of acquisition 
and analysis of the serial angiograms, several mea-
sures were undertaken to decrease the variability 
of repeated arterial measurements [24]. 
Employing such a study-design and follow-up 
protocol it was found that successful PTCA - de-
fined as a less than 50% luminal narrowing in com-
bination with clinical relief of ischemic symptoms-
was associated with an increase in both the refer-
ence and minimal lumen diameter (Table 2). This 
suggests that the changes in reference diameter and 
minimal lumen diameter as a result of PTCA. both 
contributed to the luminal enlargement. The 
changes in lesion dimensions from post-PTCA to 
follow-up were also comparable for both groups of 
patients (Table 3 and Fig. 4). However, whereas 
the reference diameter at follow-up had decreased 
to that found pre-PTCA (Table 2), the minimal 
lumen diameter at follow-up was smaller than im-
mediatelypost-PTCA, but still much improved rel-
ative to the mean values before angioplasty. In 
summary, the patients with stable angina were 
comparable to those with unstable angina with re-
gard to the extent, location and quantitatively de-
termined severity of coronary artery disease (Ta-
bles 1 and 2) before and after PTCA and at follow-
up. Therefore. as suggested previously [30], this 
finding supports the notion that factors other than 
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anatomic severity are important in the precipita-
tion of these syndromes [30-32]. 
In fact, from histologic studies [33-35], posnnor-
tem coronary angiography {36], recent recognition 
of specific angiographic morphology [37, 38], and 
angioscopy in living man [20, 21], it has become 
evident that endothelial ulceration and thrombosis 
are important processes in unstable angina. Thus, 
unstable angina is related to endothelial ulceration. 
platelet aggregation and thrombus formation with 
or without spasm leading to partial occlusion or 
interrupted total occlusion [20, 21, 33, 35, 37-39]. 
In contradistinction, angioscopy of coronary le-
sions of patients with stable coronary artery disease 
has shovm a noninterrupted smooth atheroma sur-
face, without hemorrhage or ulceration [20, 21]. 
Incidence of restenosis 
The major finding of this study is that although 
there was a wide variation in the incidence of reste-
nosis according to the angiographic criterion ap-
plied (Table 4), the cumulative incidence of reste-
nosis in patients with stable coronary artery disease 
was similar to that of patients with unstable rest 
angina, irrespective of the type of definition (Fig. 
5). Likevrise, the percentage of patients with recur-
rent angina at the time of reinvestigation, was also 
similar. 
Although these data are consistent with those 
from some previous studies [4, 5, 7, 9, 12, 18, 19], 
they are not in agreement with two other reports 
which have indicated an increased risk of restenosis 
in patients suffering from unstable angina prior to 
the time of coronary angioplasty [10, 17]. How-
ever, comparison between the few published re-
ports on angioplasty for stable and unstable angina 
must be done with caution for a number of reasons. 
Differences between studies in indication and tim-
ing of repeat angiography, follow-up rate, method 
of assessment of coronary angiograms, and most 
importantly, the bias introduced by studying a se-
lected population, all potentially distort the data 
regarding incidence and time to restenosis. 
Moreover, visual interpretation of serial coro-
nary angiograms are marked by high intra- and 
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Fig. 5. Restenosis rates (%) post·PTCA in patients with stable 
versus unstable angina pectoris prior to the time of angioplasty. 
according to three previously proposed angiographic criteria. 
Also listed are the percentages of patients with recurrent is-
chemic symptoms at the time of recatheterization. Observed 
differences are not statistically significant. A) Loss of at least 50 
percent of the gain in luminal diameter achieved at the time of 
PTCA (NHLBI IV): B) An increase of the diameter stenosis 
from less than 50 percent post-PTCA to greater than or equal to 
50 percent at follow-up: C) A decrease in minimal lumen dia-
meter of greater than or equal to 0.72mm. corresponding to a 
change ~twice the variability of minimal lumen diameter mea-
surements in mm. 
AP""' angina pectoris. 
interobserver variabilities. and a poor reproduc-
ibility (40}. Hence. visual comparison of arteria-
grams from different patients, or at different times 
in the same patient. are of limited value for assess-
ing severity or changes in severity of coronary ar-
tery stenoses. 
Fmally, the preferential reinvestigation of symp-
tomatic patients in some studies on the one hand 
can be expected to result in an artificial increase of 
the angiographic restenosis rate, and on the other 
hand to a decrease of this rate by not identifying the 
30% of asymptomatic patients with angiographic 
recurrence [41). 
Data distortion caused by a variable combina-
tion of these methodological factors may increase 
the likelihood of type I (having statistically signif-
icant results when there is no relationship between 
variables studied) and Type II (to miss finding sta-
tistical significance for a trend that does exist in the 
data) errors [42], and can result in discrepancies 
amongst studies in patient, lesion and procedure 
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related factors considered to be associated with an 
increased risk of restenosis. 
To date two studies have noted a significantly 
higher restenosis rate following successful PTCA in 
patients with prior unstable angina [10, 17]. Dan-
goisse et al. [17] reponed the follow-up of 103 
consecutive patients recatheterized within six 
months. They observed a 50 percent restenosis rate 
(>30% increase in diameter stenosis) in patients 
with unstable angina, relative to a rate of 25% in 
those without: a significant difference at p < 0.025. 
However. details regarding patient population, 
study design. follow-up strategy, definitions used 
and method of assessment of the angiograms are 
lacking in this abstract. In another report [10). con-
cerning the multivariate analysis of clinical and 
angiographic data of 787 patients from an initial 
cohort of 1758 patients (45%) with single-vessel 
disease in whom PTCA had been successful. reste-
nosis was observed in 26% of those with stable and 
34% of those with unstable coronary disease (p = 
0.0534). These results were obtained at a mean 
time to follow-up angiography of 7 ± 5 months, 
pertaining to a time frame ranging from less than 
two months to 42 months. However, if we just look 
at the patients recatheterized within four months 
for the sake of comparison. the observed restenosis 
rate was 53% and the prevalence of recurrent is-
chemic symptoms was84% [10). In contrast, in this 
study only 22.3% of all the stable and 24.8% of the 
unstable patients reported ischemic symptoms at 
the time of angiography, and the overall incidence 
of recurrent stenosis was less than half of that re-
poned by Leimgruber et al. (10]. Thus, it appears 
that this major difference in observed restenosis 
rate within the first four months might be directly 
related to the substantial dissimilarity in the pro-
portion of patients with recurrent angina. Further-
more, the patient population of our study. in which 
32% had multivessel disease, may not be directly 
comparable to one consisting solely of patients with 
single-vessel coronary artery disease [10], as sug-
gested by the apparently poorer prognosis of those 
with multivessel disease at long-term follow-up af-
ter coronary angioplasty [43). 
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Quantitative Angiographic Assessment of Elastic 
Recoil After Percutaneous Transluminal 
Coronary Angioplasty 
Benno J. Rensing. MD. Walter R.M. Hermans. MD, Kevin J. Beatt. MD, Gert Jan Laarman, MD. 
Harry Suryapranata, MD, Marcel van den Brand. MD, Pim J. de Feyter, MD, 
and Patrick W. Serruys. MD, PhD 
Little is known about the elastic behavior of the 
coronary vessel wall directly after percutaneous 
transluminal coronary angioplasty (PTCA). Minimal 
luminal cross-sectional areas of 151 successfully 
dilated Besions were studied in 136 patients during 
balloon inflation and directly after withdrawal of 
the balloon. To circumvent geometric assumptions 
about the shape of the stenosis after PTCA, a 
videodensitometric analysis technique was used for 
the assessment of vascular cross-sectional areas. 
Elastic recoil was defined as the difference between 
balloon cross~seetional area of the largest balloon 
used at the highest pressure and minimal luminal 
cross-sectional area after PTCA. Mean balloon 
cross~onal area was 5.2 ± 1.6 mm2 with a 
mean minimal cross-sectional area of 2.8 ± 1.4 
mmZ immediately after inflation. Oversizing of the 
balloon (balloon artery ratio > 1) led to more recoil 
(0.8 ± 0.3 vs 0.6 ± 0.3 mm, p <0.001), suggestive 
of an elastic phenomenon. A difference in re<:cHl of 
the 3 main coronary branches was observed: left 
anterior descending artery 2.7 ± 1.3 mm2, circum-
flex artery 2.3 ± 1.2 mm2 and right coronary ar-
tery 1.9 ± 1.5 rnrnZ (p <0.025). The difference was 
still statistically significant if adjusted for reference 
area. Thus, nearly SO% of the theoretic:aUy achiev-
able cross-sectional area (i.e., balloon cross-sec-
tional area) is lost shortly after balloon deflation. 
(Am J Cardiel 1990;66:1039-1044) 
From the Catheterization Laborator•. Thoraxcenter. Er.J.Smus Univer-
sity. Rom:ribm. The Netherlands." ~anuscnpt received Janu:u:- 4. 
1990; revised manuscript receiveci3nd accepted June JS. 1990 
Address for reprints: Patrick W. Serruys. ~D. PhD. C:nhctcriu-
tion Labor:nory. Thonxcenter. Era.~mus Universit;.-·. PO Box 1738. 
3000 DR Rottenbm. The !'-'etherlands. 
P ercutaneous transluminal coronary angioplasty (PTCA) is increasingly being used as an alterm.-tive to coronary anery b)-pass grafting in patients 
v.'ith acute and chronically obstructed vessels. 1·:: Despite 
many publications on the mechanism of this treatment 
modality. little is known about the elastic beha\'ior of 
the vessel wall during and immediately after angio-
plasty. Castaneda-Zuniga et aF proposed an anerial pa-
ralysis model in which overstretching of the vessel wall 
beyond its limits of elasticity was associated with histo-
pathologic features of smooth muscle cell lysis. Accord-
ing tO Sanborn et aL-l part of the angioplasty mecha-
nism consists of stretching the vessel wall resulting in a 
fusiform dilatation or localized aneurysm formation. It 
is. however. a common clinical observation that in some 
lesions even the application of an oversized balloon leads 
to a poor angiographic result without a visible intimal 
tear or dissection. This phenomenon may be attributed 
to elastic recoil of the vessel wall after balloon angio-
plasty. Densitometrically assessed cross-sectional areas 
are independent of geometric assumptions on the shape 
of the stenosis and should theoretically be more reliable 
than geometrically derived cross-sectional areas. espe-
cially after the disruptive action of balloon angioplasty 
which is known to cause asynunetric enlargement of the 
lumen.5 This study was undertaken to determine the 
contribution of elastic recoil to the immediate result of 
an angioplasty procedure. with the use of densitometric 
and contour detection analysis techniques. 
METHODS 
Contour detection: The quantitative analysis of the 
stenotic coronary segments was performed with the 
computer-assisted Cardiovascular Angiography Analy-
sis System (CA<\5-). which has been described in detail 
elsewhere_6.: To analyze a coronary arterial segment a 
35-mm cine frame was selected. Electronically. a region 
of interest (512 X 512 pixels) encompassing the anerial 
segment to be analyzed was digitized with a high-fideli-
ty videocamera. Contours of the anerial segments were 
detected automatically on the basis of the weighted sum 
of first and second derivative functions applied tO the 
digitized brightness profile. From these contours the 
vessel diameter functions are determined by computing 
the shortest distance between the left and right contour 
positions (the upper curve in Figure 1). Conversion of 
the diameter measurements of the vessels to absolute 
values was achieved by using the contrast catheter as a 
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scaling device. To this end the contours of a user~de~ 
fined portion of the optimally magnified catheter (opti-
mal magnification factor 2.12) are detected automati-
cally and corrected for pincushion distortion caused by 
the image intensifiers. In arteries with a focal obstruc-
tive lesion and a clearly normal proximal or distal arte-
rial segment, the choice of the reference region is 
straightforward and simple. However, in cases where 
the proximal or distal part of the arterial segment shows 
combinations of stenotic and ectatic areas. the choice 
may become difficult. To circumvent these problems. 
we implemented a method that is independent on a user 
defined reference region. This technique is denoted 
.. interpolated reference diameter measurement."~ The 
principle of this technique is the computer estimation of 
the original vessel diameter at the site of obstruction 
(Figure I). The white areas in the figure are measures 
for the '"atherosclerotic plaque" and are defined by the 
actual luminal contours and the reconstructed reference 
contours. The length of the obstruction site is deter-
mined from the diameter function on the basis of curva-
ture analysis and expressed in millimeters. Using the 
reconstructed borders of the vessel walL the computer 
can calculate a symmetry coefficient for the stenosis: a 
symmetrical lesion having a value of I and a severe ec-
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centric lesion having a value of 0. Symmetry is defined 
as the coefficient of the left hand distance between the 
reconstructed and actual vessel contours and the right 
hand distance between reconstructed and actual con-
tours at the site of obstruction. In this equation the larg-
est distance between actual and reconstructed contours 
becomes the denominator. The curvature value at the 
obstruction site. as a measure for coronary bending. is 
computed as the average value of all the individual cur-
vature values along the centerline of the coronary seg-
ment, with the curvature defined as the first derivative 
of the tangent as it moves along the centerline. which 
for a circle is equal to the reciprocal of the radius. 
Densitometric procedure: Constitution of the rela-
tion between path length of the x-rays through the ar-
tery and the brightness value requires a detailed analy-
sis of the complete x-rayjcinejvideo chain. including 
the film development process.~ For the first part of the 
chain from the x-ray source tO the output of the image 
intensifier. Lambert Beer-s law is assumed to be valid 
for the x-ray absorption and certain models for the x-
ray source and the image intensifier are applied. Sensi-
tometric transfer functions were assessed from 21 cali-
brated density frames, which are processed photograph-
ically simultaneously with the coronary cine ftlm. These 
21 density frames are then exposed homogenously with 
a specially developed sensitometer having the same col-
or temperature as the output screen of the image inten-
sifier. 
The contours of a selected arterial segment are de-
tected as previously described. On each scanline perpen-
FIGURE 1- Single frame angiograms of a proximal, circumflex 
artery (CX-PROX)- Contours and densitometric analysis of the 
severity of the obstruction (Obstr.). The white areas are a 
measure for the ''atberosc~tic .. plaque and are defined by 
the difference between the actual luminal contours and the 
"interpol<'lted"' reference contours. Superimposed on the 
videoimage an- the cfaameter function curves (upper curve) 
and the densitometric: area function curve (lower c:une) 1o-
getber with the "mterpolated re~•· CUrY1.:S. A, prcdilata· 
tion (before percutaneous trans-luminal coronary angioplasty 
[PRE-PTCAJ) minimal luminal cros-5-sec:tional area is 3-5 
rnrnZ: B. 3-5 mm baUoon, filmed at highest inflation pressure; 
C., after dilatation (POST-PTCA), minimal luminal cross--sec-
tional area is 6.0 mm2. 
dicular tO the centerline a profile of brightness values is 
measured. This profile is uansformed into an absorption 
profile by means of the computed transfer functions. 
The background contribution is estimated by an inter-
polative method and subtraction of this background 
yields the net cross-sectional absorption profile. Integra-
tion of this function results in a measure for the cross-
sectional area at the particular scanline. By repeating 
this procedure for each scanline. the cross-sectional area 
function is obtained. The severity of the obstruction can 
thus be expressed in mm:, by comparing the minimal 
area value at the obstruction with the reference value 
obtained after an interpolative approach. which is simi-
lar to that described earlier for diameter measurements. 
Validation of this densitometric analysis technique 
was done by analyzing cine films of perspex models 
fllled with a contrast agent and filmed at 4 kV levels. 
Accuracy was found to be 2.8% and precision L8%. 1o 
The densitometrically determined area stenosis. as 
found by other investigators. correlates well with per-
centage reduction of cross-sectional area measured his-
tologically in postmortem hearts. t u: 
Assessment of elastic recoil: One hundred fifty-one 
successfully dilated segments of 136 patients were ana-
lyzed. A successful PTCA was defined as a visually as-
sessed diameter stenosis after PTCA of <SO%. Single 
identical views before and after PTCA. and during 
complete expansion of the largest balloon at highest in-
flation pressure were chosen for densitometric analysis. 
Both polyvinyl chloride and polyethylene balloons were 
used for dilatation depending on the choice of the opera-
tor. Inflation pressure and duration of inflation were left 
to the discretion of the operator. Mean balloon cross-
sectional areas were calculated from diameter values. 
assuming a circular cross section at maximal inflation 
pressure. The same x-ray setting in terms of kilovoltage 
and milliamperes was used during the 3 cine recordings. 
To have the segment to be analyzed as perpendicular to 
the incoming x-rays as possible. a view was chosen with 
the coronary artery appearing least foreshortened. The 
same amount of nitrates. either nitroglycerin. 0.1 to 0.3 
mg. or isosorbide dinitrate, I to 3 mg. was given intra-
coronarily before the pre- and postangioplasty cine re· 
cordings. This was done to dilate the vessel maximally 
and thus to control the varying influence of vasomotor 
tone on luminal dimensions. Elastic recoil was then cal-
culated as the difference between the minimal luminal 
cross-sectional area after PTCA and the mean balloon 
cross-sectional area (mm=). A representative analysis, 
with the detected contours, the diameter function curve 
and the densitometric area function curve superimposed 
on the original video image. is shown in Figure I for a 
circumflex lesion. 
RESULTS 
At quantitative analysis 140 (92%) of the dilatations 
were successful using a <50% diameter stenosis after 
PTCA as the success criterion. If in addition a > 20% 
improvement in diameter stenosis was required for a 
successful dilatation. 110 (72%) lesions were successful-
ly dilated using quantitative measurements. The densi-
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TABLE I Recoil in 151 Coronary Artenal Narrowings 
tktorePTCA AtterPTCA pValue 
Retcrcnce area (mm~ 6.0±2.5 6.2±2.5 NS 
MLCA{mm:) 1-!±0.9 2.$± 1.4 p <0.001 
B.:olloon-CSA(mm~) 5.2:1:1.6 
Reco•l(mm:') 2.4±: . .:. p <0.001 
CSA ;0 Cf=··sectl0<1JI ~r<>J: MLCA - mon<r•"-J' lum•nJI cr005-$~C:I()n~ JreJ: NS -
d1terence r;ot ~lf:I'ITI<:::>nt PTCA" ~rCUlJne<:>uo 1•Jn$1vmon~l coronJ<y Jngoopl~sly· 
~ecotl - bJtloon CSA- MLCA aile• PTC"-. 
TABLE II Effect ot Balloon Oversizing on the Amount of 
Elastic Recoil 
Bolloon-Artery FOtto Sl >l pVJI\JC 
No. ot les•ons S7 64 
Reierence-oometcr (mm) 3.0±0.5 2.3±0.4- p<O.OOl 
B;:~lloon-dlameter (mm) 2.5±0.4- 2.6±0.4 NS 
Recoil(mm) 0.6±0.30 0.8±0.3 p<O.OOl 
B.:llloo<l-Jrte<y rJ11o'" ~!loon o"me'O' ;re~erenc~ d<a~ter: NS- OITf..,.Mce not 
s.snltLC.:lnt 
TABLE Ill Clinical Characteristics and Recoil in 136 Patients 
y~ No pValue 
Men (recoil) 112 (0.45± 0.31) 24{0.42±0.23) NS 
Smoktng 106(0.46±0.29) 30 (0.50 :1: 0.23) NS 
(recoil) 
HypertenSIOrl 61 {0.40 ±0.28) 75 (0.46 :1: 0.29) NS 
(recoil) 
Doabetes type 1 l 135 
(recoil) 
Unstableangtna 23(0.39±0.27) 113{0.44:1: 0.2€) NS 
{recoil) 
R..co·l corret:"'ed tor rct~ren~e YCJ 
NS ~ d1Merc~ce not So~P.M>Qnt 
I 
tometric anal;-sis of the 151 segments is listed in Table 
I. Mean age of the 136 patients was 56.8 ± 8 years. 
There was no significant change in .. interpolated'" refer-
ence area after PTCA: Before PTCA 6.0 ± 2.5 mm~. 
after PTCA 6.2 ± 2.5 mm~ (difference not significant). 
The minimal luminal cross-sectional area increased 
from 1.1 ± 0.9 to 2.8 ± 1.4 mm= (p <0.001). The mean 
balloon cross-sectional area was 5.2 ± 1.6 mm~. Elastic 
recoil was 2.4 ± 1.4 mm=. Thus. nearly 50o/c of the theo-
retically achievable cross section (i.e .. balloon cross-sec-
tional area) was lost immediately after the last balloon 
deflation. A subset of 16 patients (l8lesions) were angi-
ographically reexamined 24 hours after PTCA as part 
of a study looking at changes. in coronary flow reserve in 
the first 24 hours after balloon dilatation. Minimal lu-
minal cross-sectional area directly after PTCA in this 
group was 2.0 ± 0.8 mm:! and 1.9 ± 0.5 at 24 hours. 
(difference not significant). 
Balloon oversizing and elastic re<»~l: For each ste-
notic lesion the balloon-anery ratio was calculated. A 
ratio >I indicates oversizing of the balloon. The mean 
balloon-artery ratio in this study was 0.95 ± 0.18. This 
indicates a conservative balloon handling. considered to 
give optimal dilatation of the stenotic lesion with mini-
mal residual stenosis and the smallest incidence of coro-
TABLE IV Angiographicand Procedural Charactenstics and Reco1l of 151 Les1ons 
"' 
Les1on length >5.2 mm :ond <7 mm (recoil) 50 (0.4$ = 0.25) 
C;;~lciiled les1on (•ecoll) 22 (0.43 ± 0.29) 
Symmetry <0.37 (reCOil) 51 (0.48 ± 0.33) 
p,;::que areJ <4.5 mm: (reCOil) 50 (0.53 ± 0.33) 
Curv;;~ture <12.5 Ul1i~ (recoil) 51 (0.53±0.34) 
).!fax. 111tl. pres. <8 :1tm (rE:-COII) 49{0.46 ± 0.24) 
lnfiJt10n dur;:~;ion <220 seconds(recorl) 50 (0.47 ±0.30) 
R~o" co,.,.~c:o-<:1 1:>< retNen;e Jreo. SoX> ~M tor oe~cn~~1on o• cuton Dornto:; 
1.1J~ •ntl pr"' "-na.>:lm.:)l tnfiJtiO<"II)re-..:.u·eot me IJ.:IItoon; NS ~ :tf1erencc oet'"t"'llc.:tot 
TABLE V Recoil in the Three Main Coronary Artenes 
LAC LC R1g:ht 
(n=77) {n=34) (n ,., 40) ANOVA 
&llloon CSA (mmZ) 5.2± 1.7 5.5± 1.5 4.9± 1.4 NS 
MLCAatter P1"CA(mmZ) 2.5±1.3 3.1 ± 1.2 3.0± 1.7 NS 
Reco1l(mm~ 2.7 ± 1.3 2.3± 1.2 1.9± 1.5 p<0.025 
Reco<ljreterence ;:~rea 0.5 ::!:0.3 0.4±0.2 0.3±0.3 p<O.OS 
ANOVA - ~n~IY''~ ot vor~~ncc. CSA - cros~~..ect1or>:>l ~re~ LAD - 1~ Jnten01" 
e<-~er>dtn<: JM<"Y lC ~ le-t c~rc-Jm!lon< J<:er; MLC« ~ mtnl""'l.:ll lu'T"I~~· cro~~· 
:;.:,c:.cnol oreo: N$ " d~erenC<> not <Jgnrt<:oM 
nary dissection. 1 ~- 1 ..: Lesions with a ratio >I (oversizing) 
were compared with lesions with a ratio .:5 L The com-
parative data are listed in Table II. Ko difference was 
found in balloon diameter between the groups. As ex-
pected, reference diameter was higher in the group with 
a ratio :51. Elastic recoil was more pronounced in the 
second group (0.84 ± 0.29 vs 0.64 ± 0.30 mm. p 
<0.001). Thus. oversizing of the balloon leads to more 
elastic recoil. These results agree with elastic phenome-
na: more stretch leads to more recoil (within limits of 
elasticity). 
Clinical characteristics and recoil: Clinical charac-
teristics and risk factors of the 136 patients are listed in 
recoil(mm2) 
No pV;::,ue Mean 
101 (043::0.33) NS 64±2.~mm 
129(0.~5::!::045) NS 
i00(0.41 :=0.301 p"' 0.07 0.5±0.3 
101 (0 41 = 0.27) p <O.Ol 6.8±3.9mm~ 
100(0.43±0.31) p<O.Ol 17.7±10.4 
102(0.46:::0.35) NS 9.6±2.5Jtl"'"'. 
101 {0 . .14:=0.29) NS 309::: 170 seconds 
Table IIl. No differences in elastic recoil were observed 
for gender. the presence or absence of risk factors and 
the presence or absence of unstable angina. 
Quantitative angiographic lesion characteristics 
and recoil: Quantitative data on lesion morphology be-
fore ang:ioplasty are listed in Table IV. To avoid arbi-
trary subdivision of data. cutoff criteria for lesion 
Ienith. symmetry. plaque area and curvature value were 
derived by dividing the data in 3 groups so that each 
group contained about one-third of the population. The 
group with the highest amount of recoil was then com-
pared \\ith the 2 other groups. Lesions with a small 
plaque area and lesions with a shallow curvature 
showed significantly more recoil (Table IV). 
Procedural related variables and recoil: Table IV 
lists the total inflation duration and maximal balloon 
inflation pressure in relation to elastic recoil. Ko differ-
ences in elastic recoil were observed. 
Recoil in the three main coronary arteries: The 
amount of recoil was calculated in the left anterior de-
scending artery (n = 77). the circumflex artery (n = 
34) and in the right coronary artery (n = 40). Data are 
listed in Table V. The amount of recoil was significantly 
larger in the left anterior descending artery compared 
\\ith the circumflex and right coronary arteries, 2.7. 2.3 
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FIGURE 2. In this scatterplot the differ-
ence in interpolated ~area before 
and after percutaneous transluminal coro-
nary angioplasly is plotted ag;amst: the 
~of recoil for each segment. The 
mean cifference in r~ area was 0.2 
± 1.3 mm2 (rerlica/ Jines in graph}. The 
values are randomly cf"JStributed around 
the mean value of 0.2 mm2. suggesting: 
that spasm was effe<:tively eiiminated. 
and 1.9 mm:. respectively (p <0.025). \~.Then normal-
ized for reference area the difference was still statisti-
cally significant. 
DISCUSSION 
Vasoconstriction at the dilatation site is a common 
cause of early luminal narrowing. As has been shown 
elegantly by Fischell et al 1: this can be rapidly reversed 
by an intracoronary injection of nitrates. Because we 
gave intracoronary nitrates before the pre- and post-
PTCA cine runs. it seems unlikely that the amount of 
recoil observed was caused by vasomotion. In Figure 2 
the difference between the reference area before and af-
ter PTCA is plotted against the amount of recoil for 
each site. The values are randomly distributed around 
the mean value of 0.2 mm=. suggesting the absence of 
vasoconstriction at the post-PTCA film. 
Platelet deposition. and the formation of a nonocclu-
sive mural thrombus despite full heparinization. is not 
an uncommon finding in postmortem hearts obtained 
from patients who die in the first hours after angio-
plasty.16 This has also been confirmed by angioscopy 15 
to 30 minutes after PTCAY7 However. our post-PTCA 
angiograms were recorded within minutes of the last di-
latation. Although we cannot rule out the possibility 
that mural thrombus formation is partly responsible for 
the observed phenomenon. we believe it cannot explain 
the 50% decrease in luminal area found. Subintimal 
hemorrhage is also a cause of severe early luminal nar-
rowing or acute closure. a process which is usually im-
possible to reverse and nearly always results in a failed 
PTCA. In this study only successfully dilated lesions 
were analyzed. 
The mean balloon cross-sectional area was derived 
over the tOtal length of the balloon and compared with 
the minimal luminal cross-sectional area measured im-
mediately after PTCA. In this study. recoil of the pan 
of the dilated segment adjacent to this area was not spe-
cifically studied. We assumed a uniform expansion of 
the balloon at maximal inflation pressure. Theoretically, 
recoil should be assessed using the minimal luminal bal-
loon cross-sectional area. 
The 18 lesions restudied 24 hours after PTCA 
showed no difference in minimal luminal cross-sectional 
area with respect to the cross-sectional area directly af-
ter PTCA. This suggests that elastic recoil is an instan-
taneous phenomenon. This finding does not agree "vith 
the findings of Nobuyoshi et al. 18 who found a signifi-
cant deterioration of minimal luminal diameter 1 day 
after PTCA. However. the small size of this subgroup 
may not be representative of the total population. A 
trend toward more recoil was observed in asymmetric 
lesions. In these lesions the balloon will preferrably 
stretch the nondiseased part of the vessel circumference 
v.'ith a subsequent larger elastic recoil. 19 The fact that a 
small plaque area and a low curvature value are attend-
ed with a significant higher amount of elastic recoil may 
be due to the fact that dissections have been found most 
often in areas containing thick atherosclerotic plaques 
and lesions with a high bending.~o.::l Gross disruption of 
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the vessel wall may prevent the recoil phenomenon. Pro-
cedural variables had no influence on the amount of re-
coil. Longer inflations and higher inflation pressures are 
often used after an initially poor angioplasty result. 
Only a randomized trial can indicate to what extend 
procedural factors influence procedural outcome. 
Jain et aF found. using an in vivo technique for ob-
taining balloon pressure-volume loops. a pattern consis-
tent with stretching of the arterial wall in 56% of le-
sions. A pressure-volume loop consistent with stretching 
of the vessel was a far more common event than a 
cracking pattern (17%). Stretching within limits of elas-
ticity implies its counterpan elastic recoil. More stretch-
ing should lead to more recoil. In our series. oversizing 
of the balloon (i.e .. a balloon-artery ratio > 1) was asso-
ciated with more recoil. indicative of the elastic phe-
nomenon. Dobrin described pressure radius curves of 
potassium cyanide-poisoned carotid arteries of mongrel 
dogs. At low pressures. the vessel exhibited large 
changes in radius with each step in pressure. whereas at 
high pressure it showed very slight changes in radius. 
The curve described an elastic hysteresis loop. v:ith the 
ascending and descending limb close to each other at all 
pressures. suggesting no active muscle contraction in-
volvement in the retraction process.23 
The differences in elastic recoil observed in the 3 
coronary arteries cannot be easily be expiained. Differ-
ences in histologic structure or differences in plaque 
composition in the coronary arteries might be an expla-
nation. To our knowledge these differences have not 
been reponed. 
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Restenosis After Coronary Angioplasty: New Standards for 
Clinical Studies 
KEVIN J. BEATT. ME. BS.'t PATRICK W. SERRUYS. MD. PHD. FACC." 
PAUL G. HUGENHOLTZ. MD. FACC" 
Rouerdam, The Netherlands and London, England 
With the high initial success rates for coronar~' angioplasty 
that are reported regularl:y, it has become increasing!~· 
difficult to demonstrate methods or techniques that are able 
to provide more beneficial early results than can be 
acbie~·ed b~· conventional angioplasty. On the other hand. 
the incidence of late restenosis has remained much the same 
over the 10 years that angioplasty has been part of clinical 
practice. and there is still no proved intervention that 
modifies the restenosis process. Therefore. the problem of 
restenosis has assumed increasing relevance in determining 
the clinical value of corona11· angioplasty and. accordingJ~·. 
studies that address the problem of restenosis need to 
become more exacting. 
Studies :aimed at reducing the incidence of restenosis after 
coronary angioplasty have become an important field of 
investigation in intervemional cardiology. In general. the 
early results of medical treatments and interventions are 
relatively simple to assess. but the long-term studies fre-
quently prove more difficult to evaluate and. historically. 
often have been unreliable. Early or prelimlnary results 
often have been misleading and frequently contradict those 
of well controlled definitive studies. It appears that innova-
tors and exponents of new treatments may allow their 
enthusiasm to compromise their objectivity. Therefore. it is 
imponant that any new technique or pharmacologic treat-
ment is assessed objectively using a methodology with 
known reproducibility and in which the technical limitations 
are known and understood. 
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Although numerous .articles have addressed the problem 
of restenosis in the clinical setting. many defining certain 
f.actors.associ.ated ""ith restenosis and possible interventions 
to reduce the incidence of restenosis. there is surprisingly 
little consensus. Most of the discrepancies can be .attributed 
to three f.actors: 1) the selection of p.atients. 2) the method 
of analysis. and 3) the definition of restenosis employed. 
This re•;iew shows how these three [.actors influence the 
outcome and conclusions of restenosis studies. 
(J A.m Cell Cardioll990;15:491-8) 
Over the past 2 to 3 years. there has been a rapid increase 
in new devices and techniques designed to augment or 
replace conventional balloon angioplasty. With Ute progres-
sive improvement in the immediate success rate and com-
plication rate of the convenrional procedure. it has become 
more difficult to demonstrate the additional efficacy of new 
devices and interventions. Any improvement in the imrnedi· 
ate results may be. as it was v.'ith coronary anery bypass 
surgery in the past. misleading and. therefore. the attention 
of investigators has rightly turned from the immediate results 
to the long-term outcome. Restenosis after coronary angie~ 
plasty. a recognized late complication in 25% to 35% of cases 
since the introduction of the procedure in I97i (I). remains 
its main limitation. 
Despite the established imponance of this topic. there has 
been no consensus on ho'-" these studies should be per-
formed. v.ith widely differing methodologic approaches giv-
ing diverse and conflicting results. Although the long-term 
clinical outcome will remain imponanr in any assessment. 
the most objective means of assessing restenosis following 
angioplasty is by carefully controlled coronary angiography 
at the time of the procedure and at a defined follow-up time. 
In the past the visual estimation of the angiographic films has 
been used. but a consensus is now beginning to emerge th.at 
89 
Table 1. Studies Addressing the Incidence of Coronary Restenosis 
Patients 
First .... uthor 
" and Ref 
'"" 
Total Follow-Up 
Meyer ('12) 1983 70 90 
Thonon (5) 1984 
'" 
7! 
Holmes (7) 1984 665
" Kaltenbach (14) !9S5 356 94
"Levine (13) 1985 100 
" Corcos (8) 1985 92 100 
Leimsruber (6) 
'"' 
!758 57 
Bertrand (23) 1986 :29 NO! reported 
Vandormael (3) !987 119 
" 
Studies addressing the timing and incidence of restenosis 
Serruys (9) 1988 
"'" 
85 
Nobuyoshi (1) 1988 18~ 81 
!..'9 100 
219 % 
149 65 
lntervaJ (mOl 
PTCA to 
Follow-Cp 
' 6-9 
6.2 
5.6 
8.2 
7 
24h 
I 
6 
Restenosis Criterion 
AS >857C 
NHLBI4 
~HBU4 
OS <10% of pre-PTCA 
NHLBI 4 
>70% OS at follow-up 
NHLBI4 
NHLBI4 
'"'20% reduction and 
~50% 0S 
=:o:r.:mm 
:;:::0.72mm 
;::0.72 mrn 
2::0.72 mrn 
NHLBI4 
NHLBI4 
NHLBJ 4 
NHLB14 
" Restenosis 
"' 31 
34 
" 
"' 18.5 
30 
32 
33 
0.9 
12.J 
22.6 
15.5 
14.6 
1:?:.7 
4l0 
49.4 
AS "' %are:. stenosis: OS "" 'ic diameter stenosis lmml: NHLBI 4 == criterion 4 of the National Heart. Lung. and Blood Institute (loss of :=:50% of gain): 
Ref== reference. 
recognizes the limitations of this approach. The use of a 
quantitative angiographic measuring system for assessing 
both the immediate and the long-term results of therapeutic 
interventions such as angioplasty appears mandatory. 
Methodoiogic Considerations 
Currently there are many studies on coronary restenosis 
reponed that are distinguished by their lack of consistency in 
their methodologic approach. their definition of restenosis 
and the reponed factors influencing restenosis (Table l)_ 
These studies are demanding in terms of time and financial 
resources and are also demanding on the patient because. at 
least for the time being. there is a need for repeat angiogra-
phy even if the patient is asymptomatic. This is because of 
the reported incidence of silent restenosis. which may be as 
high as 33% if a sensitive enough index is used (2). Particu-
larly with studies that look at the impact of a new interven-
tion on restenosis. it is important that their design is capable 
of showing the effect of the intervention. if indeed one exists. 
Many of the studies published so far have failed to be 
sufficiently exacting to form a basis for their conclusions. In 
order to improve the situation. there are in principle three 
areas that need to be addressed: 
I. Study population. If the results are intended to apply to 
the angioplasty population. then the study population must 
reflect this. This means a high angiographic follow-up rate 
with individual patient's time for restudy being predeter-
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mined at the time of angioplasty. and not influenced by the 
recurrence of symptoms or the anatomy of the lesion after 
angioplasty. This will avoid a selection bias of symptomatic 
patients or patients with borderline postangioplasty results. 
It can be estimated that if a 30% reduction in the 
restenosis rate is to be realized at the 0.05 significance level. 
then in a double-blind randomized study 400 patients 'Will be 
needed in each of the placebo and active treatment groups. 
For a 50% reduction in restenosis rate. 150 patients will be 
needed in each group. 
2. A well validated system of analysis .,.,:ith known accu-
racy and variability should be employed. The use of a visual 
percent diameter stenosis measurement with its inherent 
variability precludes meaningful results. and edge tracing by 
hand or other techniques that can produce values not phys-
iologically possible are also unacceptable. 
3. The measured variables must be chosen so as to reflect 
the restenosis process and distinguish between the results of 
angioplasty and this process. The conventional assessment 
of percent diameter stenosis is not sufficiently discrit;n.inating 
to do this. because. when there is a concomitant decrease in 
the reference or normal diameter of the vessel. a smaller 
lumen may have a larger measured percent diameter stenosis. 
Angiographlc Definitions of Restenosis 
Limitations of criteria to define resteiiosis. The definition 
of restenosis of choice has been the subject of much debate. 
;:~re-ptc;a post -ptca tollow-up 
15$ /28% 45% / 70% 
~\ (fiit,;\ 
70%/91% /! ( 1 L-.. I 
.. /\~42%'V 
(, ) 45% / 70% 55% / 80$ 
~'\.~ 1\ 
1 Q ha~l 0 i DIAMETERSTENOSI~ ,~ 
/AREA STENOSIS 
Figure 1. Shov:n in terms of cross-sectional.area are two possible 
outcomes of an initially severe lesion after coronary angioplasty 
(PTCA). On the left, the lesion before angioplastY with a 70% 
diameter stenosis (area stenosis = 91%). Middle, a good result. 
represented by the upper profile leads to a 15% diameter stenosis 
(area stenosis """ 28%). At follow-up (right). there has been a 42% 
change in the area of stenosis represented by the shaded area in the 
top circle. Although there is a considerable increase in the plaque 
cross-sectional area. the follow-up diameter stenosis is only 45% 
and. therefore, using the criterion of >50% diameter stenosis at 
follow-up, this is designated as not being a restenosis. In conrrast. 
the lesion represented on the bottom. which is successfullv dilated. 
but to a lesser degree (45% diameter stenosis after angiopl:isty). will 
be designated as restenosis if there is even a small deterioration in 
the plaque area (change in diameter stenosis of 10%) resulting in a 
follow-up diameter stenosis of 55% (percent diameter stenosis/ 
percent area stenosis). 
and there is currently no satisfactory definition that takes 
into account both the functional and the angiographic out-
come of the patient after angioplasty. The confusion and 
controversy that surround the subject of restenosis are 
essentially due to four factors: 
1) Many angiographic definitions try to combine the 
angiographic outcome with a clinical outcome. The known 
discrepancy between these two variables means that this 
objective will nor be realized. particularly in multivessel 
disease (3). 
2) A single '"stenosis .. measurement should not be con-
fused with a measurement of "restenosis ... which should 
represent the change in stenosis severity. 
3) Criteria that are defined by a cut-off value at follow-up 
or that are biased by the improvement in lesion diameter 
obtained at angioplasty will preselect those lesions with a 
Jess satisfactory result postangioplasty. The definition of a 
~50% diameter stenosis at follow-up is used to illustrate this 
point in Figure 1. 
4) Definitions based on percent diameter stenosis mea-
surements may fail to identify lesions undergoing significant 
deterioration. These criteria are chosen to reflect the change 
in minimal luminal diameter in relation to the so~called 
normal diameter of the vessel in the immediate vicinity of the 
obstruction. It also assumes that this normal dlameter (or the 
reference diameter) of the vesseL proximal or distal to the 
obstruction. does not change either as a result of angiopiasty 
or during the immediate follow-up period when restenosis of 
the dilated lesion is a well recognized phenomenon. Quanti-
tative angiographic studies have shown this premise to be 
false. This seriously questions the use of percent diameter 
stenosis as the only index of restenosis (2.4). 
Figure 2 illustrates how the choice of reference diameter 
may influence the assessment of restenosis in what is a 
relatively simple segment to analyze. The choice of refer· 
ence diameter. whether interpolated. proximal or distal. has 
little effect on the percent diameter stenosis in the examples 
before (Fig. 2A) or after (Fig. 2B) angioplasty because the 
reference diameter is similar in all cases. In contradistinc-
tion. the choice of reference diameter is highly relevant 
to the determination of the percent diameter stenosis at 
follow-up (Fig. 2C). largely because of the discrepancy 
between the reference diameter proximal to the stenosis 
and the one distal to it. The "moving baseline .. created 
by the fact that the reference diameter may decrease 
means that lesions that should be regarded as restenosis may 
not be. 
Criteria of restenosis in current use. What is the rationale 
for the restenosis criteria in current use? Most are entirely 
arbitrary. some are based on doubtful logic and some, 
although of some relevance for visual estimation of percent 
diameter stenosis. are unrealistic when applied to the more 
accurate values obtained from quantitative angiography. 
The definitions of restenosis used in major restenosis 
studies are: 
L Loss of at least 50% of the initial gain achieved at 
angioplasty (5). 
2. A return to within I 0% of the preangioplasty stenosis 
diameter (6). 
3. An immediate postangioplasty stenosis diameter of 
<50% that increases to ~50% at follow~up (6.7). 
4. As for 3. but for a stenosis diameter ~70%at follow-up 
(8). 
5. Deterioration of 0.71 mm in minimal luminal diameter 
or greater from immediately postangioplasty to follow-
up (9). 
6. Deterioration of 0.5 mm in minimal luminal diameter 
or greater from immediately postangioplasty to follow-
up (2). 
Examining the commonly used definition of ==50% steno· 
sis diameter at follow-up. This is based historically on the 
physiologic concept of coronary flow-reserve and is taken 
because it represents the approximate value in animals 'IIIith 
normal coronary arteries at which a blunting of the hyper-
emic response occurs (10). Although this value may be of 
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fi~re 2. Singk fr.;~me angiogram~ of a pro;.;imal 
left anterior descending artery stenosis. A. predi-
lation !PRE-PTCAI. B. po~tdilation lPOST-PTCAI 
and Cat follow-up. Quantitative coronary analysis 
was performed using a coronary angiography anal-
ysis sy5tem. The arterial boundaries detected by 
the system are shown on the angiogr..tm and below 
the diameter function curve deri\·ed from these 
contours. Tht.' example illustr.;~tes the importance 
of the choice of reference diameter. th<: fact that 
the dilated but non stenotic coronary artery mJ.y be 
involved in the restcnosis process. and the value of 
the interpolated reference diameter for ealculatin[! 
the appropriate di::tmeter steno~is. A. Before angio-
pbsty.the lesion is relatively eas~ to analy;::e. The 
segments proximal and distal to the sreno~is are of 
similar caliber and the lesion is rciati\ ely discr<!le. 
so that its length can easily be defined on the 
diameter function curve. B. After ::tngioplast~. 
there is a satisfactory result. the diameter stenosis 
decreasing from 59'/f to 360 tarea stenosis from 
S37r to 59~). C. At follow-up. the result is very 
dependent on the method of analysis. The artery 
proximal to the stenosis ha~ already been involved 
in the restenosis process: if thi~ i~ chosen as a 
reference diameter lleftl. J 42'11: diameter stcno~is 
is obtained 1no ··restenosis""J. The distul portion is 
of a la:-gcr caliber than the proximal portion: if it is 
chosen as a reference di.::meter lmiddlr:L the result 
is a 620C diameter stenosis (""restenosis""J. If the 
interpolated technique i~ used {rightJ. the reference 
diameter i~ similar to the postangioplasty value. 
and a 58'/( diameter steno~is is obtained that accu-
rately reflects what is happening between the post-
angiopla::.ty result and the follow-up. Even with 
this high qu.::lity angiogram of a well visualized 
segment with a discrete stenosis. there are prob-
lems in obtaining accurate and realistic results. 
USER DERNEO 
USER DEFINED lN"TERPOLATEO 
l.ISER DEFINED PROXIMAl USER DEFINED DISTAL INTER?Oi...A T£t> 
some relevance in determining a significant stenosis in 
human atherosclerotic vessels. it te!ls us nothing about the 
way the lesion has behaved since the angioplasty procedure. 
It is clear from Figure I that no criterion defining the 
92 
re$tenosis as $UCh can include the second example and not 
the fir$!. Similar arguments concerning a bia$ in selection 
can be applied to the other commonly used definition of a 
loss >500( of the gain. 
~ew res:teMsis criteria based on quantitative angiograph~·. 
As a result of quantitative angiographic studies. a new 
concept for defining restenosis criteria based on the change 
in minimal luminal diameter has been introduced (9). The 
change in this value from postangioplasty to follow-up can 
be expected to give a good quantitative measurement of the 
de2fee of restenosis. The restenosis criterion or the cutoff 
point dividing the restenosis group from the nonrestenosis 
group is then derived by determining the variability of 
measurement (1 SD of the difference in means) of the same 
lesion taken from separate catheter sessions. Twice the 
variability (95% confidence intervals) defines with reason-
able certaimy those lesions that have undergone significant 
deterioration from those that have not. Reiber et a!. ( ll l 
found this value to be 0.7::!. mm on the basis of angiograms 
taken 90 days apart. whereas Nobuyoshi et al. (2). using a 
different measurement system. have taken 0.5 mm on the 
basis of angiograms taken 7 to 10 days apan. It is important 
to realize that the variability will be considerably greater for 
angiograms taken from repeat catheterization sessions. as 
opposed to repeat angiograms from the same session (11). 
something that has not been appreciated by all investigators 
using this methodology (12). 
Criteria based on rhe absolute change in minimal luminal 
diameter are nevertheless limited because they make no 
attempt to relate the extent of the restenosis process to the 
size of the vessel. What may be a significant increase in 
plaque area in a 1.5 mm diameter vessel may be of no 
hemodynamic consequence in a larger vessel of 3.5 mm. 
Studies need to be undertaken ro assess the variability of 
measurement in different diameter vessels. and a ·'sliding 
scale" criterion created that adjusts for vessel size. 
Incidence of Restenosis 
Role of defined criteria of restenosis. In the same way as 
the method of analyzing an angiographic frame will infl.uence 
the measurement of percent diameter stenosis. so it will 
infl.uence the restenosis rate. However. the factor that most 
infl.uences the rate is the definition of restenosis used. Figure 
3 shows the number of lesions fulfilling three criteria of 
restenosis: although 43 of the lesions included by at least one 
criterion are included by all three. 32% of those included in 
one criterion ("·a loss of greater than half the gain··) are not 
included in either of the other two. Despite this discrepancy. 
the incidence of restenosis is not too dissimilar. ranging from 
21% to 34% (Fig. 4). What should be clear is that a similar 
incidence of restenosis with different criteria may be defining 
different populations. This point has particular relevance 
when determining the risk factors for restenosis: if restenosis 
cannot be reliably determined. then it is unlikely that the 
associated risk factors will be identified. The most sensitive 
index of restenosis in common use is that of a loss of ~50% 
of the gain. with reported incidence rates ranging from 16% 
NHL.8!4 ~ 
{N•121) / 1 / """· ."' i ! 17 \ \ 
: 39~' ', 17' 
' ' ' 
'., I \. 43 / _.' 
\ /22 \ J 0 \... I I 
~
' 15 1 \~ 
~ 0.72 mm 
(N•80) 
~50% OS 
(N•67) 
Figure 3. The number of lesions fulfilling three restenosis criteria. 
taken from a group of 4-90 lesions measured at follow-up within 6 
months. The rota! number of lesions that fulfill each criterion are 
shown under the criteria. and those lesions fulfilling that criterion 
and none other are enclosed by only one circle. Lesions included by 
any two criteria are enclosed by two circles. and lesions that fulfill 
all three criteria (n = 431 are enclosed by all !hree circles. It can be 
seen that lesions that are designated as restenosis are highly 
dependent on the criteria for restenosis employed. :i'\HLBI4 = 
criterion .! of the ::--rational He:trt. Lung. and Blood Institute: loss of 
>50% of the gain at angioplasty. '2:50% DS = '2:50% diameter 
stenosis at follow-up. '2:0. 72 mm = ~0. 7:: mm change from postan-
gioplasty to follow-up. 
to 52% (2.5.6.9.13). On the other hand. 2:50% diameter 
stenosis at follow-up will tend to give a lower incidence of 
restenosis because lesions that deteriorate significantly. but 
remain within the 0 tO 49Yc range. are not designated as 
restenosis. Of the two studies with larger numbers that 
document the change in minimal luminal diameter. only one 
uses this value to derive a restenosis value of 26% at 4 
months (9). 
Figure 4. Incidence of restenosis (RESTI according to three criteria 
in tile first 150 days after angioplasty derived from the patient group 
with 490 successfully dilated lesions shown in Figure 3. Abbrevia-
tions in Figure 3. 
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35,.--- /~---~~--~HB~~--.... 30"-----------------~----~~~~-
/_./ ::!0.72 MM 
25~----~/~-~~~--~--~ .. ~--~~~~ 
20~--------~~--~~~~------~ 
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Role of quantitative angiography. The use of quantitati\·e 
angiography has given valuable insight into the problem of 
defining an incidence of restenosis. It has been demonstrated 
that the restenosis process takes place. to some extent. in 
most of the lesions dilated and. furthermore. it takes place 
not only !n the stenotic ponion. but also in the dilated but 
nonstenotic segments (4). This observation in itself demands 
the use of a measurement system that v.ill define the change 
in the minimal luminal diameter independent of the change in 
the '"reference diameter:· 
Timing of Restenosis 
It has been clear for some time that restenosis most often 
takes place within the first 6 months after dilation (7.14). 
Further progression after this time is unusuaL with lesion 
improvement or deterioration occurring in a small number of 
instances. a pattern more characteristic of coronary artery 
disease in general (15-17). Recently two reponed studies 
(2.9) performing follow-up angiography at different prese-
lected follow-up intervals gave remarkably similar results 
and showed more precisely how the lesion behaves after 
angioplasty. Early after angloplasty. within 30 min. ··recoir· 
may take place. which in principle should be regarded as a 
separate problem from that of the restenosis (Fig. 5). This 
decrease in the luminal diameter may be exaggerated by a 
vasoconstrictive component if vasodilators are not adminis-
trated after the an...cioplasty procedure. The recoil. together 
with remodeling and possibly thrombus formation. results in 
··restenosis·· in II% to 16% of the lesions in the first 24 h 
(using the National Hean. Lung. and Blood Institute defini-
tion 4 of restenosis) (2). It then appears that healing and 
remodeling may lead to improvemem in an appreciable 
number of lesions. so that at 30 days the restenosis rate lies 
between 6% and 13%. Between I and 3 months. most lesions 
that ""'ill develop restenosis do so. with the restenosis rare 
reaching 25% to 37% (Fig. 6). A small number may show 
further progression between 4 and 6 months. It seems likely 
that the restenosis process begins early and is progressive 
over the first 3 to 4 months. 
The limitations of even the most accurate measurement 
systems mean that these early changes are not detected 
early, and it is not until substantial progression takes place at 
3 months that the process is fully recognized. This early 
change has been shown in animals. v.rith evidence of smooth 
muscle proliferation as early as 7 to 14 days after dilatation 
(18). This same process has been identified in at least 7 
postmonem beans (19-21) that were examined over a period 
of 17 to 150 days after angioplasty. 
Videodensitometric Analysis 
Although videodensitometric analysis has been advo-
cated as the method of choice for studies addressing: the 
a) GroUP l N=276 I><~.Cl 
lmml 
l.O 
2.> 
2.0 
1.> 
1.0 
05 
2.63 
~o.ss 
0.75 
2.84 
~O.ti1 
l.S1 
~0.53 
,...-"<O.DI--, 
2.81 2.79 ~0.61 ~0.57 
1.72 1.86 ~0.52 ~o.5a 
~0.49 '--"<DOOI-~"<001- '"-P.:C.Il::l--' 
-<><o oo,__. ~'a L'lll 
2.70 
~0.5S 
UJ 
~o.S7 
tll Grouo: N=l95 ~----•~<a.ol,-----, 
94 
:mm: 
" 2.> 2.63 2.86 2.81 2.81 2.75 2.69 ~0.67 ~0.64 ~ll.S1 ~o.ss '0.60 ~0.59 
" 
1.5 1.95 1.76 1.93 1.66 l.SS ~0.54 ~0.53 ~0.56 ~a.5a ~D.S2 
1.0 0.77 L."<O.Ili)1.JL.....:u,..JL.~<tooJ..J 
0.5 ~us L.....-~<0.00~ 
'-"<O.DCI.J "<l.Cil 
Prr PTC,r. Pest OTCA 
'" 
,_
:l Mon:"":; 
·-
cl Grouo m 
.,...,, 
l.O 
2~ 
2.0 
1.0 
~· 
N=91 ~(J.D\ 
P<D.O. 
1.67 2.92 2.86 2.82 
~0.74 =o.ss ~0.67 ~0.58 
1.99 LBO 1.94 ~0.52 
=0.51 ~0.49 
~"'"- -"'"-
2.77 2.70 
~o.ss ~0.54 
1.67 us 
~0.59 ~0.56 
2.72 
=D.S4 
1.56 
=0.57 1.5 r( 
0.5 L.,...~~~~~~~,~·,~, '~'~":;;;:~:=:;:;:=""',...... '-"<~ ~1-' . ~(0 001 
~ "TC"- Po::t F'":"CA 0.> I ' lwll;!"tn :llwl011i;'lS 6 Mon\tl$ l 'lt~r lmmec,•:-e 
Figure 5. Serial changes in the absolute diameter of normal (open 
circles) and stenotic (closed circles) segments after coronary angie· 
p!asty (PTCA) for three follow-up groups. Group I = 3 month 
angiographic fo!low-up. Group II = 6 month angiographic follow-up. 
Group III = I year angiographic follow-up. The change in both the . 
normal (0) and stenotic (8) segments with time are illustrated. Most 
ofthe deterioration in the stenotic segments occurs between 1 and 3 
months. whereas there is a less pronounced steady deterioration in 
the nonstenotic segments up to 6 months. {Reprinted with permis-
sion from :;-,iobuyoshi eta!. [2]). 
problem of restenosis. it has not proved practical in large 
studies. The technique is promising. but the number of 
lesions that can be analyzed effectively by this technique is 
limited. and the use of the videodensitometric technique 
would mean that a significant number of patients undergoing 
routine anglopiaity (>I 0%) would be excluded from resteno-
sis studies. Future developments may mean that this 
method. which is potentially easier to perform and requires 
only one ang:iographic projection to obtain a three-dimen-
sional representation. will become the method of choice for 
restenosis studies. 
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Risk Factors for Restenosis 
Identifying the risk factors. There are no srudies using 
quantitative coronary angiography that reporr on the risk 
factors in large numbers of patients. There are some factors 
relating to the restenosis process that have been identified 
and confinned in more than one study. These include a 
proximal left anterior descending coronary artery stenosis. a 
totally occluded vessel before angioplasty. the presence of 
collateral vessels supplying the distal part of the dilated 
coronary artery and associated insulin--dependent diabetes. 
Factors that relate to the success of the angioplasty. such as 
a residual stenosis >30% or 40%, with current knowledge 
should not be considered as risk factors for ··restenosis." 
For most of the other described risk factors, there are as 
many studies that do not as studies that do identify a 
particular factor. No procedure-related factor. that would 
allow the operator to modify the way angioplasty is per-
formed has yet been identified. and no pharmacologic inter-
vention has been able to show a reduced rate of restenosis. 
Quantitative angiography offers the possibility of objective 
measurement of lesion morphology. such as length of lesion 
and eccentricity. and when this more objective infonnation 
becomes available. then perhaps it v.ill be possible to iden-
tify lesion-related factors associated with restenosis. 
Role of quantitath·e angiography in evaluating new proce-
dures and inten·entions. To date. quantitative coronary 
angiography has been used in a limited number of studies 
addressing the problem of restenosis. It has already provided 
valuable insight into the restenosis problem and has identi· 
fied some of the sources of confusion surrounding this topic. 
It seems likely that. with better measurement systems. 
particularly those that become on-line in the catheterization 
laboratory, it v.ill be easier to perform these studies. and 
with more reliable data in smaller numbers of patients. the 
effect of various interventions to prevent restenosis will be 
assessed more accurarely and more efficiently. Currently 
there is a v.ide variety of revascularization devices, proce-
dures and pharmacologic interventions under investigation. 
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Figurt 6. Individual minimal luminal diameter (mm) after coronary 
angioplasty (PICA) compared with the control angiographic study 
for three different groups at 30. 60 and 90 days. The two solid lines 
on either side of the identity line correspond to the long-term 
variability (0.36 mm) of repeat measurement for rhis variable 15). 
This variabilitv is 1 standard deviation of the difference in means of 
duplicate angi~grapb.ic measurements. Therefore. 2 standard devia-
tions C. x 0.36 = 0.72 mm) define the 95% confidence limits for 
lesion progression or regression. The lesions sbov.ing progression or 
regression is represented by closed circles. and the numbers are 
shown in the brackets in the left upper and right lower comers. 
and of crucial importance in their evaluation will be the 
restenosis rate associated with each of these strategies. It is 
already clear that a meaningful comparison among the 
various strategies and evaluation of their relative merits is 
not possible because of a lack of standardization of method-
ology and lack of objectivity. In the future. we should 
demand that quantitative analysis be employed in important 
studies addressing the long-term outcome of new coronary 
interventions. so that the present confusion is not perpetu-
ated. 
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Editorial 
Stenting of coronary arteries. Are we the sorcerer's apprentice? 
P. w. SER.RUYS, K. J. BEATT AND W.J. VAI'DERGIESSEN 
Thoraxcemer, Erasmus University, Rotterdam, The Netherlands 
Introduction 
The original work of Andreas Gruentzig in 1977[11 
provided the stimulus for the rapid technological 
growth of interventional cardiology. More recently 
there has been an explosion in the number of new 
devices designed to ablate coronary artery narrow-
ings, recanalize occluded vessels.. and prevent re-
stenosis. so much so that it is currently difficult to 
evaluate the relative merits of each and to define 
their place in clinical practice. In many of these 
areas the cardiologist has been acting solely as tech-
nician. limiting his concern tO the technical and pro-
cedural aspects. and sometimes overlooking the 
complex biological and physiological mechanisms 
of atherosclerosis in general. and more particularly 
of the restenosis process. 
In achieving the perceived benefit of the thera~ 
peutic intervention with these devices the vessel wall 
is subjected to thermal and mechanical insults 
which may have bidden long~term consequences as 
novel as the restenosis process was when this new 
pathological mechanism was first describedr-31. and 
which has now been iatrogenically induced in tens 
of thousands of patients. 
One ofthemostrecent developments has been the 
use of the intravascular stentl4l, although the orig~ 
inal concept of intravascular stenting preceded the 
introduction of coronary artery interventional car· 
diology by many years. In 1969. Dotter developed a 
coilspring endovascular prosthesis in an attempt to 
improve the long·term patency of peripheral 
atherosclerotic vessels submitted to recanalization 
and dilatation. Even at that time he envisaged that 
'prompt fibroblastic development and a rapid for-
mation of a new, fumly anchored autogenous lining 
surface' would be a critical factor in the long-term 
patency of the devicef5l. 
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Since the original description of Dotter's tubular 
coil springiSl. there have been many variants of 
the original concept deployed experimentally. 
including: thermal shaped memory alloy stenrsl6-8l. 
self.expanding steel spirals!9-12l. self-expandable 
stainless steel mesh stentsfl:J-ISJ, balloon expand-
able stainless steel mesh stentsl16-19l, balloon expand-
able interdigitating coils~.2IJ, synthetic polymeric 
stents and biodegradable stentsl22l_ These various 
devices differ greatly in their fundamental geometry 
(mesh., single ..-vire). composition (metal, plastic) 
and mechanical behaviour (active or passive expan-
sion). Besides these fundamental differences. there 
are a variety of subtle dissimilarities which may be 
important in themselves. such as thickness of fila-
ments. alloy composition. electrostatic behaviour, 
biocompatible or therapeutic coatingsi2Jl. The 
prolonged presence of these materials residing in 
the arterial wall may generate late unknown and 
unexpected consequences. 
What is the rationale for stenting an atherosclerotic 
vessel during or after dilatation? 
In the first place. the stent may optimize the dila-
tation process, by containing the irregular surface 
of the atherosclerotic plaque created by the disrup-
tive action of the balloon. Two potential adverse 
effects. distal embolization of macroscopic debris 
originating from the plaque and a protruding ob-
structive flap may be contained by the stent acting 
as a scaffolding device. The balloon expandable 
stent in particular may be advantageous when the 
operator electively uses the device to dilate the 
lesion and implant the stent in a single manoeuvre. 
The self.expanding stent on the other hand. by 
exerting a continuous radial force. bas the effect of 
increasing the diameter of the lumen until a balance 
is reached beween the expanding force of the stent 
and the circumferential compliance of the vesseJl4.24l. 
The physiopathological consequence of this is 
unkno'.'.n, but recently this interaction has been 
documented to continue for at least 24 h and poss-
ibly longer. resulting in continued improvement in 
the vessel lumen over and above that obtained at 
implantationr-sl. The recoil phenomenon which is 
poorly documented and probably underestimated 
as a cause of ·restenosis' '.'.ill be equally prevented 
by both types of stentr-61_ In addition. both types 
of stem have a smoothing effect which reduces the 
turbulent and laminar resistances and may be 
beneficial in preventing restenosisr14· 15'i. Much has 
been made of the ability of the stent to prevent re-
stenosis. with various theoretical proposals as to 
how this can be achieved and why one particular 
design might be more effective than anotherr4~0l. An 
attractive concept which favours the rigid stent is 
that the limitation of vessel wall stress seems to 
be protective against atherogenesis[ZIJ. ·The self-
expanding stent. by stretching the walL might have 
the effect of accelerating the restenosis process. 
'However. whether the accelerated process is mostly 
related to pulsatile stress rather than stress per se 
remains to be demonstrated. Although there may 
be some experimental work in animals to support 
these claims. there is as yet no evidence to support 
them in the clinical situation and they must there-
fore be regarded as speculative. There may be ulti-
mately little difference benveen compliant and 
uncompliant devices (considering the amount of 
radial forces at the site of the wires exened on the 
vessel -wall). The initial intuitive and simplistic 
concept. not supponed by experimental evidence. 
that the stent may act as a barrier preventing the 
migration of cellular structures (monocytes. macro-
phages. smooth muscle cells) into the intima during 
the healing process. has not been realized and the 
other potential mechanisms of prevention of re-
stenosis. by stenting the internal wall of the vesseL 
have not yet been fully elucidated or unequivocally 
demonstrated. An alternative mechanism is that 
chronic compression by the stent of vasa vasorum 
underl)ing an atherosclerotic plaque may result in 
ischaemia ofthis microscopic vascular nenvork and 
thereby limit the subsequent progression of the 
atherosclerotic plaquer-sl. 
The mechanism of restenosis prevention put 
fo!""').·ard by Palmaz ec a[_[lSJ is open to criticism on 
the basis that it is an interpretation too dynamic for 
what is in essence a series of post mortem ·snap 
shots' which are difficult to reconstruct in time 
(Fig. 1). This evidence. recently reiterated by 
Schatz. is extremely appealing and attractive, but 
remains an unsubstantiated interpretationr.:9l. The 
struts of the mesh prevent the protrusion of sizeable 
atherosclerotic plaques inside the lumen of the 
vessel and act as a ·macroscopic sieve·. containing 
and pushing the atherosclerotic plaque away from 
the nee-intimal lining into the adventitia. In 
addition. a sclerotic thinning of the media is 
apparently induced. converting the muscular and 
dynamic medial layers of the vessel into a practi-
cally non-vasoactive and non-compliant ·pipe'. 
Whether this is true and applicable to the human 
clinical situation remains to be demonstrated. 
There is a consensus among investigators in the 
field that stent implantation improves the immedi-
ate post-dilatatiOn result. producing a smooth 
straight appearance of the dilated segment. This 
visual impression has been confirmed by quantitat-
ive analysis using both edge detection and video 
densitometric techniquesl:!4 l. Favourable results 
have also been reported in the 'bail-out" situation. 
when the stent has been implanted following dila~ 
tation where presence of intimal dissection had 
led to a poor and even critical haemodynamic 
resultP0-311• • 
The thrombogenic nature of the stem remains a 
concern. although there may be imponant differ-
ences between different devicesr-9-3:.3JJ. This concern 
is reflected in the anticoagulant regimens used in 
patients in whom the Medinvent stent was 
implanted (Table 1). This complex and aggressive 
protocol reflects the insecurity of the clinician and 
the knowledge that none of the anticoagulant 
agents on their own will reliably prevent thrombus 
formation. It is a paradox that similar devices. 
although with different metallic compositions. have 
been used for just the opposite effect-to create 
thrombotic occlusion in experimental animaU*36l_ 
At the tenth congress of the European Society of 
Cardiology. Richard Schau reported the immedi~ 
ate results in 15 patients who had received a Palmaz 
stent. According to an FDA-approved protocol. 
the stems were implanted in vessels (mostly right 
coronary arteries) supplied by a collateral circu-
lation. At that time he was convinced that all 
patients could be treated with heparin and dextran 
during the procedure and aspirin and dipyridamole 
alone after discharge. There were no instances of 
abrupt closure_and no patient required warfarin. 
These initial results s1.:gges.ted that this balloon 
expandable stent was relatively non-thrombogenic. 
which eliminated the need for both routine adminis-
tration ofl"ytic agents during the procedure and war-
farin thereafter. Unfortunately. the angiographic 
follow-up at 6 months of these first 15 patients 
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Fis:ure I Microphotography of cross section of an: athero-
sclerotic rabbit aorta(::~.) 1 week and (b) 6 months after stent-
ing. Note the thin layer of thrombus (T) covering the stent 
struts ('") and the thick media (M) at 1 v:eek. By 6 months, 
thrombus is replaced with :teellular ground substance :a.nd 
endothelium. A la.tge plaque is evident (arrows) but does not 
encroa.ch the lumen (from Sch:ltzCOI, reprinted "ith the per-
mission of Circulaiion). · 
--- ,-.. 
:c~,'._~.;••, ,-
':,-"".:":.'. /;: 
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disclosed four total occlusions and one restenosis. 
Since then. patients have been given coumad.in. 
Concern has also been expressed as to whether 
the composition of the stent is able to trigger an 
allergic response. particularly in individuals who 
may be hypersensitive tO the individual metals 
that make up the device. Although there have been 
reports of transient infiammatory infiltrates in the 
adventitia following stent implantation. it is reas-
suringthat there are no reports of foreign body cells 
in the immediate vicinity of the implanted device in 
the experimental animal modeJ[O.ll:l37J_ Human data 
to support this assumption are still lacking. how-
ever. 
Stent-induced restenosis 
DO WE KNOW 'NHAT HAPPENS AT PTCA AN'D 
UNDERSTAND THE PROCESS OF RESTENOSIS? 
Data from normal and atherosclerotic arteries of 
experimental animals and human autopsied hearts 
have shown that following balloon dilatation the 
arterial intima or atherosclerotic plaque may split 
down to the internal elastic membrane~.JsJ_ Fre-
quently also damage of the arterial media with 
overdistension and splitting occurs. Next to or par-
tially as a result of locally turbulent blood :flow, a 
complex interaction between the exposed suben-
dothelial surface and blood elements occurs. This 
results in platelet deposition locally in the region 
Figure 2 Histologic cross-section of :t porcine left descending anterior coronary artery 1 
monthafterstent placement (magnification x 120). The voids r:narked (•) origina.llycontained 
the stent wires. In the neointima str:mds of elongated cells (arrows) are present in abundance. 
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Table 1 Intracoronary stent: Multicenter European Trial Drug Regimen 
Day before implant procedure -Salicylic acid 2 x 500 mg 
- Dipyridamole4 x 75 mg 
- Sulphinpyra.zone 4 x 200 mg 
- Ca-antagonist: nifedlpine 3 x 20 mg day- 1 
Day of implant procedure -Salicylic acid 1 x !00 mg 
-Dipyridamole 4 x 75 mg (Patients above 90 kg: 
3x ISOmg) 
-Sulphinpyrazone4 x 200mg 
.&fore PTCA - Diltiazem 5 mg 
-Heparin 10 000 r.u. 
-Dextran500mg. (4h)-' 
At implantation -100000 LU. Urokinase in 250ml NaCI given intra-
coronary (i.e.) up to the end of the procedure. Start drip at 
guide-wire insertion given over 30-60 min and another 250 ml 
(100 000 I.U.) for each extra hour. 
-Heparin5000 I.U. I.V. 
( Post-implamation) At stan of transfer. patient to receive heparin at the rate of 
24000 I.U. (24h)-' tocontrolP.T.T. at minimum 70s. (This 
corresponds to about 400 I.U. kg-'. (24h)-'. For large 
patients.. the maximum rate is 30 000 I.U.(24h)- 1 • 
IfP.T.T. >200s (5 xcontrol value) the infusion is slowed. If 
P.T.T. <70s infusion flow is increased. No less than 24000 
Ll.l. heparin per 24 his to be given. 
Post-implantation (day) Start the oral anticoagulation with acenocoumarol to be 
started from the first day (i.e. six tablets of 1 mg each the first 
day. then four the day after and two the third day and then 
according to 'QUICK'. 
Continuing anticoagulation -Oral anticoagulation: acenocoumarol: Qulck to be main-
tained in the range of: 17%-25% (T.P. Thromborcl S. 
&hring). 
N.B. Heparin will be stopped when the therapeutic level of 
oral anticoagulo.ntsis reached. 
-Salicylic acid 1 x lOOmgday- 1 
-Dipyridamole 4x75mg day-' (Patients >90kg: 
3xl50mgday-') 
- Sulphinpyrazone 4 x 200 mg day- 1 
- Ca·antagonist: nifedlpine 3 x 20 mg day- 1 
Long-term This anticoagulation regimen is stopped after the 6-month 
coronary angiography contrOL Aspirin (100 mg 1 x day) 
should be given ad eternam. 
of the internal elastic membrane, which may be 
massive in the case of medial tearing. and the release 
of a variety of m.itogens which may contribute to 
neointimal cell invasion and proliferation[39]. The 
best recognized of these factors is platelet derived 
growth factor (PDGF) which is released predomi~ 
nantly by platelets. endothelial cells as well as 
intimal smooth musclecells[40J. Recently the dim eric 
structure of this protein has been identified:~~, the 
three isoforms of PDGF may stimulate effects 
unique to each isoform through interaction with 
different classes ofPDGF receptor14 ZJ. There is now 
evidence that intimal mesenchymal cells or modi-
fied smooth muscle cells (but not medial smooth 
muscle cells) may themselves release PDGF[401• This 
may initiate the vicious circle responsible for the 
sustained proliferative process as it occurs in re-
stenosis. However, neither the conditions under 
which this takes place nor the triggers responsible 
for this event are understood. In animal exper-
iments. for example. two types of experimental 
arterial injury have been described: the first induced 
by passive trauma such as a catheter in situ or 
balloon denudation of the endothelial lining. and 
the second induced by a more disruptive stimulus.. 
causing not only endothelial denudation. but also 
tearing of the media. which is the typical sequel of 
balloon dilatationD9AJ . .uJ_ Both are associated with 
the deposition of platelets ott the vessel wall. with 
subsequent migration of smooth muscle cells from 
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Figur~: 3 Tra.nsmisslon electron microscopy of th<: clon· 
gated cell·type of Fig. 2 (Magnification x 15 000). Abundnnt 
rough endoplasmic reticulum (RER) is present within these 
eclls. Along the cell m=brane bundles of myofilaments 
(:~.rrows) are also prominent. 
the media and their proliferation to form a nee-
intima. and both can be prevented or inhibited by 
reducing the circulating platelets to very low levels. 
The first type. associated -with repeated trauma. 
and presumably repeated thrombus formation. 
regresses following removal of the traumatizing 
stimulus. The second. more disruptive. type how-
ever results frequently in a lesion that is progressive 
in terms of smooth muscle cell proliferation and 
lipid accumulation. The reason that one type of 
lesion regresses while the other progresses is not 
dear. A possible explanation may come from 
studies on failure of synthetic arterial grafts. Once 
endothelial covering of synthetic grafts has pro-
gressed. smooth muscle cell proliferation appears to 
slow down. except in the region ofanastomosis14 SJ. 
Thus a continued release of growth factors may 
occur even· after complete endothelial covering 
either in areas of turbulent flow. which results in 
continuous endothelial damage and repair. or at 
sites where the barrier between neointima and 
media is minimal. Evidence for continued mediator 
release by endothelial cells under specific conditions 
has very recently been published[#J. The presence of 
a non~degradable stent in the anerial wall may 
form such a trigger for continued mediator release. 
Immediately after stent implantation its luminal 
surface becomes covered with a combined platelet-
fibrin deposition113l. Within 1 week of implantation 
into previously dilated normal porcine aneries 
(Fig. 2). there is complete endothelial covering of 
the stenting devicef-!7J varying between 60 and 
125 ).tiD. which acts to isolate the thrombogenic 
stimulus from the vessel lumen. Within this laver 
are abundant myofibrillar cells and macrophaies: 
the harbingers of the restenosis process. These cells 
can be seen to originate in the immediate vicinity of 
the individual stent filament adjacent to the internal 
-elastic lamina. forming 'geysers· of elongated cells 
fanning out to fill the neointimal tissue in an evenly 
distributed fashion. In some animals this process 
results in complete obstruction of the stented co ron~ 
ary anery as early as 1 month after implantation. 
Electron microscopic examination (Fig. 3) of these 
fusiform elongated cells reveal oval nuclei with 
marginated chromatin. and abundant rough endo~ 
plasmatic reticulum. Bundles of contractile proteins 
can be demonstrated (small arrows) in a subplasma-
lemmal situation. These myofibroblasts or synthetic 
type smooth muscle cells are identical to those 
observed in the neointima after 1 week. It is there~ 
fore attractive to speculate that the same modified 
smooth muscle cells that migrate through the 
internal elastic membrane (IEM) and which are 
implicated in therestenosis process after PTCA. [-16,4.7] 
can be operative in an accelerated fashion once a 
stenting device damages this natural barrier (IEM). 
Thus. the latter becomes more permeable to the 
migrating cells orproviding a direct stimulus for cell 
migration. It has recently been suggested that re-
stenosis followingprimary balloon angioplasty is an 
unfavourable lesion for interventions such as ather~ 
ectomy and stentingi-18-SOJ_ From preliminary data 
presented by Simpson et al. at the 38th session of the 
American College of Cardiology. it appears that 
restenosis rate following atherectomy as a primary 
intervention is 23·5%. while the restenosis rates are 
36·8%), 42·1% and 53·8% when atherectomy was 
performed as the secondary treatment following a 
first. second and third recurrence of stenosis!SIJ. A 
similar opinion bas been expressed by the group of 
Sigwart et a/.1481 Their prelim.inary data suggest that 
elective stenting for restenosis early after previous 
angioplasty carries an increased risk (41 %) of re-
stenosis within the stent. It could be that the active 
fibrocellular proliferation associated with the early 
phase of restenosis after balloon angioplasty is 
further stimulated by stent implantatiOn. 
In this respect. one of the questions posed by 
Spencer King III in his editorial is judicious 
and pertinent: is the treatment worse than the 
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implantation. The individual minimal lumen diameter (MLD) immediately follov:ing s.tent implantation 
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ch:mge in tenns of percentage diameter stenosis. The circles falling both outside the limits of the long-
term variability of quantitative aD.giograpbie measurement and have >50% di=eterstenosis.. represent 
true •restenosis" unequivocal v.rithin the stent. 
disease?P31 Perhaps a more appropriate question is 
whether we have to apply these more costly inter-
ventions. as the initial procedure. in order to 
achieve a reduction of the restenosis rate? Such is 
the dilemma we have to face. Certain authors have 
already drawn the conclusion that atherectomy. for 
example is a favourable primary approach for the 
treatment of selected unfavourable lesionslSQJ. 
The intracoronary stent like many other novel 
forms of treatment seems to be follo-..ving the well-
worn path of initially elated euphoria where enthu-
siasm holds sway over scientific evidence followed 
by critical scepticism with little optimism for the 
future. A period of criticial scientific evaluation is 
now needed. in which the lessons learned from the 
past are implemented. The initial experience has 
revealed three factors associated with compli-
cations: small vessels <3 mm.low blood :B.ow with 
poor run off, and evidence ofhypercoagulability or 
local thrombus formation. This has led most inves-
tigators to restrict the use of this stent to saphenous 
bypass grafts v.ith large diameters and to the native 
circulation as 'bail-out• 9-evice. In Europe. accord-
ing to the data from the Working group on endo-
luminal prostheses"'. Medinvent stents have been 
implanted in 187 patients between March 1986 and 
June 1989 in both native coronary arteries and by-
pass grafts. Although stent implantation is capable 
of producing a superior haemodynamic resuJtl 19~. 
the preliminary data suggest that the restenosis rate 
is between 15% and 30% according to the applied 
criteria (diameter stenosis;;;-:50%. ;;?:0·72mm re· 
duction in the minimal luminal diameter!S~.SJJ 
[Fig. 4(a).(b)]. The Palmaz stem. currently used in 
three centres in Europe has been implanted in situ-
ations which are considered at low risk of acute 
problems. but at high risk of reocclusion (total 
occlusions. myocardium protected by collaterals). 
The intracoronary stent represents a "double-
edged sword": although the scaffolding properties 
of the device are attractive and of proven benefit it 
may provide an iatrogenic stimulus for erratic and 
uncontrolled cell proliferation. This potential has 
not been fully appreciated by the interventional 
cardiologist who may have opened a new 
•Pmticipatint;Centres and Collaborators: :xeappc:ndix. 
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Pandora·s box of complex biological interactions. 
but who may well be rescued by the cellular biol-
ogist in the future. The device is a logical vehicle for 
the topical release of agents that will ideally enhance 
endothelialization but suppress the keloid-type 
reaction of the traumatized vessel wall. Solution of 
this problem is not helped by the lack of joint effort 
on the part of the pharmaceutical industry and the 
industry producing the mechanical device. This is a 
source offrustration to investigators in the :field. but 
hopefully will be overcome in the future. The initial 
hopes that stent implantation may prevent or dim-
inish restenosis have not been fulftlled. In addition. 
early thrombotic occlusion in the native coronary 
circulation has led many temporarily to abandon 
this as an indication except for emergency ·bail-out" 
indications. 
Are we sorcerer's apprentice? 
A case report will illustrate our concern better 
than a long series of arguments. A male patient 
from Los Angeles. who had two major risk factors 
for CAD: diabetes and hypercholesterolaemia. sus-
tained in 1977 an inferior mvocardial infarction. 
Post infarction angina was tr~ted by two saphe-
nous vein grafts on an obtuse marginal and on a 
diagonal branch. Following recurrent angina he 
was reoperated upon and both internal mammary 
arteries were used tO bypass the LAD and the RCA. 
Between 1984 and 1987 the vein graft on the left 
marginal artery was dilated on four occasions. In 
April 1987. his cardiologist referred the patient to 
Ulrich Sigwartin Lausanne for a stent implantation 
in both saphenous vein grafts. Seven months later. 
in November 1987. repeated dilatation was necess-
arY within both stents. Five months later the patient 
again had restenosis: this time, a hot balloon angio-
plasty was considered but rejected by Richard 
Spears in Detroit (would the absorbed laser energy 
convert the stent into a "hot roster'), and the first 
atherectomyinsidethe stent was performed by John 
Simpson in Phlo Alto. In July 1988, the patient 
underwent a second atherectomy. which did not 
prevent restenosis. Disappointed by these results 
lasing with excimer laser (wavelength 308 nm) was 
successfully attempted in Los Angeles by Jim 
Forrester and his groupf54l. Unfortunately for the 
patient. the stenotic lesion seemed to be more stub-
born than the treating physicians and recuned once 
more. Tired of these multiple and varied inter-
ventions. the patient has decided for the time being 
to stay away from the sorcerer's apprentice and this 
long and thorny path has certainly brought down to 
earth theinterventional cardiologist who has to face 
the unavoidable reality: in addition to a mechanical 
device a pharmacological approach will be necess-
ary to achieve victory over restenosis. 
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ANGIOGRAPHIC FOLLOW-UP AFTER PLACEMENT OF A SELF-EXPANDING CORONARY-
ARTERY STENT 
PATRICK W. SERRm:s. ).i.D .. BRADU:Y H. Sn .. Auss. :M.D .. K.Evl:'\j. BEATT, ).1.B., B.S., 
MICHEL E. BERTRA.,D, M.D.,J."-CQUES Pun, 1LD., AxrHOhl:" F. RicKARDS, M.B., B.S., 
BER.,HA.RD ~IER, )..LD.,jE..>,..'\:·]ACQUES GOY, M.D .. PIERRE VOGT, M.D., Lt:K.-\S K.\.PPEJ\"BERGER, M.D., 
AND LLRICH SIC.WART, )v:[.D. 
Abstract Background. The placement of stents iri cor~ 
onary arteries after coronary angioplasty has been investi-
gated as a way of treating abrupt coronary-artery occlu· 
sion related to the angioplasty and of reducing the late 
intimal hyperplasia responsible for gradual restenosis of 
the dilated lesion. 
Methods. From March 1986 to January 1988, we im-
planted 117 self-expanding, stainless-steel endovascular 
stents (Wallstent) in the native coronary arteries (94 
stents) or saphenous·vein bypass grafts (23 stents) of 
105 patients. Angiograms were obtained immediately be-
fore and after placement of the stent and at follow·up 
at least one month later (unless symptoms required angi· 
ography sooner). The mortality after one year was 
7.6 percent (8 patients). Follow·up angiograms (after a 
mean [::SO] of 5.7:::4.4 months) were obtained in 95 pa· 
tients with 1 OS stents and were analyzed quantitatively 
by a computer~assisted system of cardiovascular anglo-
graphic analysis. The 10 patients without follow-up angie-. 
grams included 4 who died. 
Results. Complete occlusion occurred in 27 stents in 
T WO major limitations of coronary angioplasry are acute occlusion and late restenosis. The con-
cept of implanting an endoluminal stent in the coro-
narv arteries after balloon dilation to circumvent these 
problems was first suggested in 1964.1 This procedure 
\\fd.S successfully performed in patients in 1986.::: In 
May 1988, the five European centers testing this de~ 
v-ice agreed to set up a core laboratory for quantita-
tive angiographic analysis to assess the results ob-
jectixely. The early follow-up results reponed by 
the core laboratory showed that immediately after 
stent implantation, there was an additional increase in 
the minimal luminal diameter of the vessel and a de-
crease in the percentage of stenosis of the diarncter.5 
However, after three months slight but diffuse narrow-
ing was observed in the artery containing the stent:' 
In the present study, we have focused on the results 
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25 patients (24 percent); 21 occlusions were documented 
within the first 14 days after implantation. Overall. Immedi· 
ately after placement of the stent there was a significant 
increase in the minimal luminal diameter and a significant 
decrease in the percentage of the diameter with stenosis 
(changing from a mean [±SO] of 1.88±0.43 to 2.48=0.51 
mm and from 37::o::12 to 21±10 percent, respectively; 
P<O.OOOl ). Later, however, there was a significant de-
crease in the minimal luminal diameter and a significant 
increase in the stenosis of the segment with the stent 
(1.68± 1 .78 mm and 48::=34 percent at follow-up). Signifi-
cant restenosis, as indicated by a reduction of 0.72 mm in 
the minimal luminal diameter or by an increase in the per-
centage of stenosis to ~so percent, occur'red in 32 per~ 
cent and 14 percent of patent stents, respectively. 
Conclusions. Early occlusion remains an important 
limitation of this coronary-artery stent. Even when the 
early effects are beneficial. there are frequernly late 
occlusions or restenosis. The place of this form of treat-
ment for coronary artery disease remains to be deter-
mined. (N Engl J Med 1991; 324:13-7.) 
of long-term angiographic follow-up of the initial 
117 stem implantations. 
MEnroDS 
Study Patients 
One hundred :five patient> g;avo:: info~ed cons<:nt anci were en-
rolled :>.t po.rticipating study centers ber>--·een 'Mar<:h 1986 :wdJanu-
ary 1988. The study protocol"'= approved by the ethic:> commit-
tee:; of the individual hospitals. The clinical characteristics of the 
patients are shown in Table 1. Kinety-five patients received one 
stent. and 10 received more than one (Table 1). Seven of the 10 
patients who received multiple Stcnts required twO overlapping 
('"tekscopin:;'") stent» to cover long lc,;ions adequately. "nd the oth-
er 3 rtquire-d stcnts in multiple ve$SeiS or in different locations in the 
same vessel. The sites of stent placement are shov..-n in Table l. 
Si::vemy-one stents were implanted after redil..:l.tion of a rcstenosis. 
14 were placed as an emergency procedure during an angioplasty 
complio.tcd by acme occlusion, 5 were placed after angioplasty for 
chronic occlusion. and ::!7 were placed as an adjunct procedure to 
primary percutaneous trnnsluminal coronary angioplasty (PTCA). 
Some of the pa:ients who reccived stent:; for bypass <;rafting or 
abrupt c!O»ure have been included in previous reports.:._c, 
In this trial. the endO'--ascular prosthesis Wailstem {).fedinvent. 
Lausanne. Switzerland) was used. The method of implantation and 
a description of this stem have been previously reported.~This stent 
i5 a sclf-(.'<p.J.Ildin:;, stainless-steel, woven-mesh prosthesis that can 
be positioned in the coronary an:ery "'cith an 8-French or 9--Frrnch 
guiding catheter. aecording to the standard over-the-wire tec.ll-
nique. The de;cice is con.~tructed of 16 wire filaments. eac..'-, 0.08 mm 
wide. It is constrained in an elongated configuration on a delivery 
cathet<:r 1.5i mm in diamete~: the distal end of the prosthesis is 
covered by a remo,·able plastic sleeve. -~ the sleeve is withdrawn. 
the constrained de;-ice returns to its original. larger diameter and 
becomes anchored apinst the vessel waiL The diameter of the 
prosthesis ranges _from 2.5 to 6 tn.'Tl when the stent is unconstrained. 
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Table 1. Clinical Charactedstics of the Study 
Pa1ients. 
No. of patients 
AIJ.C (_vr)~ 
'= [Wf) 
No. ofSlrnl< 
Site of stc:nt implanction (no. of stents) 
Left nmcrior descending artery 
Cireumfle,; artery 
Right coronary artery 
Bypa.s:ogroft 
lndi<;ation for implamation (no. of StallS) 
R""tenosis 
PTCA wah ac:ute ocdusion 
PTCA os adjunCt procedure 
Chronic OCG!usion 
Time tO o.ngiogrnphic follow-up (mo)• 
All patient:: 
Patient:: with patent stents 
No. of .>tc;nt:: per patient (no. of pati(:llt::) 
Ooo 
Two 
-
"' 57;:::9 
91!14 
w 
" 6 
" 
" 
7C 
" 
" 5 
5.7:4.4 
7.2;:::3.6 
95 
8 
We sele<:ted a diameter 0.50 mm larger than the reference diameter 
of the stenosed vesseL 
Anticoagulation regimens evolved throughout the study period, 
and difTerem protocols were used at the "':lrious centers. In the first 
23 of the 32 patients treated in Toulouse, heparin '-'"<IS administered 
subcutaneously three times a day to =inuin the activated cepha· 
lin-bolin time (an indc.x of coagubtion status} at rwice the control 
value, surtine; three to five days before thc proccdure and continu· 
ing for six weeks afterward. During the prOCedure:. the 7th through 
the 32nd patients received an additional 10,000 units of heparin 
intr::l.venously and 20,000 to 50.000 units of streptokinase by intra-
coronary infusion. Aspirin (100 mg) and dipyridamole (300 mg} 
were given daily by mouth. st:U"cing 24 hours before the procedure. 
The 24-th through the 32nd patients treated in Toulouse received a 
vitamin K antagonist (warUrin or acenocoumarol} by mouth, surt-
ed on the day of the procedure and continued for three to six 
months. The subcutaneous hepa."'"in injections were stopped after a 
therap~utic level of oral a..·uicoagul.ant '-'"aS reached (International 
Nol"I'n;l)ized Ratio, ..,2.3}. In th~ other centers, aspirin (I g orally} 
"-assurr~doned.ay before the procedure. Heparin (10,000 to 15.000 
units} and urokinase (100,000 units by intracoronary infwion) were 
administered during the proc~d:u-e. Hepa.."'"in was given intravenous-
ly, and then the vitamin K antagonist by mouth for thr~e to six 
months as described above. Aspirin (initially I g daily and later 100 
mg daily}, dipyridamole (300 to450 mg daily). and in some patients 
sulfinpyrazone ( 400 mg daily} were also administered. The first four 
patients treated in Rotterdam did not receive aspirin. 
Quantitative Coronary Arteriography 
."J.l cineangiograrns were ana.ly;:ed at the core laboratory in Rot-
terdam by means of a computer-assisted cardiovascular-angiogra-
phy analysis system, discussed in detail elscv.·hcrc.7-"The important 
steps will be briefly described. Selected areas of the cine frame 
encompassing the desired arterial segment were optically magni-
fied. dispbyed in a vldeo format, and then digitally converted. Ves-
sel contour was deterrnin~d automatically on the basis of the 
'-''cig-hted sum of the first and second derivative functions applied to 
the digitized information on brightness. A computer-derived esti-
mation of the original dimensions of the artery at the sire of th~ 
obstruction was used to determine interpobted reference values for 
arterial diameter and area. The absolute diameter of the sepnent 
with stenosis as "·ell a:;. the reference diameter "-as measured by the 
computer, ,.,·hich used the diameter of the guiding catheter as a 
calibration factor. after colTC(:ting for pincushion distortion. The 
imerpolat~d percentage of stenosis of the narrowed segment was 
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then derived by assuming a circular model and comparing the ob-
served value for stenosis ,_,_.;th the reference value. The minimal 
lwnin.:>.l diameter of each segment immediately proximal and distal 
to the stent was also measured. The angiographic analysis was per-
formed before and after angiopl:.l.sty. immediate!~· after stcrlt im-
plantation, and at long-term follow-up evaluation in all patients. 
with the use of the average of multiple matched views with orthog-
onal proje<:tions whenever possible. 
Restenosls 
Two different setS of criteria wete applied to determine the rate of 
restenosis. We have found a reduction of 0.72 mm or more in the 
minimal luminal diameter to be a reliable indicator of angiographic 
progression of vessel narrowing.'-')Th.is value takes into ac~ount the 
limitations of coronary ;:,.ngiographic measurements and represents 
rw:icc the long·term variability of repeat measurements of a coro-
nary-artery obstruction with the cardiovascular-angiography analy-
sis svstem. The other criterion for restenosis was an increase in the 
perCentage:: of stenosis from less than 50 percent after stent implan-
tation to 50 percent or more at follow-up evaluation. Thls criterion 
was selected since common clinical practice has continued to ex-
press lesion severity as a pcrccnuge of stenosis. 
Statistical Analysis 
Values obtained by qu=titative =giographie anal~-sis are ex-
pressed as means :!:SD. The means for eacb angiographic variabl~ 
before PTC.'\. after PTC.~. immediately after pbcement of the 
stent. and at follow-up were compared by analysis of variance. If 
significant differences were found. two-tailed t-tests wac applied to 
paired data. A statistical probability of less than 0.05 was consid· 
ered to indicate significance. 
The results of angiographicand clinical follow-up were expressed 
in a life-table format according to the Kaplan-Mcier method. 10 
Stent occlusions, cardiac deaths (whicb were assumed to be due to 
occlusion. for statistical purposes}. and c<:stenosis as defined by the 
two criteria were considered an¢ographic end points. ThefoJlo,.,~ng 
events were considered clinical end points: death. myocardial in-
farction. bypas:; surgery, and nonsur¢cal rC\--ascularization (PTCA 
or athetectomy}. The life table was constructed accor<ling to the 
initial clinical event. 
REsvl.TS 
The overall mortality after one year was 7 .. 6 percent 
(eight deaths) (Table 2). The mean (±SD) period of 
angiographic follow-up was 5.7:!:::4.4 months in all pa· 
tiems and 7.2±3.6 months in patients whose stents 
were patent at follow-up. Angiographic follow-up 
(Fig. 1) v.:as performed in 95 patients (90 percent) 
v.--ith 105 stents (90 percenr); 78 stems were patent, 
and 27 were occluded (Table 3). Angiographic follow-
up could not be obtained in 10 patients for the follow-
ing reasons: 4 patients died, 4 refused follow-up angi-
ography, and 2 had follow-up angiograms that were 
technically inadequate for analysis (but did not show 
tOtal occlusion). Twenty angiograms were obtained 
during the first month after stent implantation; all 
were obtained because clinical symptoms had oc-
curred, and all showed occlusions. Angiograms ob-
tained after the first month were part of the routine 
follow-up evaluation; all showed patent stents except 
in five patients with stent occlusions. Overall, the 
minimal luminal diameter increased from 1.21:::0.56 
mm to 1 .. 88:::0.43 mm after PTCA and then further. to 
2.48±0.51 mm, immediately after stent implantation 
(P<O.OOOl) because of the intrinsic dilator function of 
the device (Table 4). At follow·up the diameter was 
found tO have decreased to 1.68:±: 1.20 mm. The per-
centage of stenosis changed similarly, v-rith an initial 
decrease from 61::':14 to 37=::12 percent after angio-
plasty and an additional decrease to 21=::10 percent 
immediately after stent placement (P<O.OOOI). How-
e-.·er, at follow-up the percentage of stenosis had in· 
creased to 48=::34 (P<O.OOOI). When only patent 
srents were included in the analvsis of late follow-uP. 
the minimal luminal diameter ~nd the percentage ~f 
stenosis were 2.26±0. 78 mm and 30:±: 17 percent, re-
spectively. A small, nonsignificant increase occurred 
in the reference diameter after stent placement (from 
3.15:=:0.54 to 3.22±0.79 mm). During the study, no 
significant change was seen in the minimal luminal 
diameter of the proximal or distal segments adjacent 
to the stem. 
The incidence of restenosis (Fig. 2) depended on the 
definition 6f stenosis (Fig. 3). \Vhen a change of 
;;o::0.72 mm in minimal luminal diameter was used as a 
criterion. restcnosis was· observed ""-ithin the patent 
stent in 17 patients (19 stents), in the proximal seg-
ment adjacent to the stem in 3 patients, in the segment 
immediately distal to the stent in 2 patients, and in 
both proximal and distal regions in 1 patient. There· 
fore. the total rate of restenosis was 32 percent among 
stents and 33 percent among patients. At follow-up the 
percentage of stenosis had increased to ;;::50 percent 
v..i.thin 10 Stents (13 percent) in 9 patients ( 13 percent) 
and in the segment proximal to the stem in 1 stem in 
l patient, for a total rate of 14 percent. J\.fter one year 
of clinical follow-up, two of the patients with resteno-
Table 2. Deaths after Stent Implantation. 
PAT!I:!;T Tl><E A"1LLl 
l'o. lMPJ.A~T.-nOI" C..ti$( Of Dr...Tii 
1 
' 
<:::!4 hr $tent occlusion after v~sscl closure 
"'"' ::! day:; 
s day> 
11 day:; 
l't:mo 
::!0-mo 
'~ 
dunn~; PTCA 
Sudden death 
Stem occlusion an~r ::!4 hr. followed by 
em<:rJ;:"ney bypass proeeduro 
Stent occlus.ion durin~; impl:mmtion. 
myoc<U'dial infarction. shock 
Sudden death 
Sudden death 
Surgcy for new lesion cf left main :u-
tery, aftel: bypass proeedure 
Chronie c¢ngestive hc:an: fail\li'C 
sis underv.:enr repeat balloon angioplasty, one patient 
(two stents) underwent atherectomy, performed with~ 
in the narrowed stent, and six patients underwent cor-
onary bypass surgery. Death or myocardial infarction 
did not occur in any of these nine patients. 
DISCUSSlON 
The data from the six European centers at which 
the coronary-anery stent described above was used 
show a stent·occlusion rate of 24 percent. The antico-
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Figure 1 Angiographic and Clinical Follow-up in 95 Patients Who 
Received 1 05 Stents. 
Occlusion of the stent. cardiac death, and restenosis as deter-
mined by either or both of the criteria used (;;>SO percent stenosis 
of the vessel and a change of :;;,72 mm in the minimal luminal 
diameter) were considered angiographic end points (Panel A). 
Death, myocardial Infarction, bypass surgery. and PTCA or ather-
ectomy were considered clinical end points (Panel 8). 
agulation regimens and methods for selecting patients 
differed among the centers. which may explain some 
of the variability in the occlusion rates between 
centers. The highest occlusion rate (39 percent) was 
observed at the Toulouse center, where the initial 
patients were treated with long-tenn subcutaneous 
heparin after placement of the stent, instead of a vita· 
minK antagonist. The clinical factors that contribut· 
ed to the occlusions could be identified in II patienTS 
- i.e., disorders of the coronat'\· arret'\· that are asso-
ciated- v.ith thrombosis (unstable angi~, recent myo-
cardial infarction, and chronic occlusion) in 5 pa-
tients, technical problems in stent placement in 
3 patients, interruption of anticoagulation because of 
Table 3. Findings at Anglographic Follow-up. 
':-to.(); Sn:NT:; l'o. OF P~TlE.'<T> 
(N~117J (N~IOSJ 
Pateot>tent 7S (67) 70 (67) 
Occludcdstent :7 (13) :s (::!4) 
:-:o follow-up angiography 
llo>w 
"" 
4(4) 
Rcfu>al 4 (3) 4(4) 
lrmdequate srudy ::! (::!) ::! (::!) 
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Table 4. Findings at Quantitative Angiography."-
Minimal luminal di== (mm) 
Stenosis(%) 
1.;?.1:0.56 1.88:0.43 ~ .. ~:0.78 1.68:l.ZO 
43::':3.+ 61:14 37:1.::: Zl:IO 30:17 
P<O.OOOl ?<0.0001 P<O.OOOJ 
P<O.OOZ 
•Value:; (m= :oSD) we<: compat1;<1 by Mlll~>l•cfv=ce. lf sJgcitic:>nt d>ffo=oce; were fcood. two.ta.llo<! ,.,..,,. ,.= oppll<d topoln ofd:lt:l.. A probabiltl)' ofO~ wos 
coru;1"=<1 to !ndlctto •toti;doal "gnificMco. 
A 
B 
Figure 2. Restenosis Six MonthS after Implantation of a Stent in a 
Bypass Graft. 
In the follow-up angiogram (Panel A), the outline of the stent 
appears slighly radiopaque and hyperplasia has resulted in a 
complex narrowing within the vessel segment contain"1ng 
the stent 
In the gross specimen (Panel B) of the surgically retrieved bypass 
graft containing the segment shown In Panel A. the longitud'maJ 
cross section of the vessel shows the stentfilaments (arrow) pro-
truding from the wall. The striking similarity between the anglo-
graphic contours of the vessel and its actual appearance 
is evident. 
bleeding problems in 2 patients, and hemodynamic 
compromise before placement of the stent in 1 patient 
with cardiogenic shock. In ..,-:jew of the early expe-
rience with stent occlusion, the investigators agreed 
to avoid placing stents in patients with acute coro-
nary artery disorders and chronic occlusions or in pa-
tients v.'ith poor distal runoff (vessels with collat-
eral flow, small vessels less than 3 mm in diameter, 
or vessds supplying akinetic or severely hypokinetic 
myocardium). In addition, four patients ·with six 
stents died before undergoing angiographic follow-
up. Some of these deaths were sudden, suggesting 
possible stent occlusion. Ir was difficult to determine 
whether late occlusion (after 14 days) was super-
imposed on marked restenosis. Therefore, the rates 
of occlusion and restenosis may have been underesti~ 
mated. 
The patients in this study underv;ent two serial 
interventions, balloon dilation and then stent implan-
tation. Quantitative coronary angiography showed 
that ~e initial effect of angioplasty in these patients 
was similar to that observed :in previous ang:iograph-
ic studies,8•11 and moreover, the result immediately 
after placement of the stem was markedly improved. 
However, the minimal luminal diameter in the entire 
study group at follow-up (including patients known 
to have occlusions) was 1.68 mm, v.:hich is compa~ 
rable but not superior to values previously document-
ed in late follow~up studies of coronary balloon 
angioplasty (1.69 to 1.82 mm).8·: 1 The rate of re-
stenosis in patent stents, when based on a change 
of ~0.72 mm in the minimal luminal diameter, was 
23 percent among segments within the stem and 
8 percent among segments adjacent to the stem, for a 
total rate of 31 percent. When the altemative crite-
rion, ~50 percent stenosis of the luminal diameter, 
v.·as used, the rate of restenosis was 13 percent 
among segments within the stent and I percent among 
segments adjacent w the stent. Two previous stud~ 
ies that used similar quantitative methods for late 
follow-up evaluation after coronary balloon ang:io~ 
plasty have been published. In one study,8 the reste-
nosis rate for angiograms obtained at four months 
was 25.5 percent when the criterion of a change of 
0.72 mm was used, and 13.2 percent when the crite-
rion of 50 percent stenosis was used. In the other 
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Figure 3. Change in the Minimal Luminal Diameter of 78 Patent 
Stents betWeen Stent Implantation and Anglographic Follow-up. 
The diameter of each segment immediately after implantation is 
plotted against the diameter at follow-up. The Jines on each side 
of the identity line (diagonal) represent the limits of long-term 
variability of repeat measurements (a change of ;;o.Q.72 mm 
[arrows]). The symbols below the right-hand nne represent 
stents with involvement by severe hyperplasia. 
study. 1 ~ when the criterion of 50 percent stenosis was 
used. the restenosis rate was 37 percent for angie-
grams obtained four to seven months after angio-
plasty. 
Studies in animals have confinned that fibroimimal 
hyperplasia may develop in arterial segments contain-
ing stems. Within one week after stents (\'v"allstent) 
were implanted in normal porcine arteries, the pros-
theses became completely covered by endothelium 
and the vessel lumen had diffuse narrowing, -...-ar;.'ing 
in thickness from 60 to 125 ,u.m. 13·1+ By si-..:: months, 
the thickness of the neointima increased from 50 
tO 400 ,urn, 1 ~ corresponding to a decrease of 0.1 to 
0.8 mm in the vessel diameter. 
Earlv thrombotic occlusion remains a serious clini-
cal prOblem with this prosthesis despite anticoagula-
tion. It remains to be determined whether increased 
experience of operators, changes in the anticoagula-
tion regimen, or selection of patients 'Will circumvent 
this limitation. Nev.· biologic coatings that may make 
the stent less thrombogenic are currently under inves-
tigation. Angiographically detectable narrowing, 
probably due to :fibrointimal hyperplasia, occurs to a 
marked degree in patients whose stents are patent at 
late follow-up. Although six months is assumed to be 
the time frame for the development of restenosis after 
angioplasty, this may not be true of stent implanta-
tion. The clinical indications for the use of an endo-
vascular prosthesis remain unclear. Controlled clini-
cal trials are imperative to determine whether such 
devices can decrease the rate of restenosis among pa-
tients who have unden::;one PTCA and whether thev 
can be of any benefit in ~particular clinical situations o"r 
subgroups of patients. 
V•:e are indebted to Dr.Jan Tys~. Dr. Roger"I"lulmann. ).-brie-
Angele ).-:(ord, o.nd Eline Monuuban van S"''ijndregt for assistance. 
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Stenting of venous bypass grafts: A new 
treatment modality for patients who are poor 
candidates for reintervention 
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Patients first seen with medically refractory anginal 
symptoms after saphenous vein bypass surgery pose 
a difficult problem for cardiologists and cardiovascu-
lar surgeons. These patients axe generally older, "With 
more eA-tensive, diffuse disease involving the native 
coronary arteries and venous bypass grafts. Repeat 
coronary artery bypass graft surgery (CABG) for re-
current ischemia is technically more difficult. is asso-
ciated with a higher mortality and morbidity, and has 
inferior long~term clinical results when compaxed 
with a :first bypass operation.1·3 Conventional balloon 
angioplasty offers an alternative mode of revascular~ 
ization :in selected patients. The immediate results of 
this procedure have been shown to be favorable in 
patients with discrete lesions in venous bypass grafts 
but considerably less satisfactory in diffusely dis-
eased, ulcerated. or thrombosed venous grafts.4-6 
Furthermore, it appears that the rate of restenosis is 
high, varying from 40% to 70% depending on the site 
of the lesions in the graft and the overall extent of 
disease in the conduit_i-13 
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Stent implantation has been proposed as an alter~ 
native or adjunct to percutaneous transluminal cor~ 
onary angioplasty (PTCA) for diseased venous by~ 
pass grafts. Results of eaxly studies with small num~ 
bers of patients have shown that stents can be placed 
safely and successfully in bypass grafts with an 
encouraging low rate of restenosis_14-21 Therefore we 
initiated this observational study to assess the acute 
and late results of stem implantation in stenosed 
coronary artery bypass grafts in symptomatic pa~ 
tients with diffuse, e~-tensive native coronary artery 
and bypass graft disease who axe poor candidates for 
conventional balloon angioplasty or reoperation. 
METHODOLOGY 
Study population (Tables I and II). Between Janu-
ary 1988 and March 1990, a total of 136 stents were 
implanted in 69 patients (12 women and 57 men) in 
the four participating hospitals in The Netherlands 
and Belgium. The study protocol was approved by 
the ethics committees of the individual hospitals and 
informed cOnsent was obtained from all patients. A 
senior investigator (P_ W. S.) was present for all stent 
implantations. 
The decision to implant a stent was reached after 
discussion bet'Ween cardiologists and surgeons (Table 
ill). Forty-two patients wer'e considered inoperable 
because of either a high risk/benefit ratio related to 
repeat surgery (n = 28), unfavorable coronary vessel 
anatomy such as diffusely diseased distal vessels 
(n = 4), poor left ventricular function (ejection frac~ 
tion <35%) (n = 6). or concurrent noncardiac risk 
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Table I. Study population 
No. of p.:ttienu; 
No. of bypasses 
No. of lesions 
No. of stenu; 
Ejection fraction (%) 
Risk factors 
Hypercholesmolemin >7 rnmol/L 
Hypertension 
Smokers 
Diabetes mellitus 
Table II. Specific lesion characteristics 
~o. of b:ypasses 
Age of bypass groft {mo) 
Mean diameter of g:t'ait (mm) 
Mean minimal lumen diameter {rnm) 
Length of stenosis {rom) 
69 
74 
95 
136 
53.9 (26-71) 
26 
15 
46 
14 
74 
S3 (1-166) 
3.3 (1.6-7.0) 
1.4 (0-2.9) 
16.5 (2-50) 
factors (n = 4). Conventional coronary angioplasty 
was considered high risk in 39 patients because of the 
age of the grafts, the length of the stenosis, and/or 
unfavorable angiographic features (tandem lesions, 
eccentric lesions, lesions containing ulcers, aneu-
rysms. calcifications, or dissections) (Figs. 1 to 4). 
The mean age of the patients was 63 years (range 
44 to 78), and the mean age of the implanted bypass 
gTafts was 83 months (range 1 to 166). Forty-eight 
patients had at least one previous myocardial infarc-
tion, and eight had undergone more than one previ-
ous bypass procedure. Single-, double-, and triple-
vessel disease was present in 3%, 23%, and 7 4% of 
the patients, respectively. Eleven patients were in 
New York Heart Association (N'lHA) class II, 27 
~rein class III. and 29 were in class IV; in two pa-
tients the stents were implanted during evohing my-
ocardial infarction. Jill patients had documented 
ECG evidence of ischemia 
The stent implantation data are presented in Ta-
ble I\7. A single stent was implanted in 30 patients, 
tw'O stents in 24 patients, three stents in seven 
patients. four stents in five patients. five stents in one 
patient, and 6 stents in two patients. The stent was 
placed in single grafts in 25 patients and in sequen-
tial gTafts in 44. In five· patients the stent was 
implanted into totally occluded vessels (during an 
'evolving myocardial infarction in tw'O and in chronic 
occlusions in three. 
Implanted device. In the fust 26 patients we used 
the Medinvent W allstent (Medinvent, Lausanne, 
Table Ill. Reasons for preferring stent implantation (cate-
gories are not mutually excllJSive) 
Patients not suitable or high risk for repeat CABG 42 
Reasons 
High risklbene.fit proill.e 28 
Unfavorttble coronury vesscl anatomy 4 
Poor left ventricular function (ejection fraction <35%) 6 
Concurrent noncardia.c risk factors 4 
Patients considered high risk for conventional PTCA 39 
Reasons 
Long lesions (>15 rnm) 32 
Tandem lesions 23 
Lesions containing ulcers 25 
Dissections 17 
Clot 18 
Diffusely disooscl bypass graft 34 
Eccentric lesions 53 
Table IV. _Stent implantation data 
No. of stents 
Mean diameter of stent C=l 
Position 
Ostial 
SM£' 
Distal anastomosis 
Procedure~ 
Single stent-single lesion 
).{ultiple stent-single lesion 
Multiple stent-multiple lesion 
136 
4.3 (3.5-6.0) 
7 
127 
4 
30 
90 
16 
Switzerland), and later we used the polymer-coated 
Medinvent Biogold stent. The stent consists of a 
stainless steel alloy with a self-expanding mesh 
design.15 The unconstrained length varied between 
15 and 27 mm, and its diameter in the fully expanded 
state was between 3.5 and 6.0 mm and was selected 
to be 0.50 mm larger than the reference diameter of 
the vessel 
After stent implantation the patients were moni-
tored in the coronary care unit. The rigorous a:ntico~ 
agulation regimen has been described previously.22 
.All patients received aspirin the day before the pro-
cedure and intravenous heparin (10.000 IU) at the 
beginning of the procedure. Before stent implanta-
tion 10,000 IU heparin and 500 mg dextran every 4 
hours were given intravenously. Immediately after 
stent implantation 100,000 to 250,000 IU urokinase 
was infused :into the coronary bypass graft via the 
guiding catheter. Intravenous heparin administra-
tion was continued at a minimum dosage of 24.000 
IU/24 hours; the dosage was adjusted according to 
the activated partial thi-omboplastin time (80 to 120 
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Fig. 1. Jump graft to left anterior descending artery (ar-
row), then to first diagonal branch. and then to marginal 
branch. A, Two lesions in jump graft between diagonal and 
marginal branches (arrowheads). B, Immediate result af-
ter stenting. Distal end of stent may have extended into 
native coronary artery. 
seconds). Oral acenocoumarol was started on the day 
of implantation. The heparin infusion was continued 
until the prothrombin time measured by th:tom-
botest (Nycomed, Oslo, Norway) was lowered to 5% 
to 10% for 2 subsequent days and discontinued 
slowly thereafter . .After stent implantation the pa-
tients were also given aspirin (300 mg/day), dipy-
ridamole (300 to 450 mg/day), and nifedipine (30 to 
60 mg/day), which in addition to the oral anticoagu-
lant were maintained for 3 to 6 months after the pro-
Fig. 2. Top panel, Two tandem lesions with aneurysm of 
bypass g:raft located proximal to first lesion. Second panel. 
Balloon angioplasty catheter in position across lesion. Bal-
loon dilatation resulted in dissection. Third panel. After 
implantation of distal stent, intraluminal flap (arrow) is 
still e,.-ident in proximal lesion. Lower panel, After im-
plantation of second stent in proximal lesion. 
cedure. The patients were followed at our outpatient 
clinic at 1 and 3 months and underwent repeat cor-
onary angiography 6 months after the initial proce-
dure or earlier if symptoms recurred. 
Quantitative coronary angiography. The quantita-
tive analysis of the stenotic coronary segments was 
carried out with the computer-assisted Cardiovascu-
lar Angiography Analysis System (CA.A.S), which has 
been described in detail.23·28 The angiographic anal-
ysis was done before and after angioplasty, immedi-
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Fig. 3. A, Bypass graft to right coronary artery (7 -inch image intensifier). Long segment bypass vessel is 
severely diseased with involvement of ostium and several complex features including ulceration in prox· 
imal aspect of graft (arrow) and intraluminal defect in midgraft (arrowhead). 6, After placement of three 
stents (5-inch image intensifier). C, Six-month follow-up angiogr::un showing late excellent result. 
ately after stent implantation. and at follow-up in all 
patients with the average of multiple matched views 
with orthogonal projections wherever possible. 
Restenosis. Two different sets of criteria were ap-
plied to determine the rate of restenosis. We have 
found a change in minimal luminal diameter of 0.72 
mm or more to be a reliable indicator of angiographic 
progression of vessel narrowing. 23·25 This value takes 
into account the limitations of coronary angiographic 
measurements and represents two times the long-
term variability for repeat measurements of a coro-
nary obstruction by means of the C.A.A.S. The other 
criterion for restenosis was an increase in the diam-
eter of the stenosis (DS) from less than 50% after 
stent implantation to more than or equal to 50% at 
follow-up. This criterion was selected according to 
common clinical practice.29 
OBSERVATIONS 
Stent implantation procedure. All patients under-
went successful stent implantation (DS <50% im-
mediately after placement of the stent). In two 
patients the initial stent was not optimally positioned 
and did not cover the entire lesion, so that an addi-
tional procedure was required to implant another 
stent to achieve an optimal result. Although no im-
mediate major complications ocCUITed during the 
procedure, two patients required intracoronary 
thrombolytic therapy because of distal embolization 
without subsequent elevation of the creatine kinase 
level. Three other patients had increases in the cre-
atine kinase level ( <200 IU). 
In-hospital complications. Acute thrombotic events 
in the stent occurred in seven patients (10%)- One of 
these occlusions was related to cessation of anticoag-
ulation treatment. This patient (considered inopera· 
ble) had a severe retroperitoneal hematoma 7 days 
after stent implantation, which necessitated discon-
tinuation of the anticoagulation therapy. Thirty days 
after implantation the patient had an acute myocar-
dial infarction, leading to cardiogenic shock and 
death. One patient, who had the stent implanted 
during an evolving myocardial infarction, had an 
acute thrombotic closure of the stented vessel! day 
after stent implantation. The resulting myocardial 
infarction was treated conservatively. 
Two other patients. who had unstable angina pec-
toris and .angiographic defects consistent with 
thrombi. had acute thrombotic occlusions and myo-
cardial infarctions 7 and 12 days after stent implan-
tation, respectively. One of these patients, who was 
treated conservatively, died suddenly 6 months after 
implantation. having remained stable with mild an-
gina pectoris. The other patient underwent CABG 
after emergerit reopening of the vessel during repeat 
PTCA. The last thrombotic occlusion occurred 1 day 
after implantation in one of the patients with stent 
implantation after recanalization of a chronically oc-
cluded graft. This patient was referred for repeat 
CABG. 
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Fig. 4. A, Complex lesion ~ith ulceration (arrow) in jump bypass graft before stenting. B, Immediate re-
sult after stenting. C, Six-month follow-up angiogram showing restenosis within stt!nt.. Outline ofstent is 
faintly "isible. 
Two patients had unstable angina pectoris 3 and 10 
days after stentimplantation, which was related to an 
angiographically ·visible but nonocclusive thrombus. 
In one patient this thrombus was related to cessation 
of anticoagulation 6 days after the proceduxe as are-
sult of Mallory-Weiss syndrome with persistent gas-
trointestinal bleeding.30 Because of symptomatic re-
current ischemia, the patient was sent for surgery. 
The second patient, who bad been treated for unsta-
ble angina pectoris, had resting angina pectoris 1 day 
after implantation of two stents. Angiography re-
vealed a partially occlusive thrombus between the 
two stents and another stent was placed between the 
two pre,ious stents. The following day resting angina 
pectoris recurred and the patient was treated suxgi-
cally. 
Bleeding complications occurred in 23 patients 
(33% ). Two patients bad fatal intracranial bleeding, 
one patient had a retr<Jperitoneal hematoma, and two 
patients had gastric bleeding. An additional 18 pa-
tients had hematomas at puncture sites requiring 
blood transfusions, and seven of these patients re-
quired surgical repair of a false aneurysm. Bleeding 
complications were associated with a considerably 
longer hospital stay-18 days in comparison to 7 days 
when the postimplantation course was uneventful 
Discharge status. Stent implantation resulted in 
complete relief of angina pectoris (NYHA class I) in 
45patients (64%). Ten patients (14%) still had mild 
symptoms (N'Y'HA class II) after stent implantation 
(Nl:"HA class II), and :five patients (7%) remained in 
N1:""HA class m. Foux of these patients were consid-
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ered inoperable and the .fifth was referred for reoper-
ation. 
long-term follow-up 
.~rriography. In 53 (90%) of the 59 patients with 
successful stenting and no major in-hospital compli-
cations. follow-up angiography was performed at 
4.9 ± 3.4 months. Of the remaining six patients 
without angiographic follow-up, five refused to un-
dergo control angiography, and in another patient 
the implantation film was technically inadequate for 
analysis, although no si.gni:ficant restenosis was seen 
at follow-up. 
In the oYerall group the mean minimal luminal di-
ameter increased significantly from 1.4 ± 0.82 to 
2.7 ± 0.7 m.m (p < 0.001) and the diameter stenosis 
decreased significantly from 58 ± 15% to 24 = 9%. 
However. at late follow-up (including occlusions) 
there was asignificantreduction in the mean m.inimal 
luminal diameter to 1.9 ± 1.1 m.m (p < 0.001) and a 
significant increase in the diameter of the stenosis to 
43 ± 30% (p < 0.001). 
The incidence of restenosis depended on the def-
inition. According to the criterion of a change in 
minimal luminal diameter of 0.72 m.m, detectable 
angiographic narrowing occurred within the stent in 
25 patients (47% ). An increase in the diameter of the 
stenosis to 50% at follow-up was seen in 21 patients 
(40%) and immediately adjacent to the stent in four 
patients (7% ). Stent occlusion was found in three of 
these patients. 
Clinical follow-up. In the group of patients with 
angiographic restenosis (diameter stenosis >SO% 
criterion) (n = 25), 19 patients bad a recurrence of 
angina pectoris necessitating reintervention (repeat 
PTCA. n = 10; atherectomy, n = 2; repeat CABG. 
n = 7). Three of the patients who underwent surgery 
died during the postoperative period. 
In the group without restenosis (n = 28), 15 pa-
tients had a recurrence of significant angina pectoris 
'Within 1 to 24 months after stent implantation. Ten 
patients underwent further intervention. In six a 
second stent was implanted in either the same or an-
other bypass graft. Three patients underwent PTCA 
of one or more native vessels and one patient had re-
peat bypass surgery. The five remaining patients 
were treated medically. One patient without signifi-
cant restenosis at the 6-month angiography died 
suddenly 500 days after stent implantation. 
COMMENTS 
The management of recurrent ischemia in patients 
who have had previous bypass surgery presents a se-
rious and growing problem. S:ymptoms of myocardial 
ischemia recur or progress in approximately 5% of 
patients per year.3·26• 27 and after 5 years up to 25% 
of vein grafts are occluded and 25% may show 
stenoses greater than 70%.23 Reoperation is techni-
cally more complicated to perform and is generally 
associated with a higher mortality and morbidity 
than a primar:y operation and achieves symptomatic 
relief in only 60% to 70% of patients as compared 
with the 80% to 90% success rate after primary op-
erations. The perioperative myocardial infarction 
rate varies among surgical groups between 2.0% and 
11.5%. The mortality rate after repeat bypass sur-
gery ranges from 1.2% to 12.5%.1-3 Conventional 
balloon angioplasty has reported angiographic suc-
cess rates of 75% to 100% for bypass grafts.7•13 with 
complications rates similar to angioplasty in native 
vessels. However, restenosis appears to occur more 
frequently with rates as high as 46% reported for 
proximal sites.24• 27 
The majority of our patients were considered high 
risk for surgery or repeat PTCA. Inasmuch as all of 
these patients had severe symptoms in spite of max-
imal medical therapy, it was decided to try to attempt 
stenting of the angina-related bypass graft, although 
in some cases it was clear that full relief could not be 
expected because of diffuse native vessel disease that 
prohibited additional intervention. Most of the pro-
cedures were done without surgical standby. Since 
the introduction of stenting of stenosed saphenous 
bypass grafts in our institution in 1988. a total of 69 
patients have been treated successfully with this new 
intenrention compared with only 84 patients who 
underwent conventional angioplasty for stenosed sa-
phenous bypass grafts during the period 1980 to 1988. 
This new treatment modality has significantly ex-
panded our therapeutic options in this particular pa-
tient group. 
Our results show that stenting bypass grafts is 
technically feasible 'With excellent immediate results. 
Two advantages of the W allstent for use in bypass 
grafts are (1) the length of the stent can be selected 
up to 25 m.m for long lesions and (2) the self-expand-
ing property appears to be an effective splint to tack 
back friable, protuberant atheromatous material and 
minimize embolization into the native coronary cir-
culation. In 30 patients the stent was implanted di-
rectly without prior balloon dilatation for lesions that 
appeared high risk for embolization. No increase in 
creatine kinase levels was documented in this group 
of procedures. 
Several important lessons emerge from this study. 
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First, the majority of stent occlusions occurred in 
patients with acute ischemic syndromes (myocardial 
infarction or unstable angina pectoris with angie-
graphic evidence of thrombi). The combination of 
thrombi during evolving myocardial infarction and 
unstable angina and the implantation of intracoro-
nary stents seems to be highly thrombogenic leading 
to further thrombus formation and acute occlusion of 
the stent. Therefore we now carefully select our pa-
tients and when the dia,crnostic angiogram suggests 
the presence of intravasculax clots, the patients are 
treated with intravenous heparin (25,000 IU/24 hr) 
for 1 week before stent implantation. Although 
improved patient selection should decrease the oc-
currence of acute stent closure, it will remain an un-
predictable event as e"idenced by stent occlusion in 
one patient who was optimally anticoagulated and 
without the previously described risk factors. Fur-
thermore. the timing of stent occlusion is also unpre-
dictable (between 2 and 12 days), which complicates 
discharge planning decisions. Second. a meticulous 
anticoa,oul.ation schedule must be followed with fre-
quent monitoring to minimize bleeding complica-
tions. As our experience evolved. bleeding and occlu-
sion problems were encountered much less frequently 
and as a result, sulphinpYI"azone was withdrawn be-
cause of a lack of evidence of its efficacy in the pre-
vention of acute closure. Special care must also be 
given to insertion and removal of the femoral arterial 
sheath. since this accounted for the majority of 
bleeding complications. In particular, removal of the 
sheath > 12 hours after implantation was associated 
"With increased vascular complications. During the 
last 15 stent implantation procedures. no throm-
bolytic agents were administered leading to a con-
siderable decrease in bleeding problems in the groin. 
Furthermore, oral coumadin was started the day be-
fore stent implantation leading to a quicker optimal-
ization of the oral anticoagulation therapy, which 
made a shorter hospital stay possible. 
The stent-related restenosis rate (47%) seems to 
be comparable to that in historical studies of con-
ventional angioplasty in venous coronary bypass 
grafts.4.5.30 However, these comparisons may not be 
valid since our population consisted of patients who 
were less than suitable candidates for conventional 
angioplast:y. Earlier reports from Lausanne sug-
gested a much lower restenosis rate (9%) in lesions 
implanted with the Medinvent stent in bypass 
grafts_l7· 32 However. these differences may be there-
sult of either differences in selection criteria meth-
ods of angiographic assessment (quantitative vs vi-
sual estimation), or both. 
Frequent reintervention in our study group was 
required because of restenosis or progression of dis-
ease in other lesions, a problem similar to that 
encountered with conventional aJlgioplasty in byj:lass 
grafts. Three recent reports have been published on 
the late clinical follow-up of patients with conven-
tional angioplasty in bypass grafts. The Thorax-
center reported that only 41% of patientS were alive 
and event free (myocardial infarction, repeat CABG. 
repeat PTCA) at a median follow-up period of 2.1 
years.4 A review of the overall Dutch experience also 
showed limited late beneficial results with 2-year and 
:five-year event-free s\ll"\ival rates of 52% and 26%. 
respectively, in 454 bypass patients.5 Webb et al}1 
have described a 71% freedom from death. infarc-
tion, and surgery at 5 years in bypass patients who 
underwent PTCA at their institution but did not in-
clude the 27% incidence of second angioplasty pro-
cedures also required in their patient group. It is clear 
that stenting and angioplasty are only short-term so-
lutions and do not affect the underlying problems of 
progressive graft atherosclerosis and iatrogenically 
induced restenosis. 
Conclusions. Patients with severe coronary artery 
disease and previous bypass surgery who bave.re-
fractory symptoms as a result of progression of dis-
ease in the bypass graft comprise a difficult challenge 
to the physician. In patientS who are poor surgical 
risks and unsuitable candidates for balloon angio-
plasty because of unfavorable anatomy, coronary 
stenting with the W allstent can be performed suc-
cessfully and offers an alternative therapy. However, 
stent implantation remains complicated by acute 
thrombotic occlusion and bleeding complications as-
sociated with the intense anticoagulation. The early 
benefits of stenting may be mitigated by the progres-
sion of disease in bypass grafts and iatrogenic in-
duced restenosis. Stenting should be considered a 
palliative procedure in medically refractory patients 
with coronary bypass graft disease. 
SUMMARY 
During a 2-year period, 136 self-expanding Wall-
stents were implanted in saphenous vein b~"PasS 
grafts in 69 patients with end-stage coronary artery 
disease. All patients bad severe symptoms and· the 
majority were poor candidateS for either repeat sur-
gery or conventional bypass coronary angioplasty 
because of unfavorable native anatomy, impalled left 
ventricular function, or a high-risk bypass lesion 
anatomy for coronary angioplasty. Al1 procedures 
were technically successful without major complica-
tions and a need for emergency bypass surgery. 
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However, during the hospital stay acute thrombotic 
complications occurred in seven patients (10%) re-
sulting in one death and acute myocardial infarction 
in five patients and necessitating emergency repeat 
PTCA in two patients and repeat CABG in four. 
Twenty-three patients had serious hemorrhagic com-
plications directly related to the rigorous anticoagu-
lation schedule. Two patients died of fatal cerebral 
bleeding. During follow-up, another five patients 
died accounting for a total mortality rate of 12% ._At 
late angiograph.ic follow-up (4.9 ± 3.4 months, 
n =53), 25 patients (4i%) had a restenosis (~50% 
DS) within or immediately adjacent to the stent, ne-
cessitating reintel""\Tention in 19 patients (PTCA. 
n = 12: repeat CABG, n = 7). In the group without 
stent-related restenosis (n = 28). 15 patients had 
progression of disease in either the native or bypass 
vessels leading to recurrence of major anginal symp-
toms within 1 to 24months. Ten of these patients re-
quired further intervention (stent, n = 6: PTCA, 
n = 3; repeat CABG, n = 1). Stenting in saphenous 
coronar:y bypass grafts can be performed safely with 
excellent immediate angiographic and clinical re-
sults. Early occlusion, late restenosis, and bleeding 
complications associated with the aggressive antico-
agulant treatment remain significant limitations. 
Reintel""\Tention as a result of restenosis or progression 
of disease in other lesions is common. Stenting of 
diseased bypass grafts in symptomatic patients 'With 
end-stage coronary artery disease (who are at high 
risk for conventional angioplasty or surgical reinter-
vention) may be useful as palliative therapy. 
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Chapter 11 
Comparative quantitative angiographic analysis of directional 
coronary atherectomy and balloon coronary angioplasty. American 
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Comparative Quantitative Angiographic Analysis 
of Directional Coronary Atherectomy and 
Balloon Coronary Angioplasty 
Victor A. W. M. Umans, MD. Kevin J. Beatt, MD. Benno J. W. M. Rensing, MD, 
Walter R. M. Hermans. MD. Pim J. de Feyter, MD. PhD, and Patrick W. Serruys. MD, PhD, 
with the technical assistance of Eline Montauban van Swijndregt 
An attempt to assess the uutility" of directional 
atherectomy was made using a new quantitative 
m:cgiogt: aphic index. This index can be subdivided 
into an initial gain component and a restenosis 
component. 1be initial gain index is the ratio be--
tween the gain in diameter during intervention 
and the theol etically achievable gain (i.e., refer. 
ence diameter). The restenosis index is the ratio 
between the decrease at follow-up and the initial 
.... during the procedure.,., net ........ at 
long·tenn --.. eharaderized by the --ty index, which is the ratio between the final 
gain in diameter at follow.gp and what theoreti~ 
eally ...,ld have been adUevecl. For !!Us.....,...., 
30 coronary artery lesions were selected from a 
consecutive series of successfully dilated primary 
angioplasty lesions and were matched with the 
ntial30 successfully- primmy --tomy lesions. Matclling by location of ......... 
and 1 efereuce diameter resulted in 2 comparable 
groups with identical prq:N: o :edural stenosis 
charaeteristics Att.e~~ e tomy resulted in an in· 
crease in minimal luminal diameter 2 times larg· 
er than angioplasty (1.53 vs 0.77 mm; p 
<0.0001). However, at foOow..up there was a 
significant decrease in minimal luminal diameter 
and a significant increase in percent diameter 
.sttenosis in the groups with athea ectonry and an--
gioplasty (1.69 ± O.SS vs 1.57 ± O.SS mm, 
p =not significant [NS], and 37 ± 18 YS 47 ± 
18%, p = NS, 1espeetiwel}'). The decrease in min· 
imalluminal gain was more pronouneed in the 
group with atherec:tomy than in that with angio-
plasty (0~ ± 0.69 vs 0.35 ± 0.51 mm; 
p = 0.0005). Consequently, directional atherec-
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Address for reprints: Patrick W. Serruys. MD, PhD, Catheteriza-
tion Labota.tocy, Tboraxcentcr, En!smus University Rotterdam, P.O. 
Box 173l3, 3000 DR Rotterd:un. the Nethc:rlands. 
tomy resulted in a significantly higher initial gain 
ratio than did baDoon angioplasty (0.84 vs 0.41, 
p <0.00001). At follow-up, restenosis and utility 
ratios were comparable in both groups (0.56 vs 
0 .. 62, p = NS, and 0.29 vs 0.23, p = NS, respec-
tively). In matched groups, directional atherec-
tomy is a very effective device with a substan-
tially better initial result than that with balloon 
angioplasty. However-, it appears to be a potent 
stimulator of the restenosis proces$y because at 
follow-up this initial favorable result is lost, and 
the minimal luminal diameter is comparable to 
that alter-angi-. Thus, the final 
utility of directional coronary atherectomy is not 
significantly different from that of conventional 
balloon ang;.plasty. 
(Am J Canfioi1991;68,1556-1SG3) 
R estenosis after conventional balloon angioplasty remai.ns the major limitation of this proce-dure.l-5 Despite extensive efforts to elucidate 
this phenomenon, our knowledge remains incomplete. 
In recent years studies have suggested that intimal hy-
perplasia is the major mechanism respons"ble for reste--
nosis6-9 and that lesion characteristics and regional flow 
dynamics influence this proliferative process.lO Because 
improved operator experience and a.ngioplasty tech-
niques have not caused a reduction in restenosis rates, 
interventional cardiologists have designed new devices 
aimed at debulking instead of dilating atherosclerotic 
plaque. Directional atherectomy is a new technique 
with the p:nential advantage of creating smoot:lllumi-
nal surface. However, early experience "With atherec-
tomy indicates that restenosis rates are comparable 
with those after conventional balloon angioplasty, al-
though a randonllzed study has not been initiated . l 1-l3 
Recently it has been demonstrated that the immediate 
results of atherectomy are superior to those achieved by 
balloon angioplasty 1~ whether this initial advantage 
can be maintamed during follow-up and may ultimate-
ly result in a reduction of the restenosis rate needs to be 
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assessed. Therefore. the present study was performed to 
determine whether this initial favorable result obtained 
with atherectomy affects the incidence of restenosis. 
METHODS 
Patient· group: From September 1989 through Jan-
uary 1991.66 patients underwent 74 atherectomy pro-
cedures. For the purpose of this study. the initial 30 
consecutive patients (23 men and 7 women. mean age 
±standard deviation 602 ± 10.1) who underv:ent an 
angiographically successful procedure (postprocedurnl 
diameter stenosis <50%. -..vith tissue retrieval) of a pri-
mary lesion in a native coronary artety were selected. 
At the time of atherectomy. 16 patients were in New 
York Heart Association functional class IV. 7 in III 
and 7 in II. Coronary angiography showed 1-vessel djs. 
ease in 25 patients.. 2-vessel disease in 4 and 3-vessel 
disease in L The site of obstruction was located in the 
left anterior descending coronary artery in 1 S patients.. 
the right coronary artery in 7 and the circumflex ar-
tery in 5. 
Athuec:toa•l) procedure: After ad.minjsu-ation of lo-
cal anesthesia. an 11Fr sheath was inserted in the fem-
oral artery. All patients received 250 mg of acetylsali-
cylic acid and 10.000 U of heparin intravenously. Intra-
coronary injection of isosorbide dinitrate was performed 
to optimally vasodilate the vesseL After initial angie-
grams in multiple views were obtained. a specialllFr 
guiding catheter was placed into the ostium of the coro-
nary artery. Under fluoroscopy. the guid.ev.ire was ad-
vanced in the distal part of the artery. Then.. the ather-
ectomy device was directed over the guidewire and po-
sitioned across the stenosis. The SUPJXlrt balloon was 
then inflated up to 0.5 atm. the cutter v.ras retracted 
and balloon inflation pressure was increased to 2 to 3 
atm. The driving motor was activated. and the rotating 
cutter was slowly advanced to cut and collect the pro-
~0~~=~ 
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truding atherosclerotic lesion in the collecting chamber 
located at the tip of the catheter. After every pass. the 
balloon was deflated and either removed or reposi-
tioned. On average. 6.7 ± 2.9 passes in multiple dll'ec-
tions were performed across a stenosis. Atberectomy 
-was considered successful when the residual stenosis 
-was <50% after tissue retrieval After atherectomy. the 
arterial and venous sheaths were usually left in place 
for 6 hours. Patients were monitored for 24 holliS.. and 
electrocardiograms and cardiac enzyme levels were ob-
tained twice daily. Nifedipine v•:as administered every· 2 
hours for 24 hours after the procedure. and the patients 
were administered aspirin for 1 year. 
Follow-up eYaluation: After successful atherectomy 
or angioplasty (i.e.. <50% postprocedural diameter ste-
nosis on v:isual. inspection). patients were examined at 
the outpatient clinic. The follow-up coronary angio-
gram was obtained within 2 weeks after an exercise 
test Angiography was performed earlier if symptoms 
occurred -..vithin 6 months. 
Quantitative coronmy angiography: Quantitative 
analysis of the coronary segments was performed -..vith 
the computer·based Coronary .Angiography Anal)'$ 
System (CA.t.S). previously described in detail. 4.S.IS.r6 
In essence. boundaries of a selected coronary artery 
segment. were detected automaticaDy from opticaDy 
magnified and ,ideo-digitized regions of interest (512 
X 512 pixels) of a cineframe. The absolute diameter of 
the stenosis in millimeters was determined using the 
guiding catheter as a scaling device. Each individual 
catheter was measured with a micrometer and used as 
a scaling device. Correction for pincushion distortion 
was performed. The computer-estimation of the origi-
nal dimension of the artery at the site of the obstruction 
was used to defme the interpOlated reference diameter. 
The percentage diameter and area Stenosis. as well as 
the cross--sectional area (mm2), were then calculated. 
CIJRVAT1JRE:;: 
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FIGURE 1. Graphic ilustndion of :d1:nosi$ paniiMten. obtained by quantit:atM coronary ana1y$is. Ld4 y axis ~ refer. 
enee ciameter, and vead iength is~ alon& x axis. ~diameter and k:$ion iength ane cletennimd by diametet" 
.at bounderies of lesion that are defined by c:ummre anatpi&.. Right. c:urvature analysis is desc:ribed. ~is defined by 
rate of change of an;1e thnlqgt.l whid:l tanpnt: of curve turns. and whieh tor a c:irc:le is equal to ~ of racliuiO (R). 
MLD = minimal luminal diameter. 
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The length of the lesion (mm) was determined from the 
diameter function on the basis of curvature analysis 
(Figure 1 ). Symmetry was defmed as the coefficient of 
the left~band distance between the reconstructed inter· 
JX)lated reference diameter and aCtUal vessel contours.. 
and the rigbt·hand ilistance between the reconstructed 
and actual contours at the site of the obstruction. Sym-
metry index· ranged from 0 (totally eccentric stenosis) 
to 1 (symmetric). The degree c:i coronary bend was 
assessed by the CUI'\'arute value at the obso:uction site. 
11ris parameter was computed as the average value of 
all individual curvature values along the centerline of 
the coronary segment, with curvature defined as the 
first derivative of the tangent as it moves along the cen· 
terline. which for a circle is equal to the reciprocal of 
the radius. The area between the actual and recon· 
so:ucted contours at the obstruction site was defmed as 
the area plaque (expressed in rom~). To standardize the 
method of analysis of the interventional and follow·up 
angiograms, the following measures were taken16: Flrst, 
the x·ray system was exactly p:lSitioned. as was noted 
at the time of the intervention. Second. all study frames 
to be analyzed were selected at end-dtastole to mini· 
mize foreshortening. Third. the investigator-determined 
beg:inrring and end point of a segment of a major coro-
nary artery were J:ientified according to the definitions 
of the American Heart AssociationY Fmally, Polaroid 
photographs were taken of the video image with the 
detected contours superimposed to ensure that the anal-
ysis was performed on the same coronary segments in 
consecutive angiograms. Patients with balloon angio-
plasty were enrolled in ongoing restenosis trials, and 
therefore, according to the protocol, systematically re--
ceived intracoromuy nitroglycerin before and after an· 
gioplasty. and during follow-up catheterization, where· 
(mm) 
FIGURE 2. ~ i!lbstra5on of principle of initial cain, re-
stenosis and utiity inOexes. lnitiaJ pin index is ~
by the nrtio B/A. n:st.erlosis index by CIB, and utiily index by 
D/A. A= maximal adlievable ~in minimal: luminal&.. 
.wneter (MLD); B =pin in MLJ) daring proc:edare; C = redue-
tion during~; D "' long--t.:nn reRIII; RD = re1era1ce &.-
......... 
as patients with atherectomy were less frequently ad-
ministered intracoronary nitroglycerin at recatheteri· 
zation. 
Restenosis: Two different criteria were used to de-
fine the restenosis rate. We have found a change in 
minimal lumen diameter ;;:0.72 mm to be a reliable 
indicator of angiograpbic progression of vessel narrow· 
ing. 4•15.16 11ris value takes into account the limitations 
of coronary angiograpbic measurements and represents 
the long-term variability for repeat measurements of a 
coronary stenosis using CAAS. The second criterion for 
restenosjs chosen was an increase in the diameter sreno-
si; from <50% after intervention to ~50% at follow· 
up. This criterion \1135 selected because clinical practice 
continues to assess lesion severity by percent stenosis. 
Aq e 1 s uent of initial gain. restenosis and utility ra-
tio: To compare the relative efficacy of various inter· 
ventional techniques, it is critical to relate the procedur~ 
al outcome and changes during follow.up to the maxi-
mal achievable result. Therefore we propose the use of 
the aforementioned ratios in the evaluation of intracor· 
onary interventions. Briefly, quantitative angiographic 
changes after intracoronary intervention may be divid-
ed in 3 stages (Flgure 2). The fJrSt or -operational 
stage.~ is characterized by the interaction of the opera-
tional device with the lesion. In becoming operational 
the diameter of the device may expand (directional ath-
erectomy. balloon. stent) or maiD.tain its original di-
mensions (laser, transl.uminal extraction catheter, rota-
tional ablation)_ During this stage, the maximal effect 
of the device is achieved and determines to what extent 
the :arinimalluminal diameter may be increased. The 
initial gain index represents the ratio between the 
achieved luminal and maximal achievable lum.inal im-
provements (reference diameter minus minimal lumen 
diameter (MLD) before intervention), and is described 
by the follov.ing equation: initial gain index: change in 
MLD at intervention/reference diameter - :Ml.D be-
fore intervention. The initial gain index ranges from 0 
(no effect) to I (no residual stenosis). The second stage 
or -restenosis stage" begins during follow-up when bio-
logical prOCeSSeS determine the extent of intimal hyper· 
plasia ultimately leading to a loss of l1lllllnal gain. 
The restenosis index represents the ratio of decrease 
in luminal diameter improvement during follow·up and 
the achieved changes induced by intracoronary inter· 
vention, and is described by the following equation: re-
stenosis index: MLD after intervention - MLD follow-
up j change in MLD at intentention. The :restenosis in-
dex ranges from 0 (initial benefit intact) to 1 (initial 
benefit completely lost). · 
The utility index represents the ratio of the net gain 
in lumen improvement at follow-up and the maximal 
achievable luminal improvement. and is described by 
the following equation: utility index: change in MLD at 
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intervention - change in MLD at follow-upjreference 
diameter - MLD before intervention. The utility index 
ranges from 0 (no utility) to 1 (perfect result). 
Matching process: The coronary artery tree was 
subdivided in 15 segments accordmg to American 
Heart Association guidelines. IS and the lesions were in-
dividually matched according to stenosis location and 
reference diameter. The principles of matching are 
threefold: the angiographic dimensions of matched le-
sions are assumed to be 'identicaL" the observed differ-
ence between the 2 'identical" lesions must be 'Nithin 
the range of CA..AS reprod.ucr.Oility of 0.1 mm (l stan-
dard deviation).5 and finally. the reference· diameters of 
the matched vessels are selected ·within a range of ± 
03 mm (3 standard deviatio~ 99% confidence limits). 
To assess the immediate result of atherectomy and bal-
loon angioplasty. 30 coronary artery lesions were select-
ed by an independent technician (EMvS) from a con-
secutive series of successfully dilated balloon angio-
plasty lesions while complying 'Nith the selection criteria 
of matching. At the time of selection. the investigators 
were unaware of the 6-month angiographic outcome of 
these lesions. Matching was considered adequate if the 
mean difference of the reference diameter between 
the groups equaled 0 with standard deviation <0.3 
mm.t9 Currently. the Thoraxcenter angiographic data-
base contains quantitatively assessed stenosis data for 
2.300 patients treated with either angioplasty (n = 
1847). intracoronary stenting (n = 406). or directional 
or rotational atherectomy (n = 120). 
statistical analysis: All values are expressed as 
mean ± 1 standard deviation. Comparisons of the se-
verity of minimal luminal diameter. area plaque. dia-
meter stenosis. curvature value symmetry index and 
length between the groups were performed using anal-
ysis of variance and the unpaired Student's t test. 
Differences were considered statistically significant at 
p <0.05. 
RESULTS 
Preprocedw:al stenosis characteristics of the 
matched patients are listed in Table L Matching for 
stenosis location and reference diameter resulted in 
groups of patient with comparable severity of lesions. 
Matclring was considered adequate because the refer-
ence diameter was equal in both groups (3.03 ± 0.57 vs 
3.07 ± 0.55 mrn; p =not significant), whereas the 
mean dill"erence for this parameter between the groups 
was 0.0 rnm (standard deviation 0.2 mm). Preproce. 
dural minimal luminal diameter in the groups with ath-
erecromy and angioplasty were LOS ± 0.37 and 1.15 ± 
0.36 mm. respectively. The other stenosis parameters 
(diameter stenosis., area plaque. symmetry index and 
length) did not differ significantly, with the sole excep--
tion of curvature value. which was lower in the group 
TABLE I Matched Preprocedural Stenosis Characteristics of 30 
Patlerrts with Successful Cor-mary Atherectomy Compared with 
Successful &llloon Angioplasty 
Before Before 
Amerectcmy Angioplasty 
Reterencedlameter Cmml 3.03;:;. 0.57 3.07;:;. 0.55 
Minimal lumina: dlametllr 1.08;:;. 0.37 US: C.36 
(mm) 
Qjameter stenos~ {%) 64: 10 63 = 8 
AI"(!Zl pla~ue (mmZJ 9.5 = 6.4 8.4::::3.6 
Curvaturev.llue 15.9 = 7.0 22.2 = 13.1-
Symmetry index 0.6 = 02 0.5 = 0.3 
l """' 6.8 = 2.7 6.5 = 2.6 l •p <0.02. 
! TABLE II Quantitative Comparison of the Immediate and 
Long-Term Results of Atherectomy and Balloon Angioplasty 
(n = 30) 
Unpaired 
Atherectomy Ar.giopla~ 
""' Reference d•ameter 
(mmJ 
P• 3.03:::: 0.57 3.07::::0.55 NS 
Po:;~: 324 = 0.32 3.09:::: 0.56 
" Follow-up 2.81:::: 0.57 3.04 = 0.65 NS
Minimal lumina: 
~Jametllr(mm) 
P• 1.08 = 0.37 us = 0.36 
" Pott 2.61 = 0.33 1.92 = 0.31 0.0000 
FollOW•Up 1.59;:;. 0.58 1.57 = 0.58 
" Dtflerence m mlntmal 
luminal diameter (mmJ 
Post to pre 1..53::::0.47 0.77 = 0.30 0.0000 
Post to follow-up 0.92 = 0.69 0.35 = 0.51 0.0005 
Dlameters-.enosis C%) 
'" 
64:::: 10 63:::: s 
" 
'"' 
19 = 9 37 = 10 0.0000 
FoiiOW·UP 37 = 18 47 = 18 0."' 
Difference in diameter 
:r:enosls(%) p,___ 45 = 1:2 :26 = 12 0.0000 
Follow-up-po:>t 18 = 17 10 = 17 
" 
with atherectomy than in that with angioplasty (15.9 ± 
7.0 vs 22.2 ± 13.1: p <0.02). 
The immediate efficacy of atherecoomy and angio-
plasty as assessed by quantitative angiography is shown 
in Table TI and FJ.gJJte 3. As expected. both atherec-
tomy and balloon angioplasty significantly improved 
minimal. luminal diameter (LOS ± 0.37 to 2.61 ± 0.33 
mm [p <O.(XJ011 and 1.15 ± 0.36 to 1-92 ± 0.31 mm 
[p <0.0011 respectively). but the increase in minimal 
luminal diameter was superior in the group with ather-
ectomy than in that 'Nith angioplasty (1.53 vs 0.77 mrn; 
p <0.0001 ). Accordingly, the initial gain ratio of ather-
ectomy was also superior when compared with that of 
angioplasty (0.84 ± 0.36 vs 0.41 ± 0.18~ p <0.00001). 
Thus. percent diameter stenosis was reduced from 64 ± 
10 to 19 ± 9% (p <O.OOCll) in the group with atherec-
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TABLE Ill Quantitative Assessment of Initial Gain, Restenosls 
and Utlllty Ratios After Atl1erectomy and Balloon Angioplasty 
(n "'30) 
Unpaired 
Atherector1y Ang.opJasty 
""' lnitJal g3ln rano 0.$4:::: 0.36 0.41 = 0.18 0.0000 
Reste~os;s ratJo 0.56 = 0.55 0.62 = 1.10 NS 
Ub"Hty ratto 029 = 0.33 0.23 = 028 NS 
NS- nQt Slg!HIJcaot. 
tomy, and from 63 ± 8 to 37 ± 10% (p <0.001) in the 
that \\ith angjoplasry. 
At follow-up. all patients v.i.th atherectomy and an-
gjoplasty included in this study underwent 6-month 
control catheterization. Angjographic follow-up in the 
groups with atherectomy and angjoplasty were 95 and 
92%. respectively . .Angiographic analysis at follow-up 
(Table II and Figure 4) showed a decrease in minimal 
luminal diameter in both groups (2.61 ± 0.33 tO 1.69 
± 0.58 mm v.ith atherectomy. 1.92 ± 0.31 to 1.57 ± 
0.58 mm with angioplasty ). Thus, the loss in minimal 
luminal diameter was more pronounced in the group 
with atherectomy than in that with angioplasty ( 0.92 ± 
0.69 vs 0.35 ± 0.51 ~ p <0.0005). Accordingly. 
percent diameter stenosis increased from 19 ± 9 to 37 
± IS% in the group with atherectomy, and from 37 :: 
10 to 47 ± 18% in that with angioplasty. The concomi-
tant restenosis and utility ratios are listed in Table ill 
Percent restenosis (detectable hyperplasia by quantita-
tive coronary analysis) according to the 0.72 mm de-
crease in minimal luminal diameter (2 times the stan-
dard deviation of the long-term variability of the mini-
% (N•30 LESIONS) 
100 
90 ' 
so Pre Post 
70 FIGURE3. ~ frequenqt of im-
60 medilrte resutt& of direc:tional ~ (DCA) and balloon~ (PTCA) in 
50 30 matched k:llion5. Directional atberec:-
torn)' Jautted ill an increase in minimal lu-
40 minal ~ (MLD) from 1.0S to 2..61 
30 
mm, whereas~ induced an in-
cteaR from 1.15 to 1.92 ttWIL Post "' 
20 I-DCA 
~ into ueutiou; ~ = before inb:rven-
.... 
. ···· PTCA 
0.5 1.5 2 2.5 3 3.5 4 
MLD (mm) 
% 
100 
(N•30 LESIONS) 
90~ 
sol Pre F-up I 
701 ' ' 
60r FIGURE 4. Cumcdatnre frequency of ion&· 
50~ term resalts of directioaal ati&U «::tucn)' and angioplasty in thi$ matched pOpUia-
lll 
tion.. At 6-monaz folowq~~ (F-cJP), iMial 
taYorabfe. re=Utof atiiCiecloiol)' is lost 
compared witb tflat of balloon ang)oplasty. 
I-DCA 
Other abbtcuia5ow as. in F"cure 3. 
PTCA 
0 0.5 1 1.5 2 2.5 3 3.5 4 
~LD (mm) 
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mal luminal diameter measurements using CA.AS cri-
terion) was 60% in the group v,.ith atherectomy versus 
36% in that with angioplasty. Vv'hen restenosis is de-
fmed by an increase in diameter stenosis <:::50% at fol-
low-up. the restenosis percentages are 20 vs 16% (ath-
erectomy .vs angioplasty). 
DISCUSSION 
Coronary angioplasty is now an accepted form of 
treatment for patients with coronary artery disease.. In 
the past, exponential growth in angioplasty has panly 
been the result of an increase patients returning with 
restenosis. Despite extensive efforts to improve catheter 
equipment we are still unable to effectively reduce 
the rate of restenosis.. Because no fundamental design 
changes in balloon or balloon-derived catheter tech-
niques are emerging. debulking techniques. such as di-
rectional atberectomy. have been introduced to improve 
the angioplastic process and to presumably reduce the 
rate of restenosis. The potential advantages of debulk-
ing atberomatoU<> tissue over remodeling plaque with 
balloon angioplasty include: m.inimizing smooth muscle 
cell injury by wall stress. eliminating smooth muscle 
cells and thereby reducing their proliferative potentiat 
improving regional blood flow and rheology by indue· 
ing fewer fissures or dissections: reducing radial stretch 
forces. as applied with a dilating balloon: and creating 
larger increases in m.irrimal luminal diameter. Indeed, 
recent studies have reported a larger increment in lumi-
nal improvement after atherectomy than after conven-
tional balloon angioplasty,l4 whereas other investigators 
observed a low incidence of postproced:ural dissec-
tions.ll.l2.14 
Study design: \Vhether atherectomy is superior to 
balloon angioplasty c:an only be assessed by a random-
ized study. This type of study would take several years. 
during which continuing refinements and improvements 
of catheter systemS would take place. rendering the 
comparison unreliable and open to criticism. Therefore. 
we proposed a matching technique based on stenosis 
location and reference diameter to compare the results 
of various intracoronary interVentional techniques. At 
present. this technique may be the best surrogate for a 
randomized trial when one tries to compare the short-
and long-tenn results of atherectomy with those of con-
ventional angiopl.asty. Using our matching program we 
selected comparable stenotic lesions with respect to 
baseline characteristics (minllnalluminal diameter. di-
ameter stenosis. length. area plaque and symmetry in-
dex) as assessed by quantitative angiography. This 
study group reflects the baseline stenosis characteristics 
in patients treated with atherectomy-"'0 or balloon angio-
plasty:~.:.l 
Immediate results: This study confums previous re-
ports of improved luminal gain after atherectomy com· 
pared with that after conventional angi.oplasty.1.:. Ather-
ect:omy resulted in a t\l.'ofold increase in minllnallumi-
nal diameter (1.09 ± 0.37 to 2.61 ± 0.33 mm) 
compared with that with angioplasty (1.15 ± 0.36 to 
1.92 ± 0.31 mm). Accordingly. percent diameter ste--
nosis decreased more dramatically after atherectomy 
than after angioplasty. This improvement in luminal 
gain with atherectomy may be due to 3 mechanisms. 
First. introduction of the bulky device itself causes a 
lumen enlargement due to the .. Dotter~ effect. Second. 
the subsequent inflation of the support balloon may 
lead to further enlargement by stretching of the vessel 
wall Fmally. excision of the plaque determines the final 
result. 
Restenosis: Recurrence of a stenosis after intracoro-
nary interVention may be assessed by clinical symp--
toms.. stress testing or coronary angiography. Because 
symptoms and functional achievement at exercise test-
ing have low predictive values in regard to restenosis. 
diagnosis of restenosis should be based on reproducible 
quantitative angiograpbic measurements using a com-
puter-assisted technique with either automated edge de--
tection or videOO.ensitometry. Furthermore. the defmi· 
tion of restenosis is a matter of ongoing debate. It has 
been shown by our investigative group.4.:.2 as well as by 
others..3 that the determination of the severity of steno-
sis using percent diameter stenosis does not reflect 
changes after angioplasty. because the adjacent pan of 
the dilated vessel may also be involved in the restenosis 
process. or the reference diameter may be s.im.ulta-
neously reduced. Therefore, we selected minimal Ju. 
minal diameter as a parameter for the morphologic 
changes after atberectomy or angioplasty. !vfinimallu-
m.inal diameter at follow-up was 1.69 mm for the group 
with atherectomy compared with 1.57 mm for that 
with balloon angioplasty (p = not significant). These 
findings are similar to previously documented late fol· 
low-up studies of coronary balloon angi.oplasty (1.69 to 
1.82 mmf and stenting (1.68 mm).23 Using the ~50% 
diameter stenosis criterion. the r:ues of restenosis after 
atherectomy and angiopl.ast:y were 20 and 16%. respec--
tivdy. Preview; studies on restenosis after primary coro-
nary atherectomy reponed an incidence of restenosis of 
20%11.1:. using the <:::50% criterion.. Thus.. during fol· 
low·up. the initial greater gain in luminal diameter af-
ter atherectomy compared with that after balloon angi-
oplasty is totally lost.. At follow-up. the reduction in 
rn.icimalluminal diameter was 0.92 mm after atherec-
tomy compared \\':ith 0.35 mm after angioplasty (p = 
0.0005)_ Although mimmallumfual <fuuneter changed 
more dramatically in the group with atherectomy than 
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in that with angioplasty. both had equal restenosis 
(0.56 vs 0.62: p =not significant) and utility (0.29 vs 
0.23; p =not significant) ratios. indicating that the rel-
ative changes are equal for both interventional tech-
niques. 
A..nim.aJ. and atherectomy studiesll-13.20 have dem-
onstrated that fibrointimal hyperplasia may develop in 
coronary arteries previously treated by balloon angio--
plasty or atherectomy. Pathologic findings have raised a 
theory that deeper vascular injury is associated with a 
greater intimal proliferation. Injury beyond the subinti-
mal level bas been sho'WD. to be associated 'With more 
extensive intimal proliferation. 24 These data are sup-
ported by Webster et alzs who found a greater smooth 
muscle proliferation after high-inflation pressure with 
the same balloon size when compared with that after 
low pressure. Furthermore. an initial follow-up study 
after atherectomy indicates that this process may be 
accelerated when deep vessel wall components such as 
media and adventitia are removed. 13 .Auiditionally, ath-
erectomy may lead to profound disrupture of the vessel 
wall architecture. 26 Fmally. the introduction of the 
bulkier atherectomy device may p:>tentially lead to a 
greater amount of vessel wall stretching compared with 
that with the smaller balloon catheter system. All these 
influences may account for the greater cellular prolifer-
ation of the lesion treated by atherectomy. 
Study limitatioGm:: There are several limitations to 
this study. First. it is an uncontrolled. observational 
study limited to a subset of patients with successfu1 cor-
onary atherectomy or balloon angioplasty. This consec-
utive series of patients were studied by investigators 
unaware of the late angiograpbic results. Although 
matching for angiograpbic variables is a promising 
technique to assess the efficacy of intracoronary inter-
ventions., patient- and procedure-related variables are 
not included in the analysis. Second,. lesion complexity 
was not incorporated in the analysis. This is usually de-
fined qualitativelyZ7: however, an objective and quanti-
tative description of stenosis morphology has recently 
been introduced. 28 Further improvement in quantitative 
analysis may assess lesion morphology in a continuous 
scale fashion rather than assigning lesions to discrete 
categories. This type of analysis should be incorporated 
in future trials studying the efficacy of various interven-
tional techniques. Third. this study is based on early 
experiences with atberectomy. Careful patient selection. 
future design changes and improved operator experi-
ence may further improve the immediate and long-term 
results. Thus.. controlled clinical trials are needed in the 
future to determine the immediate angiograpbic results 
and long-term efficacy of these interventions. as well as 
the b:nefit.. if any, to particular subgroups of patients. 
These studies should also address the presumed time 
frame for restenosis after any particular intervention. 
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Chapter12 
Restenosis Index: a new concept for the evaluation of the 
restenosis process 
(in preparation) 
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Comparative index for assessing the results of interventional devices 
in coronary angioplasty. 
Introduction 
KJ Beatt, PW Serruys, 
Charing Cross and Westminster Hospital, London 
and Thoraxcenter, Rotterdam. 
The limitations of balloon coronary angioplasty and the clinical, scientific and commercial pressures to 
provide more effective means of non·surgical revascularisation have led to the development and 
evaluation of an increasing number of new devices (1-11). In the past 3-4 years these devices have 
been introduced into clinical practice in the hope that they will be shown to improve the outcome of 
conventional balloon angloplasty, by achieving a better immediate result, reducing the acute 
complication rate, and perhaps most importantly by reducing the impact of restenosis on the long term 
outcome of patients undergoing the procedure. They have been designed to incorporate one of two 
principles pertinent to the long term success: debulcking to produce a sufficiently good result to more 
than compensate for the normal restenosis process. or alternatively by dilating the the stenosis in 
such a way that that the stimulus for restenosis will be minimised (12). 
It has not always been possible to define clearly the utility of these devices and to place them 
accurately in the spectrum of angioplasty armamentarium. In the past our attempts at accurate 
evaluation were hampered by a lack of understanding of our measurement systems for assessing 
nrestenosisH. The realisation that the restenosis process has a Gaussian population distribution, has 
exposed many of our past efforts as being inaccurate and even misleading and has explained why 
some the early expectations have not been realised (13-14). 
The most effective way to assess these devices would be to conduct well controlled clinical trials 
designed to compare each individual device, not only with balloon angioplasty but also to each new 
device as it becomes available. This is clearly not practical in the early evaluation stage and 
experience has shown that these trials take many years to organise and perform, by which time the 
device and related techniques have been further refined so that the results produced may no longer 
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be regarded as revenant. In the absence of such accurate data a new index is proposed which will 
allow the comparison of the devices by the use of quantitative angiographic measurements. This index 
addresses the problem of the relationship between what is achieved at angioplasty and the restenosis 
process. 
Rationale for indices 
Resent studies have shown that the "restenosis process" is influenced by the angioplasty procedure 
and in particular there is increasing evidence that the magnitude of improvement in the minimal 
luminal diameter at the time of angioplasty is the factor that most influences the degree of restenosis. 
This so called "paradox of restenosis" means that by focusing on the ability to improve the immediate 
result the more important long term outcome may be compromised by a more aggressive restenosis 
response (15). This has particularly important implications in the assessment of new devices which 
have been promoted on their ability to improve the immediate results of the procedure; whether this 
benefit is maintained in the long term remains in some doubt, with the suggestion a more aggressive 
restenosis responsive with some of the devices (16-17}. 
It is unclear whether some of the new devices used clinically exert any potential additional benefit 
over balloon angioplasty, and clearly if we are to adopt more expensive and complicated techniques 
then it is important to have direct comparative information. In the absence of controlled clinical trials 
this comparative information is unlikely to become available in the near future. It is therefore useful to 
have some method of making comparisons and in particular to relate the outcome to the ~gold 
standard of conventional balloon angioplasty.Q 
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Fig 1 
Dilating 
index 
0.68 
0.45 
Restenosis 
Index 
0.32 
0.73 
0.33 
0.66 
0.4 
Uti/iry 
Jnclex 
0.68 
027 
0 
0.45 
0.27 
0.27 
Shown are a number of possible outcomes of a vessel with a 69 % diameter stenosis (minimal luminal diameter= 1nun. 
vessel size= 3.2 mm) The outcomes from the initial dilatation are: 
no residual stenosis. dilating index"' 1 
16% diameter stenosis. dilating indices"" 0.68 
31% diameter stenosis. dllating index= 0.45 
A selection of possible outcomes at follow-up ranging from 16% to 69%. The relevant restenosis indices and utility 
indices are shown. It can be seen that whatever the initial result a final residual stenosis of 50% gives a utility index of 
0.27, whereas a return to a 69% stenosis gives a utility ofO. 
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Current Restenosis Criteria 
ln the past clinicians have tended to assess and document the acute results of angioplasty 
inaccurately with what can now be regarded as rather crude methodology. The most widely accepted 
definition of success has been a > 50% diameter stenosis with many reports offering no more 
discriminating documentation than this {degree of improvement, final post-PTCA stenosis). The long 
term result has in general been more carefully documented, but in general the concept of "resteoosis" 
being an all or nothing process has favoured a ~cut-off" point (> 50% diameter stenosis) so that often 
the distnbution of change within the population is not documented. Detailed analysis ,using 
quantitative angiography, has shown that any potential benefit of some of the new devices is likely to 
be achieved at the time of the procedure and may be at the expense of stimulating the restenosis 
process (12). 
It therefore seems logical to split the dilating effect and the restenosis process, so that the mechanism 
by which the device exerts its beneficial effect is fully realised. This can not be done without taking 
into account the fact that the severity of the initial stenosis and the acute gain influence the long term 
outcome and therefore the utility of the device. 
Dilating Index: 
This index is based on the assumption that if all the plaque is removed then the result is optimal. It is 
important to have some assessment of the how effective a particular device is at improving the luminal 
diameter of the artery. This is descnbed by the following equation: 
Change MLO at PTCA 
Dilating index - -,.,--:.:CC""="-7~:.:.._'-';~= (Vessel size - MLO pre PTCA) 
Index range: 0 (no effect) ~> 1 (perfect). 
Restenosis Index: 
This is designed to reflect the orestenosis process" and essentially assess the loss of the initial gain at 
long term follow-up. It is the ratio of the change in minimal luminal diameter from immediately post 
angioplasty to follow-up and the change in diameter at angioplasty. It is expressed by the following 
equation: 
Restenosis index = (MLD post PTCA - Change MLD at Follow- up) 
Change MLD at PTCA 
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Index range: 0 (perfect) -> > 1 (poor) 
Utility Index: 
The overall utility index is designed to give an assessment of the residual stenosis at follow-up in 
relation to the original stenosis prior to the procedure. It addresses the question of, "How effective is 
the device at improving the lumen of the vessel and maintaining this improvement at long tenn follow-
up." It is expressed by the following equation: 
Utility I index- (Change MLD at PTCA- Change MLD at follow-up) 
(vessel size - MLD pre PTCA) 
Index range: 0 (no utility) -> 1 (perfect) 
[MLD = minimal luminal diameter, PTCA =coronary angioplasty.] 
fiill Boolloon angloplaety 0 Solf ~ndlng ctenl 
,_, 
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Indices 
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Balloon angioplasty Self expanding stent 
·r--------------------------------:-
3 
Fig3 
Shown are the changes in the minimal luminal diameters during and post angioplasty for the populations 
shown in Figure 2. The filled circles represent 1he mean reference diameter for the respective populations. 
CONCLUSION 
The uses of the three indices seem to reflect the changes occurring in the vessel lumen. 
In the absence of more direct comparisons the proposed indices provide a means of comparing the 
short and long term benefits of new interventional techniques that are being introduced to improve on 
the results of conventional balloon angioplasty 
Comparisons in this way should help to reduce the misinformation that seems to accompany the 
introduction of the new devices, and will allow the resources to be directed towards those areas which, 
at an early stage are shown to be the ones with the most promise. 
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Summary 
Percutaneous transluminal coronary angioplasty has made an important impact on the 
treatment of coronary artery disease. It has become an alternative to coronary bypass 
grafting as a revascularisation procedure for coronary artery disease, and for the past 
decade, each year there has been a greater degree of acceptance within the cardiological 
community as to the indications for the procedure and the benefrts of it. 
Our understanding of the acute compncations has also improved, but progress in the field of 
restenosis, which can be regarded as the principal limitation of the procedure. has been 
disappointing. A reduction in the restenosis rate by as little as 25% would have enormous 
implications for the treatment of coronary artery disease. It would lead to an expansion in 
indications resulting in angioplasty becoming the main revascularisation procedure, while 
greater reductions in the restenosis rate would have important implications in the area of 
secondary prevention resulting in an even greater demand for the procedure. 
The thesis deals entirely with the assessment of coronary anatomy by quantitative 
angiography, and while developing the technique for the assessment of restenosis it also 
points out the limitations of the technique. By not paying sufficient attention to fundamentals 
of clinical measurement, such as variability, precision and predictability, we have followed the 
same path that many other systems for assessing disease severity have trodden before us. 
The lessons learned in dealing with this relatively new clinical problem should be applied to 
other areas of clinical medicine. 
The fundamentals of the restenosis process are not addressed. Rather the methods of 
assessing restenosis developed and some solutions to the uncertainties that have 
surrounded the topic in confusion have been put forward. The limitation in using a categorical 
approach for the assessment of restenosis is understood and developed is an alternate 
methodology for the assessment of the process. This methodology can be applied equally 
well to the new era of angioplasty as it has been to conventional balloon angioplasty. One of 
the major problems recognised at the beginning of these studies was the failure of the 
cardiological community to adopt a standardised methodology for the comparison of acute 
angioplasty results and the restenosis process. In this respect some progress has been 
made, and although there has been much controversy over the past flve years, there ·Is now 
broad agreement on both sides of the Atlantic that the arguments developed in this thesis are 
relevant to any assessment of the post-angioplasty patient, and are mandatory for any study 
critically addressing the problem of restenosis. 
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Current arguments regarding the best methods for assessing and comparing the newer 
generation of interventional devices are unresolved. It is expected that the Dilating, restenosis 
and Utility Indices with time will become as accepted as the other concepts derived from the 
these studies. These together with a more standard approach for reporting the early results 
so that potential problems have to be addressed rather than hidden will benefit our patients 
and the development of the field. 
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